0001437749-11-005505.txt : 20110805 0001437749-11-005505.hdr.sgml : 20110805 20110805114841 ACCESSION NUMBER: 0001437749-11-005505 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20110630 FILED AS OF DATE: 20110805 DATE AS OF CHANGE: 20110805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA PRO TECH LTD CENTRAL INDEX KEY: 0000884269 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 631030494 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15725 FILM NUMBER: 111013000 BUSINESS ADDRESS: STREET 1: 60 CENTURIAN DR STREET 2: SUITE 112 CITY: MARKHAM ONTARIO CANA STATE: A6 BUSINESS PHONE: 9054790654 MAIL ADDRESS: STREET 1: 60 CENTURION DR STREET 2: STE 112 CITY: MARKHAM ON STATE: A6 FORMER COMPANY: FORMER CONFORMED NAME: BFD INDUSTRIES INC DATE OF NAME CHANGE: 19930328 10-Q 1 alphaprotech_10q-063011.htm FORM 10-Q alphaprotech_10q-063011.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 10-Q

 
Quarterly Report pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the Quarterly Period Ended June 30, 2011
 
 Commission File No. 01-15725
 
Alpha Pro Tech, Ltd.
(exact name of registrant as specified in its charter)
Delaware, U.S.A.
63-1009183
(State or other jurisdiction of incorporation)
(I.R.S. Employer Identification No.)
 
 Suite 112, 60 Centurian Drive      L3R 9R2
 Markham, Ontario, Canada      (Zip Code)
 (Address of principal executive offices)      
                                                                                                          
Registrant’s telephone number, including area code:  (905) 479-0654
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes _X_ No ___
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes _X_  No ___
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).
 
Large accelerated filer___    Accelerated filer ___   Non-accelerated filer __ Smaller Reporting Company_X_
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ___   No _X_
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class       Outstanding July 29, 2011
 Common Stock, $0.01 par value        22,437,616 shares
     
                                                                                                                
 
 
 
 

Alpha Pro Tech, Ltd.
 
Table of Contents
 
 
       Page No.
PART I.  FINANCIAL INFORMATION  
       
ITEM 1.  Financial Statements  
       
  a)  Consolidated Balance Sheets (Unaudited)  2
       
  b)  Consolidated Income Statements (Unaudited)  3
       
  c)   Consolidated Statements of Shareholders’ Equity (Unaudited)  4
       
  d)  Consolidated Statements of Cash Flows (Unaudited)  5
       
  e) Notes to Consolidated Financial Statements (Unaudited)  6
     
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   14
     
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk   22
     
 ITEM 4. Controls and Procedures   22
       
PART II. OTHER INFORMATION  
       
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds   23
       
ITEM 6. Exhibits  
       
SIGNATURES  25
       
EXHIBITS  26
      
 
 
 
 
 
Alpha Pro Tech, Ltd.
 
 
PART I.  FINANCIAL INFORMATION
 
 
ITEM 1. FINANCIAL STATEMENTS
 
 
Alpha Pro Tech, Ltd. (“Alpha Pro Tech” or the “Company”) prepared the following unaudited interim condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been omitted pursuant to these rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.
 
You should read the following unaudited interim condensed consolidated financial statements and the accompanying notes together with the Company’s current year filings on Form 8-K,current year filing on form 10-Q,as well as the Company’s Annual Report on Form 10-K for the year ended December 31, 2010 filed with the SEC.  The Company’s 2010 Annual Report contains information that may be helpful in analyzing the financial information contained in this report and in comparing its results of operations for the three and six months ended June 30, 2011 with the same periods in 2010.
 
 
1
 
 
 
Alpha Pro Tech, Ltd.
 
 
Consolidated Balance Sheets (Unaudited)

   
June 30,
2011
   
December 31,
2010 (1)
 
             
Assets
           
Current assets:
           
Cash and cash equivalents
  $ 6,431,000     $ 5,316,000  
Accounts receivable, net of allowance for doubtful accounts of $62,000 at June 30, 2011 and $77,000 at December 31, 2010
    5,706,000       3,816,000  
Inventories
    15,120,000       17,318,000  
Prepaid expenses and other current assets
    3,559,000       3,719,000  
Deferred income taxes
    443,000       443,000  
Total current assets
    31,259,000       30,612,000  
                 
Property and equipment, net
    3,832,000       4,162,000  
Goodwill
    55,000       55,000  
Intangible assets, net
    144,000       164,000  
Equity investments in and advances to unconsolidated affiliates
    2,175,000       1,941,000  
Total assets
  $ 37,465,000     $ 36,934,000  
                 
Liabilities and Shareholders’ Equity
               
Current liabilities:
               
Accounts payable
  $ 620,000     $ 487,000  
Accrued liabilities
    469,000       296,000  
Total current liabilities
    1,089,000       783,000  
                 
Deferred income taxes
    639,000       639,000  
Total liabilities
    1,728,000       1,422,000  
                 
Shareholders’ equity:
               
Common stock, $0.01 par value, 50,000,000 shares authorized, 22,327,855 and 22,424,285 issued and outstanding at June 30, 2011 and December 31, 2010, respectively
    223,000       224,000  
Additional paid-in capital
    23,538,000       23,504,000  
Retained earnings
    11,976,000       11,784,000  
Total shareholders’ equity
    35,737,000       35,512,000  
Total liabilities and shareholders’ equity
  $ 37,465,000     $ 36,934,000  
 
(1)
The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date.
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
2
 
 
 
Alpha Pro Tech, Ltd.
 
 
Consolidated Income Statements (Unaudited)

   
For the Three Months Ended
June 30,
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net sales
  $ 10,278,000     $ 11,221,000     $ 19,223,000     $ 22,850,000  
                                 
Cost of goods sold
    6,407,000       7,000,000       12,079,000       13,640,000  
                                 
Gross profit
    3,871,000       4,221,000       7,144,000       9,210,000  
                                 
Expenses:
                               
Selling, general and administrative
    3,296,000       3,518,000       6,678,000       7,302,000  
Depreciation and amortization
    206,000       218,000       449,000       426,000  
                                 
Income from operations
    369,000       485,000       17,000       1,482,000  
                                 
Other income:
                               
Equity in income of unconsolidated affiliates
    107,000       99,000       234,000       172,000  
    Net gain on sales of assets
    -       -       41,000       -  
    Interest, net
    9,000       5,000       15,000       15,000  
                                 
Income before provision for income taxes
    485,000       589,000       307,000       1,669,000  
                                 
Provision for income taxes
    181,000       217,000       115,000       611,000  
                                 
Net income
  $ 304,000     $ 372,000     $ 192,000     $ 1,058,000  
                                 
Basic net income per share
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  
                                 
Diluted net income per share
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  
                                 
Basic weighted average shares outstanding
    22,427,403       22,424,285       22,431,009       22,423,788  
                                 
Diluted weighted average shares outstanding
    22,427,403       22,869,037       22,431,009       23,019,380  
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
3
 
 

Alpha Pro Tech, Ltd.
 
 
Consolidated Statements of Shareholders’ Equity (Unaudited)

   
Common Stock
                   
   
Shares
   
Amount
   
Additional
Paid-in
Capital
   
Retained
 Earnings
   
Total
 
Balance at December 31, 2010     22,424,285     $ 224,000     $ 23,504,000     $ 11,784,000     $ 35,512,000  
Share-based compensation expense     -       -       146,000       -       146,000  
Common Stock repurchased  & retired     (109,763 )     (1,000 )     (128,000 )     -       (129,000 )
Stock options exercised     13,333       -       16,000       -       16,000  
Net income     -        -       -       192,000       192,000  
Balance at June 30, 2011     22,327,855     $ 223,000     $ 23,538,000     $ 11,976,000     $ 35,737,000  

The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
4
 
 
 
Alpha Pro Tech, Ltd.
 
 
Consolidated Statements of Cash Flows (Unaudited)
 
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
 
Cash Flows From Operating Activities:
           
Net income
  $ 192,000     $ 1,058,000  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
Share-based compensation expense
    146,000       68,000  
Proceeds from dividends from equity investments in unconsolidated affiliates
    -       77,000  
Depreciation and amortization
    449,000       426,000  
Gain on sale of assets
    (41,000 )     -  
Equity in income of unconsolidated affiliates
    (234,000 )     (172,000 )
Changes in assets and liabilities:
               
Accounts receivable, net
    (1,890,000 )     2,143,000  
Inventories
    2,017,000       (4,768,000 )
Prepaid expenses and other current assets
    160,000       (668,000 )
Accounts payable and accrued liabilities
    306,000       (4,490,000 )
                 
Net cash provided by (used in) operating activities
    1,105,000       (6,326,000 )
                 
Cash Flows From Investing Activities:
               
Purchase of property and equipment
    (109,000 )     (462,000 )
Purchase of intangible assets
    (3,000 )     (4,000 )
Proceeds from sale of Janesville
    235,000       -  
                 
Net cash provided by (used in) investing activities
    123,000       (466,000 )
                 
Cash Flows From Financing Activities:
               
Payment for the repurchase of common stock
    (129,000 )     -  
Proceeds from the exercise of stock options
    16,000       6,000  
                 
Net cash provided by (used in) financing activities
    (113,000 )     6,000  
                 
Increase (decrease) in cash and cash equivalents during the period
    1,115,000       (6,786,000 )
                 
Cash and cash equivalents, beginning of period
    5,316,000       9,753,000  
Cash and cash equivalents, end of period
  $ 6,431,000     $ 2,967,000  
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
5
 
 

Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
1.
The Company
 
Alpha Pro Tech, Ltd. (“Alpha Pro Tech” or the “Company”) is in the business of protecting people, products and environments.  The Company accomplishes this by developing, manufacturing and marketing a line of disposable protective apparel for the cleanroom, industrial and pharmaceutical markets, a line of building supply products for the new home and re-roofing markets and a line of infection control products for the medical and dental markets.
 
The Disposable Protective Apparel segment consists of a complete line of shoecovers, bouffant caps, coveralls, gowns, frocks and lab coats.
 
The Building Supply segment consists of construction weatherization products, such as housewrap and synthetic roof underlayment.
 
The Infection Control segment consists of a line of face masks and eye shields.  It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.
 
The Company’s products are sold both under the "Alpha Pro Tech" brand name, as well as under private label, and are predominantly sold in the United States of America (“U.S.”).
 
2.
Basis of Presentation
 
The interim financial information included herein is unaudited; however, the information reflects all adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary for the fair presentation of the consolidated financial position, results of operations and cash flows for the interim periods. These condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, therefore, omit certain information and footnote disclosures necessary to present the statements in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).  The condensed consolidated financial statements should be read in conjunction with any of the Company’s current year filings on Form 8-K filed with the SEC, current year filing on Form 10-Q, as well as the consolidated financial statements for the year ended December 31, 2010, which are included in the Company’s Annual Report on Form 10-K (the “2010 10-K”), which was filed with the SEC on March 16, 2011. The results of operations for the three and six months ended June 30, 2011 are not necessarily indicative of the results to be expected for the full year. The consolidated balance sheet at December 31, 2010 was extracted from the audited consolidated financial statements contained in the 2010 10-K and does not include all disclosures required by GAAP for annual consolidated financial statements.
 
3.
Stock Based Compensation
 
The Company maintains a stock option plan under which the Company may grant incentive stock options and non-qualified stock options to key employees and non-employee directors.  Stock options have been granted with exercise prices at or above the current market price of the underlying shares of common stock on the date of grant.  Options vest and expire according to terms established at the grant date.
 
The Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “FASB ASC”, the “ASC” or the “Codification”) 718, Stock Compensation (“ASC 718”), effective January 1, 2006, using the modified prospective application method.  ASC 718 requires companies to record compensation expense for the value of all outstanding and unvested share-based payments, including employee stock options and similar awards.  During the first six months of 2011, there were no stock options granted under the stock option plan.  During the first six months of 2010, there were no stock options granted under the stock option plan.  The Company recognized $146,000 and $68,000 in share-based compensation expense in its consolidated financial statements for the six months ended June 30, 2011 and 2010, respectively, related to previously issued options.
 
 
6
 
 

Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
Stock options to purchase 2,511,000 and 1,567,000 shares of common stock were outstanding at June 30, 2011 and 2010, respectively.  As of June 30, 2011, no incremental shares were included in the computation of diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company’s common stock for the six months ended at June 30, 2011 and, therefore, there was no dilutive effect. As of June 30, 2010, 444,752 incremental shares were included in the computation of diluted earnings per share because the exercise prices of those stock options were less than the average share price of the Company’s common stock for the quarter and, therefore, the effect was dilutive. The remaining 1,122,248 were not included in the computation of the diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company’s common stock for the six months ended June 30, 2010 and, therefore, there was no dilutive effect.
 
The Company used the Black-Scholes-Merton option pricing model to value the options.  Prior to 2008, the Company used the simplified method as discussed in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment, for estimating the expected life of the options.  For options granted during a quarter or fiscal period, the Company uses historical data to estimate the expected life of the options.  The risk-free interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility is based on historical volatility of the expected life in years.  The Company uses an estimated dividend payout ratio of zero, as the Company has not paid dividends in the past and, at this time, does not expect to do so in the future.
 
The following table summarizes stock option activity during the six months ended June 30, 2011:
 
   
Options
   
Weighted-Average
Exercise Price
   
Weighted-Average
 Remaining Contractual
Life (in years)
 
Options outstanding at December 31, 2010
    2,542,000     $ 1.57       3.17  
Exercised
    (13,000 )   $ 1.23       -  
Granted
    -       -       -  
Forfeited or expired
    (18,000 )   $ 1.53       -  
Options outstanding at June 30, 2011
    2,511,000     $ 1.58       2.64  
Options exercisable at June 30, 2011
    1,377,000     $ 1.60       1.63  
 
As of June 30, 2011, $487,000 of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of 2.07 years.
 
4.
New Accounting Standards
 
In December 2009, the FASB issued Accounting Standards Update No. 2009-17 (“ASU No. 2009-17”), Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities.  The amendments in ASU No. 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity.  An approach that is expected to be primarily qualitative will be more effective for identifying which reporting entity has a controlling financial interest in a variable interest entity.  The amendments in ASU No. 2009-17 also require additional disclosures about a reporting entity’s involvement in variable interest entities, which will enhance the information provided to users of financial statements.  The application of ASU No. 2009-17 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.
 
 
7
 
 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
In January 2010, the FASB issued Accounting Standards Update No. 2010-06 (“ASU No. 2010-06”), Improving Disclosures About Fair Value Measurements. The amendments in ASU No. 2010-06 require separate disclosure of the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and reasons for the transfers and separate presentation of information about purchases, sales, issuances, and settlements in the reconciliation for Level 3 fair value measurements. Additionally, ASU No. 2010-06 clarifies existing disclosures regarding level of disaggregation and inputs and valuation techniques. The new disclosures and clarifications of existing disclosures under ASU No. 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years ending after December 15, 2010 and for interim periods within those fiscal years. The adoption of the disclosure requirements did not have a significant impact on the Company’s consolidated earnings nor the consolidated financial position for the periods presented.
 
In April 2010, the FASB issued Accounting Standards Update No. 2010-13 (“ASU No. 2010-13”), Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades – a consensus of the FASB Emerging Issues Task Force.  The amendments in ASU No. 2010-13 address the classification of a share-based payment award with an exercise price denominated in the currency of a market in which the underlying equity security trades.  Topic 718 is amended to clarify that a share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades shall not be considered to contain a market, performance, or service condition.  Therefore, such an award is not to be classified as a liability if it otherwise qualifies as equity classification.  The application of ASU No. 2010-13 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.
 
In December 2010, the FASB issued Accounting Standards Update No. 2010-28 (“ASU No. 2010-28), Intangibles—Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts, which modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The amendments in ASU No. 2010-28 are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. As a result of the adoption of the amendments, any resulting goodwill impairment should be recorded as a cumulative-effect adjustment to beginning retained earnings in the period of adoption. Any goodwill impairments occurring after the initial adoption of the amendments should be included in earnings.  Adoption of this guidance did not have a significant impact on the consolidated earnings nor the consolidated financial position of the Company.
 
We periodically review new accounting standards that are issued.  Although some of these accounting standards may be applicable to us, we have not identified any other new standards that we believe merit further discussion, and we expect that none would have a significant impact on our consolidated financial statements.
 
 
8
 
 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
5.
Inventories
 
            Inventories consist of the following:
 
   
June 30,
2011
   
December 31,
2010
 
Raw materials
  $ 9,488,000     $ 8,536,000  
Work in process
    929,000       1,797,000  
Finished goods
    4,703,000       6,985,000  
    $ 15,120,000     $ 17,318,000  
 
6.
Equity Investments in and Advances to Unconsolidated Affiliates
     
In 2005, Alpha ProTech Engineered Products, Inc. (a subsidiary of Alpha Pro Tech, Ltd.) entered into a joint venture with a manufacturer in India for the production of building products.  Under the terms of the joint venture agreement, a private company, Harmony Plastics Private Limited (“Harmony”), was created with ownership interests of 41.66% by Alpha ProTech Engineered Products, Inc. and 58.34% by Maple Industries and Associates.  Alpha ProTech Engineered Products, Inc. contributed $508,000 for share capital, and Maple Industries and Associates contributed $708,000.
 
This joint venture positions Alpha ProTech Engineered Products, Inc. to respond to current and expected increased product demand for housewrap and synthetic roof underlayment and provides future capacity for sales of specialty roofing component products and custom products for industrial applications requiring high quality extrusion coated fabrics.  In addition, the joint venture now supplies products for the Disposable Protective Apparel segment.
 
The capital from the initial funding, along with a bank loan, which is guaranteed exclusively by the individual shareholders of Maple Industries and Associates and collateralized by the assets of Harmony, were utilized to purchase an existing 33,000 square foot manufacturing facility in India.  This facility includes manufacturing equipment necessary to produce coated material and to sew proprietary disposable protective apparel.  This facility was expanded by a 38,500 square foot addition in mid-2010, bringing it to a total of 71,500 square feet.  Also in 2005, Harmony built a 60,000 square foot facility in India for the manufacturing of housewrap and synthetic roof underlayment.  Two additions have been made to this building: one was a 20,000 square foot addition in late 2009 and the other was a 22,000 square foot addition in mid-2010, for a total of 102,000 square feet.  During the latter part of 2010, Harmony also added a new 16,000 square foot facility in India that sews proprietary disposable protective apparel. All additions have been financed by Harmony with no guarantees from Alpha Pro Tech.
 
The Company is subject to the provisions of FASB ASC 810, Consolidation (“ASC 810”), which defines the criteria by which the Company determines the proper accounting for its investments in related entities.  Specifically, ASC 810 requires the Company to assess whether or not related entities are variable interest entities (“VIEs”), as defined.  For those related entities that qualify as VIEs, ASC 810 requires the Company to determine whether or not the Company is the primary beneficiary of the VIE, and, if so, to consolidate the VIE.
 
The Company has determined that Harmony is not a VIE and is, therefore, considered to be an unconsolidated affiliate.
 
The Company records its investment in Harmony as “Equity investments in and advances to unconsolidated affiliates” on the accompanying Consolidated Balance Sheets.  The Company records its equity interest in Harmony’s results of operations as “Equity in income of unconsolidated affiliates” on the accompanying Consolidated Income Statements.
 
 
9

 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
The Company reviews annually its investment in Harmony for impairment in accordance with FASB ASC 323, Investments – Equity Method and Joint Ventures (“ASC 323”). ASC 323 requires recognition of a loss when the decline in an investment is other-than-temporary.  In determining whether the decline is other-than-temporary, the Company considers the nature of the industry in which Harmony operates, its historical performance, its performance in relation to its peers and the current economic environment.
 
Alpha ProTech Engineered Products, Inc. initially invested $1,450,000 in the joint venture: $508,000 for share capital and $942,000 as a long term advance for materials.  Fifty percent of the $942,000 long term advance for materials is to be repaid over a six year term that commenced in July 2006, and the balance is to be paid in the seventh year.  As of June 30, 2011, Harmony has repaid a total of $525,000, leaving a balance of $417,000.  Interest of 3.5% is to be paid annually on this advance, and the Company had an interest receivable of $7,000 as of June 30, 2011 related to the agreement.
 
For the three months ended June 30, 2011 and 2010, Alpha Pro Tech purchased $3,108,000 and $3,801,000 of inventory, respectively, from Harmony.  For the six months ended June 30, 2011 and 2010, the Company purchased $5,902,000 and $6,507,000 of inventory, respectively, from Harmony.
 
For the three months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $107,000 and $99,000, respectively.  For the six months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $234,000 and $172,000, respectively.  As of June 30, 2011, the Company’s investment in Harmony was $2,175,000, which consists of its original $1,450,000 investment and cumulative equity in income of unconsolidated affiliates of $1,327,000, less $525,000 in repayments of the advance and payment of $77,000 in dividends.
 
7.
Accrued Liabilities
           
Accrued liabilities consisted of the following:
 
             
   
June 30,
2011
   
December 31,
2010
 
Payroll
  $ 266,000     $ 115,000  
Commission and bonus accrual
    90,000       48,000  
Accrued professional fees
    107,000       133,000  
Accrued rebates and other
    6,000       -  
    $ 469,000     $ 296,000  
 
The Company’s Chief Executive Officer and President are each entitled to a bonus equal to 5% of the pre-tax profits of the Company, excluding bonus expense.  Executive bonuses of $34,000 were accrued for the six months ended June 30, 2011.  The Chief Executive Officer and President voluntarily decided to forgo their bonuses for 2010.  Therefore, no executive bonuses were accrued for the year ended December 31, 2010.
 
 
10

 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
8.
Basic and Diluted Net Income Per Share
   
The following table provides a reconciliation of both net income and the number of shares used in the computation of “basic” earnings per share (“EPS”), which utilizes the weighted average number of shares outstanding without regard to potential shares, and “diluted” EPS, which includes all such dilutive shares for the three and six months ended June 30, 2011 and 2010, respectively:
 
   
For the Three Months Ended June 30,
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net income (Numerator)
  $ 304,000     $ 372,000     $ 192,000     $ 1,058,000  
Shares (Denominator):
                               
Basic weighted average shares outstanding
    22,427,403       22,424,285       22,431,009       22,423,788  
Add: Dilutive effect of outstanding stock options
    -       444,752       -       595,592  
Diluted weighted average shares outstanding
    22,427,403       22,869,037       22,431,009       23,019,380  
Net income per share:
                               
Basic
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  
Diluted
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  
 
 
9.
Activity of Business Segments
        
The Company operates in three business segments:
 
Disposable Protective Apparel: consisting of a complete line of disposable protective clothing, such as shoecovers (including the Aqua Trak® and spunbond shoecovers), bouffant caps, coveralls, frocks, lab coats, gowns and hoods for the pharmaceutical, cleanroom, industrial and medical markets.
 
Building Supply: consisting of a line of construction supply weatherization products.  The construction supply weatherization products consist of housewrap and synthetic roof underlayment.  The Company’s equity in income of unconsolidated affiliates (Harmony) is included in the total segment income for Building Supply in the table below.
 
Infection Control: consisting of a line of face masks and eye shields principally for the medical, dental and industrial markets.  It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.
 
Segment data excludes charges allocated to head office and corporate sales/marketing departments and income taxes.  The Company evaluates the performance of its segments and allocates resources to them based primarily on net sales.
 
 
11

 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
The following table shows consolidated net sales for each segment for the three and six months ended June 30, 2011 and 2010, respectively:
 
   
For the Three Months Ended
June 30,
   
For the Six Months Ended
 June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Disposable Protective Apparel
  $ 2,871,000     $ 4,845,000     $ 5,778,000     $ 9,929,000  
Building Supply
    6,356,000       4,863,000       11,103,000       9,585,000  
Infection Control
    1,051,000       1,513,000       2,342,000       3,336,000  
                                 
Total consolidated net sales
  $ 10,278,000     $ 11,221,000     $ 19,223,000     $ 22,850,000  
 
The following table shows the reconciliation of total segment income to total consolidated net income for the three and six months ended June 30, 2011 and 2010, respectively:
 
   
For the Three Months Ended
June 30,
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Disposable Protective Apparel
  $ 302,000     $ 933,000     $ 598,000     $ 2,134,000  
Building Supply
    1,095,000       746,000       1,382,000       1,408,000  
Infection Control
    328,000       319,000       691,000       840,000  
                                 
Total segment income
    1,725,000       1,998,000       2,671,000       4,382,000  
Unallocated corporate overhead  expenses
    (1,240,000 )     (1,409,000 )     (2,364,000 )     (2,713,000 )
Provision for income taxes
    (181,000 )     (217,000 )     (115,000 )     (611,000 )
                                 
Total consolidated net income
  $ 304,000     $ 372,000     $ 192,000     $ 1,058,000  
 
The following table shows the consolidated net property, equipment, goodwill and intangible assets by segment:
 
   
June 30,
2011
   
December 31,
2010
 
Disposable Protective Apparel
  $ 728,000     $ 816,000  
Building Supply
    2,173,000       2,277,000  
Infection Control
    1,038,000       1,173,000  
                 
Total segment assets
    3,939,000       4,266,000  
Unallocated corporate assets
    92,000       115,000  
Total consolidated assets
  $ 4,031,000     $ 4,381,000  
                 
 
12

 
 
 
Alpha Pro Tech, Ltd.

Notes to Consolidated Financial Statements (Unaudited)

 
On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads.  As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill.  The net gain on the sale of these assets was $41,000. Both of the transactions were executed in the three months ended March 31, 2011.
 
 
13

 
 
 
Alpha Pro Tech, Ltd.

 
ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
You should read the following discussion and analysis together with our consolidated financial statements (unaudited) and the notes to our consolidated financial statements (unaudited), which are included elsewhere in this report, and our audited financial statements and the notes thereto, which appear in our Form 10-K for the year ended December 31, 2010.
 
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
Certain information set forth in this Form 10-Q contains “forward-looking statements” within the meaning of federal securities laws.  Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to potential acquisitions, and other information that is not historical information. When used in this report, the words “estimates”, “expects”, “anticipates”, “forecasts”, “plans”, “intends”, “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. We may make additional forward-looking statements from time to time.  All forward-looking statements, whether written or oral and whether made by us or on our behalf, also are expressly qualified by this special note.
 
Our forward-looking statements are based upon our current expectations and various assumptions.  Our expectations, beliefs and projections are expressed in good faith, and we believe that there is a reasonable basis for them, including, without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties.  However, we cannot assure you that management’s expectations, beliefs and projections will result or be achieved or accomplished.  Our forward-looking statements apply only as of the date made.  Except as required by law, we undertake no obligation to publicly update or revise forward-looking statements that may be made to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
 
Any expectations based on these forward-looking statements are subject to risks and uncertainties and other important factors. Many other factors could affect Alpha Pro Tech Ltd.’s (“Alpha Pro Tech” or the “Company”) future operating results and financial condition and could cause actual results to differ materially from expectations based on forward-looking statements made in this document or elsewhere by Alpha Pro Tech, or on its behalf.
 
Where to find more information about us. We make available, free of charge, on our Internet website (http://www.alphaprotech.com) our most recent Annual Report on Form 10-K, our most recent Quarterly Report on Form 10-Q, any current reports on Form 8-K furnished or filed since our most recent Annual Report on Form 10-K and any amendments to such reports as soon as reasonably practicable following the electronic filing of such report with the Securities and Exchange Commission (“SEC”). In addition, in accordance with SEC rules, we provide electronic or paper copies of our filings free of charge upon request.
 
Critical Accounting Policies
 
The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods.  We base estimates on past experience and on various other assumptions that are believed to be reasonable under the circumstances.  The application of these accounting policies on a consistent basis enables us to provide timely and reliable financial information.  Our critical accounting polices include the following:
 
Inventories:  Inventories include freight-in, materials, labor and overhead costs and are stated at the lower of cost (computed on a standard cost basis, which approximates average cost) or market.  Provision is made for slow-moving, obsolete or unusable inventory. We assess our inventory for estimated obsolescence or unmarketable inventory and write down the difference between the cost of inventory and the estimated market value based upon assumptions about future sales and supply on-hand, if necessary.  If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.
 
 
14

 
 
Alpha Pro Tech, Ltd.
 
 
Accounts Receivable: Accounts receivable are recorded at the invoice amount and do not bear interest.  The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable; however, changes in circumstances relating to accounts receivable may result in a requirement for additional allowances in the future.  The Company determines the allowance based upon historical write-off experience and known conditions about customers’ current ability to pay.  Account balances are charged against the allowance after all collection efforts have been exhausted and the potential for recovery is considered remote.
 
Revenue Recognition:  For sales transactions, we comply with the provisions of the SEC Staff Accounting Bulletin No. 104, Revenue Recognition, which states that revenue should be recognized when the following revenue recognition criteria are met: (1) persuasive evidence of an arrangement exists; (2) title transfers and the customer assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured.  These criteria are satisfied upon shipment of product and revenues are recognized accordingly.
 
Sales Returns, Rebates and Allowances:  Sales are reduced for any anticipated sales returns, rebates and allowances based on historical experience.  Since our return policy is only 90 days and our products are not generally susceptible to external factors such as technological obsolescence or significant changes in demand, we are able to make a reasonable estimate for returns.  We offer end-user product specific and sales volume rebates to select distributors.  Our rebates are based on actual sales and accrued monthly.
 
Stock Based Compensation:  Alpha Pro Tech accounts for stock based awards using FASB ASC 718, Stock Compensation.  ASC 718 requires companies to record compensation expense for the value of all outstanding and unvested share-based payments, including employee stock options and similar awards.
 
The fair values of stock option grants are determined using the Black-Scholes-Merton option pricing model and are based on the following assumptions: expected stock price volatility based on historical data and management’s expectations of future volatility, risk-free interest rates from published sources, years to maturity based on historical data and no dividend yield, as management currently does not expect the Company to pay dividends in the near future.  The Black-Scholes-Merton option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and that are fully transferable.  In addition, the option valuation model requires the input of highly subjective assumptions, including expected stock price volatility.  Our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect their fair value.
 
OVERVIEW
 
Alpha Pro Tech is in the business of protecting people, products and environments. We accomplish this by developing, manufacturing and marketing a line of high-value, disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. We also manufacture a line of building supply construction weatherization products.  Our products are sold both under the "Alpha Pro Tech" brand name, as well as under private label.
 
Our products are grouped into three business segments:  the Disposable Protective Apparel segment, consisting of disposable protective apparel; the Building Supply segment, consisting of construction weatherization products, such as housewrap and synthetic roof underlayment; and the Infection Control segment, consisting of face masks and eye shields and which previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.
 
Our target markets include pharmaceutical manufacturing, bio-pharmaceutical manufacturing and medical device manufacturing, lab animal research, high technology electronics manufacturing (which includes the semi-conductor market), medical and dental distributors and construction, building supply and roofing distributors.
 
Our products are used primarily in cleanrooms, industrial safety manufacturing environments and health care facilities, such as hospitals, laboratories and dental offices, as well as building and re-roofing sites.  Our products are distributed principally in the United States of America through a network consisting of purchasing groups, national distributors, local distributors, independent sales representatives and our own sales and marketing force.
 
 
15

 
 
Alpha Pro Tech, Ltd.
 
 
RESULTS OF OPERATIONS
 
The following table sets forth certain operational data as a percentage of sales for the periods indicated:
 
   
For the Three Months Ended June 30,
   
For the Six Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net sales
    100.0 %     100.0 %     100.0 %     100.0 %
Gross profit
    37.7 %     37.6 %     37.2 %     40.3 %
Selling, general and administrative expenses
    32.1 %     31.4 %     34.7 %     32.0 %
Income  from operations
    3.6 %     4.3 %     0.0 %     6.5 %
Income before provision for income taxes
    4.7 %     5.2 %     1.6 %     7.3 %
Net income
    3.0 %     3.3 %     1.0 %     4.6 %
 
Three and Six Months ended June 30, 2011 compared to Three and Six Months ended June 30, 2010
 
Sales.  Consolidated sales for the three months ended June 30, 2011 decreased to $10,278,000 from $11,221,000 for the three months ended June 30, 2010, representing a decrease of $943,000, or 8.4%.  This decrease consisted of decreased sales in the Disposable Protective Apparel segment of $1,974,000 and decreased sales in the Infection Control segment of $462,000, partially offset by increased sales in the Building Supply segment of $1,493,000.
 
Sales for the Disposable Protective Apparel segment for the three months ended June 30, 2011 decreased by $1,974,000, or 40.7%, to $2,871,000, compared to $4,845,000 for the same period of 2010.  The decrease was primarily due to a decline in sales of disposable protective apparel to our former largest distributor.  Although Alpha Pro Tech was informed in the first quarter of 2010 that this distributor had decided to launch its own competing private label line of disposable protective apparel, it was not until the second quarter of 2010 that we started to experience the significant impact of this change.  With that said, sales to this distributor in the second quarter of 2010, although down from historical levels, were still significant, as we had orders to fill that were placed before the supply chain change.  Sales to this distributor are expected to be insignificant in the coming quarters, as they were only approximately $100,000 for the three months ended June 30, 2011.
 
Sales to our major international supply chain partner from whom the Company received two awards in 2010 were also down in the second quarter of 2011 as compared to the same quarter of 2010, as a result of significant initial stocking orders to fill their inventory supply for the anticipated increase in business during the second quarter of 2010.  Although sales to this partner were down as compared to the same quarter last year, sales in this quarter were higher than the average of the three prior quarters.  In addition, this partner’s same quarter sales to its end users were up 39%, demonstrating a strong demand for our products.
 
Building Supply segment sales for the three months ended June 30, 2011 increased by $1,493,000, or 30.7%, to a quarterly record of $6,356,000, as compared to $4,863,000 for the same period of 2010.  We surpassed our previous quarterly record of $5,292,000 by $1,064,000, or 20.1%.  The increase was primarily due to a 25.0% increase in sales of REX™ Wrap housewrap and a 32.8% increase in sales of REX™ SynFelt synthetic roof underlayment.  The sales mix of the Building Supply segment for the three months ended June 30, 2011 was 69% for synthetic roof underlayment and 31% for housewrap.  This compared to 68% for synthetic roof underlayment and 32% for housewrap for the three months ended June 30, 2010.
 
Our REX™ SynFelt synthetic roof underlayment, we believe, is perceived as an industry leader in terms of quality and that, as the market continues to evolve from felt paper to synthetic roof underlayment, we feel we are in a position to capitalize on significant growth opportunities.  REX™ Wrap housewrap, our high-quality, multi-color printed housewrap, we believe, gives us a distinct competitive advantage in the marketplace and as a result, our market share is growing even during the current weak building market and difficult economic environment.
 
 
16

 
 
Alpha Pro Tech, Ltd.
 
 
We plan to continue to evolve our product offering.  In the fourth quarter of 2010, we launched our new REX™ Wrap Fortis housewrap, our ICC-ES approved non-perforated breathable housewrap.  The non-perforated breathable housewrap market accounts for the majority of the total housewrap market, so this new product should increase our housewrap sales and market share.  The launch of the REX™ Wrap Fortis housewrap has been slower than anticipated, but the product should start contributing more significantly to the sales line commencing in   2012.  We remain optimistic about the future of the Building Supply segment, as our distribution channel strategy continues to strengthen.
 
Infection Control segment sales for the three months ended June 30, 2011 decreased by $462,000, or 30.5%, to $1,051,000, compared to $1,513,000 for the same period of 2010.  Mask sales were down by 38.7%, or $424,000, to $670,000, medical bed pad and pet bed sales were down by $141,000, to $0, as this product line was sold in the first quarter of 2011, and shield sales were up by 37.1%, or $103,000, to $381,000.  The overall mask sales decrease for the second quarter of 2011 was primarily due to a decline in industrial mask sales as a result of our previous largest industrial distributor launching its own line of masks as well as a decline in medical and dental mask sales.
 
Consolidated sales for the six months ended June 30, 2011 decreased to $19,223,000 from $22,850,000 for the six months ended June 30, 2010, representing a decrease of $3,627,000, or 15.9%.  This decrease consisted of decreased sales in the Disposable Protective Apparel segment of $4,151,000 and decreased sales in the Infection Control segment of $994,000, partially offset by increased sales in the Building Supply segment of $1,518,000.
 
Sales for the Disposable Protective Apparel segment for the six months ended June 30, 2011 decreased by $4,151,000, or 41.8%, to $5,778,000, compared to $9,929,000 for the same period of 2010.  The decrease was primarily due to a decline in sales of disposable protective apparel to our former largest distributor and to a much lesser extent, reduced sales to regional distributors.  The six month decrease was partially offset by a small increase in sales to our major international supply chain partner.  The year to date increase to this partner would have been greater had it not been for the large stocking orders in the second quarter of 2010, but sales to this partner’s end users were up 60% year to date, demonstrating a strong demand for our products.
 
Building Supply segment sales for the six months ended June 30, 2011 increased by $1,518,000, or 15.8%, to $11,103,000, as compared to $9,585,000 for the same period of 2010.  The increase was primarily due to a 19.5% increase in sales of REX™ Wrap housewrap and a 13.1% increase in sales of REX™ SynFelt synthetic roof underlayment.  The sales mix of the Building Supply segment for the six months ended June 30, 2011 was 68% for synthetic roof underlayment and 32% for housewrap.  This compared to 69% for synthetic roof underlayment and 31% for housewrap for the six months ended June 30, 2010.
 
Infection Control segment sales for the six months ended June 30, 2011 decreased by $994,000, or 29.8%, to $2,342,000, compared to $3,336,000 for the same period of 2010.  Mask sales were down by 36.5%, or $866,000, to $1,509,000, medical bed pad and pet bed sales were down by 63.8%, or $176,000, to $101,000, and shield sales were up by 7.0%, or $48,000, to $732,000, all compared to the six months ended June 30, 2010.  The overall mask sales decrease for the first six months of 2011 was primarily due to a decline in industrial mask sales as a result of our previous largest industrial distributor launching its own line of masks, as well as a decline in medical and, to a lesser extent, dental mask sales.
 
On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads.  As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill.  The net gain on the sale of these assets was $41,000.  Both of the transactions were executed in the three months ended March 31, 2011.
 
Gross Profit.  Gross profit decreased by $350,000, or 8.3%, to $3,871,000 for the three months ended June 30, 2011 from $4,221,000 for the same period in 2010.  The gross profit margin was 37.7% for the three months ended June 30, 2011, compared to 37.6% for the same period of 2010.
 
 
17

 
 
Alpha Pro Tech, Ltd.
 
 
Gross profit decreased by $2,066,000, or 22.4%, to $7,144,000 for the six months ended June 30, 2011 from $9,210,000 for the same period in 2010.  The gross profit margin was 37.2% for the six months ended June 30, 2011, compared to 40.3% for the same period of 2010.
 
Gross profit margin for the first six months of 2011 was affected by the change in product mix in which Building Supply segment sales, which have lower margins, increased as a percentage of total sales.  Building Supply segment sales comprised a record high 57.8% of total sales for the six months ended June 30, 2011, compared to 41.9% for the same period of 2010.  For the first six months of 2011, gross profit margin in the Disposable Protective Apparel segment, although similar to the average of the prior four quarters, was down, as compared to the same period of 2010, due to competitive pricing pressures from our former largest distributor.  Management expects gross margin on the Building Supply segment to increase starting in the third quarter, as a price increase went into effect in early July 2011 on Building Supply segment products.
 
Selling, General and Administrative Expenses.  Selling, general and administrative expenses decreased by $222,000, or 6.3%, to $3,296,000 for the three months ended June 30, 2011 from $3,518,000 for the three months ended June 30, 2010.  As a percentage of net sales, selling, general and administrative expenses increased to 32.1% for the three months ended June 30, 2011 from 31.4% for the same period in 2010.
 
The decrease of $222,000 in expenses was primarily due to a decrease in employee compensation of $136,000, a decrease of $32,000 in executive bonuses, decreased professional fees and public company expenses of $118,000, decreased travel expenses of $37,000, decreased factory indirect expenses of $23,000 and decreased miscellaneous expenses of $2,000, partially offset by increased commission for the Building Supply segment of $79,000 and  increased rent and utilities of $47,000.
 
The change in expense by segment was as follows: Disposable Protective Apparel was down $76,000, or 9.3%, Infection Control was down $122,000, or 36.7%, and Building Supply was up $140,000, or 14.5%.  The remaining change primarily consisted of a $169,000 decrease in corporate unallocated expenses, caused by a decrease in employee compensation and bonuses, professional fees and public company expenses and general office expenses.
 
Selling, general and administrative expenses decreased by $624,000, or 8.5%, to $6,678,000 for the six months ended June 30, 2011 from $7,302,000 for the six months ended June 30, 2010.  As a percentage of net sales, selling, general and administrative expenses increased to 34.7% for the six months ended June 30, 2011 from 32.0% for the same period in 2010.
 
The decrease of $624,000 in expenses was primarily due to a decrease in employee compensation of $270,000, a decrease of $152,000 in executive bonuses, decreased professional fees and public company expenses of $159,000, decreased travel expenses of $131,000, decreased factory indirect expenses of $74,000, decreased marketing expenses of $59,000 and decreased miscellaneous expenses of $8,000, partially offset by increased rent and utilities of $152,000 and increased commission for the Building Supply segment of $77,000.
 
The change in expense by segment was as follows: Disposable Protective Apparel was down $299,000, or 16.5%, Infection Control was down $254,000, or 34.3%, and Building Supply was up $278,000, or 13.6%.  The remaining change primarily consisted of a $349,000 decrease in corporate unallocated expenses, caused by a decrease in employee compensation, bonuses, and professional fees and public company expenses and general office expenses.
 
The Company’s Chief Executive Officer and President are each entitled to a bonus equal to 5% of the pre-tax profits of the Company, excluding bonus expense.  Bonuses of $34,000 were accrued for the three months ended June 30, 2011, as compared to $66,000 in the same period of 2010.  Bonuses of $34,000 were accrued for the six months ended June 30, 2011, as compared to $186,000 in the same period of 2010.
 
Depreciation and Amortization.  Depreciation and amortization expense decreased by $12,000, or 5.5%, to $206,000 for the three months ended June 30, 2011 from $218,000 for the same period in 2010.  The decrease for the quarter was primarily attributable to decreased depreciation related to the Building Supply segment.
 
Depreciation and amortization expense increased by $23,000, or 5.4%, to $449,000 for the six months ended June 30, 2011 from $426,000 for the same period in 2010.  The increase for the six months was primarily attributable to increased depreciation related to the Disposable Protective Apparel segment.
 
 
18

 
 
Alpha Pro Tech, Ltd.
 
 
Income from Operations.  Income from operations decreased by $116,000, or 23.9%, to $369,000 for the three months ended June 30, 2011, as compared to $485,000 for the three months ended June 30, 2010.  The decrease in income from operations was due to a decrease in gross profit of $350,000, partially offset by a decrease in selling, general and administrative expenses of $222,000 and a decrease in depreciation and amortization of $12,000.
 
Income from operations decreased by $1,465,000, or 98.9%, to $17,000 for the six months ended June 30, 2011, as compared to $1,482,000 for the six months ended June 30, 2010.  The decrease in income from operations was due to a decrease in gross profit of $2,066,000 and an increase in depreciation and amortization of $23,000, partially offset by a decrease in selling, general and administrative expenses of $624,000.
 
Equity in Income of Unconsolidated Affiliates.  For the three months ended June 30, 2011, we recorded equity in income of unconsolidated affiliates of $107,000, as compared to $99,000 for the same period of 2010.  For the six months ended June 30, 2011, we recorded equity in income of unconsolidated affiliates of $234,000, as compared to $172,000 for the same period of 2010.
 
Net Gain on Sales of Assets.  On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and, on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads.  As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill. The net gain from these two transactions was $41,000.  In addition, the Company signed a three year non-compete agreement that covers these product lines.
 
Income before Provision for Income Taxes.  Income before provision for income taxes for the three months ended June 30, 2011 was $485,000, compared to income before provision for income taxes of $589,000 for the three months ended June 30, 2010, representing a decrease of $104,000, or 17.7%.  The decrease in income before provision for income taxes was due primarily to a decrease in income from operations of $116,000, partially offset by an increase of $8,000 in equity in income of unconsolidated affiliates and an increase in net interest income of $4,000.
 
Income before provision for income taxes for the six months ended June 30, 2011 was $307,000, compared to income before provision for income taxes of $1,669,000 for the six months ended June 30, 2010, representing a decrease of $1,362,000, or 81.6%.  The decrease in income before provision for income taxes was due primarily to a decrease in income from operations of $1,465,000, partially offset by an increase of $62,000 in equity in income of unconsolidated affiliates and a net gain on sales of assets of $41,000.
 
Provision for Income Taxes.  The provision for income taxes for the three months ended June 30, 2011 was $181,000, compared to provision for income taxes of $217,000 for the same period of 2010.  The estimated effective tax  rate was 37.3% for the three months ended June 30, 2011, compared to 36.8% for the same period in 2010.
 
The provision for income taxes for the six months ended June 30, 2011 was $115,000, compared to provision for income taxes of $611,000 for the same period of 2010.  The estimated effective tax rate was 37.5% for the six months ended June 30, 2011, compared to 36.6% for the same period in 2010.  Management expects the effective tax rate to be in the 37% range going forward.
 
Net Income.  Net income for the three months ended June 30, 2011 was $304,000, compared to net income of $372,000 for the three months ended June 30, 2010, a decrease of $68,000, or 18.3%. The net income decrease was primarily due to a decrease in income before provision for income taxes of $104,000, partially offset by a decrease in income taxes of $36,000.  Net income as a percentage of sales for the three months ended June 30, 2011 was 3.0%, and net income as a percentage of sales for the same period of 2010 was 3.3%.  Basic and diluted income per share for the three months ended June 30, 2011 was $0.01, and basic and diluted income per share for the same period of 2010 was $0.02.
 
 
19

 
 
Alpha Pro Tech, Ltd.
 
 
Net income for the six months ended June 30, 2011 was $192,000, compared to net income of $1,058,000 for the six months ended June 30, 2010, a decrease of $866,000, or 81.9%. The net income decrease was primarily due to a decrease in income before provision for income taxes of $1,362,000, partially offset by a decrease in income taxes of $496,000.  Net income as a percentage of sales for the six months ended June 30, 2011 was 1.0%, and net income as a percentage of sales for the same period of 2010 was 4.6%.  Basic and diluted income per share for the six months ended June 30, 2011 was $0.01, and basic and diluted income per share for the same period of 2010 was $0.05.
 
LIQUIDITY AND CAPITAL RESOURCES
 
As of June 30, 2011, we had cash and cash equivalents of $6,431,000 and working capital of $30,170,000, representing an increase in working capital of 1.1%, or $341,000, since December 31, 2010.  As of June 30, 2011, our current ratio was 29:1, compared to 39:1 as of December 31, 2010.  Cash and cash equivalents increased by 21.0%, or $1,115,000, to $6,431,000 as of June 30, 2011, compared to $5,316,000 as of December 31, 2010.  The increase in cash and cash equivalents was due to cash provided by operating activities of $1,105,000 and cash provided by investing activities of $123,000, partially offset by cash used in financing activities of $113,000.
 
We have a $3,500,000 credit facility with Wells Fargo Bank, consisting of a line of credit with interest at prime plus 0.5%.  As of June 30, 2011, the prime interest rate was 3.25%.  This credit line was renewed and expires in May 2012.  Our borrowing capacity on the line of credit was $3,500,000 as of June 30, 2011.  The available line of credit is based on a formula of eligible accounts receivable and inventories.  As of June 30, 2011, we did not have any borrowings under this credit facility.
 
Net cash provided by operating activities was $1,105,000 for the six months ended June 30, 2011, compared to net cash used in operating activities of $6,326,000 for the six months ended June 30, 2010.  The net cash provided by operating activities of $1,105,000 for the six months ended June 30, 2011 was due to net income of $192,000, adjusted by the following: an increase in amortization of share-based compensation expense to $146,000, an increase of depreciation and amortization to $449,000, the gain on the sale of the pet bed and medical bed pad line of $41,000, an increase in equity in income of unconsolidated affiliates to $234,000, an increase in accounts receivable of $1,890,000, a decrease in inventory of $2,017,000, a decrease in prepaid expenses and other current assets of $160,000 and an increase in accounts payable and accrued liabilities of $306,000.
 
Accounts receivable increased by $1,890,000, or 49.5%, to $5,706,000 as of June 30, 2011 from $3,816,000 as of December 31, 2010.  The increase in accounts receivable was primarily related to increased sales in the second quarter of 2011, as compared to the fourth quarter of 2010, as well as strong sales in the latter part of the second quarter of 2011.  The number of days of sales outstanding as of June 30, 2011 was 51 days, compared to 33 days as of December 31, 2010.  The days of sales outstanding are the expected to be in the 50 day range going forward.
 
Inventory decreased by $2,198,000, or 12.7%, to $15,120,000 as of June 30, 2011 from $17,318,000 as of December 31, 2010.  The decrease was primarily due to a decrease in inventory for the Disposable Protective Apparel segment of $1,492,000, or 22.1%, to $5,267,000 as of June 30, 2011.  Inventory for the Infection Control segment decreased by $390,000, or 8.4%, to $4,246,000, primarily due to the sale of the Company’s line of medical bed pads and pet beds.  In addition, inventory for the Building Supply segment decreased by $316,000, or 5.3%, to $5,607,000 as of June 30, 2011.  From a cash flow perspective, the inventory net change of $2,017,000 is comprised of the balance sheet inventory net change of $2,198,000, less the $181,000 of inventory sold through the sale of the pet bed and medical bed pad lines.
 
Prepaid expenses and other current assets decreased by $160,000, or 4.3%, to $3,559,000 as of June 30, 2011 from $3,719,000 as of December 31, 2010.  The decrease was primarily due to a decrease in prepaid deposits on inventory from Asia.
 
Accounts payable and accrued liabilities as of June 30, 2011 increased by $306,000, or 39.1%, to $1,089,000 from $783,000 as of December 31, 2010.  The change was primarily due to an increase in trade payables of $133,000 and an increase in accrued liabilities of $173,000.  Accrued liabilities for the six months ended June 30, 2011 increased as follows: accrued payroll expenses increased by $151,000, rebates and other increased by $6,000 and commission and bonus accrual increased by $42,000, partially offset by a decrease in accrued professional fees of $26,000.
 
 
20

 
 
Alpha Pro Tech, Ltd.
 
 
Net cash provided by investing activities was $123,000 for the six months ended June 30, 2011, compared to net cash used in investing activities of $389,000 for the same period of 2010.  Our investing activities for the six months ended June 30, 2011 consisted primarily of the cash proceeds from the sale of the pet bed and medical bed pad lines of $235,000, offset by the purchase of property and equipment of $109,000 and the purchase of intangible assets of $3,000, compared to the purchase of property and equipment of $462,000 and the purchase of intangible assets of $4,000 for the same period of 2010.  Also in 2010, we received a payment of dividends from our joint venture of $77,000.
 
Net cash used in financing activities was $113,000 for the six months ended June 30, 2011, compared to net cash provided by financing activities of $6,000 for the same period of 2010.  Our net cash used in financing activities for the six months ended June 30, 2011 was due to $129,000 for the repurchase of common stock, partially offset by the proceeds of $16,000 from the exercise of stock options.  Our net cash provided by financing activities for the six months ended June 30, 2010 was due to the proceeds from the exercise of stock options.
 
In February 2010, the Company announced an expansion of $2.0 million to its existing stock repurchase plan.  As of June 30, 2011, we had $2,734,000 available for additional stock purchases under our repurchase program.  We repurchased 109,763 shares of common stock during the three and six months ended June 30, 2011 at a cost of $129,000.  As of June 30, 2011, we had repurchased a total of 6,303,563 shares of common stock at a cost of $7,787,000 through our repurchase program. We retire all stock repurchases upon repurchase. Future repurchases are expected to be funded from cash on hand and cash flows from operations.
 
We believe that our current cash balance and the funds available under our credit facility will be sufficient to satisfy our projected working capital and planned capital expenditures for the foreseeable future.
 
New Accounting Standards
 
In December 2009, the FASB issued Accounting Standards Update No. 2009-17 (“ASU No. 2009-17”), Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities.  The amendments in ASU No. 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity.  An approach that is expected to be primarily qualitative will be more effective for identifying which reporting entity has a controlling financial interest in a variable interest entity.  The amendments in ASU No. 2009-17 also require additional disclosures about a reporting entity’s involvement in variable interest entities, which will enhance the information provided to users of financial statements.  The application of ASU No. 2009-17 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.
 
In January 2010, the FASB issued Accounting Standards Update No. 2010-06 (“ASU No. 2010-06”), Improving Disclosures About Fair Value Measurements. The amendments in ASU No. 2010-06 require separate disclosure of the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and reasons for the transfers and separate presentation of information about purchases, sales, issuances, and settlements in the reconciliation for Level 3 fair value measurements. Additionally, ASU No. 2010-06 clarifies existing disclosures regarding level of disaggregation and inputs and valuation techniques. The new disclosures and clarifications of existing disclosures under ASU No. 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years ending after December 15, 2010 and for interim periods within those fiscal years. The adoption of the disclosure requirements did not have a significant impact on the Company’s consolidated earnings nor the consolidated financial position for the periods presented.
 
In April 2010, the FASB issued Accounting Standards Update No. 2010-13 (“ASU No. 2010-13”), Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades – a consensus of the FASB Emerging Issues Task Force.  The amendments in ASU No. 2010-13 address the classification of a share-based payment award with an exercise price denominated in the currency of a market in which the underlying equity security trades.  Topic 718 is amended to clarify that a share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades shall not be considered to contain a market, performance, or service condition.  Therefore, such an award is not to be classified as a liability if it otherwise qualifies as equity classification.  The application of ASU No. 2010-13 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.
 
 
21

 
 
Alpha Pro Tech, Ltd.
 
 
In December 2010, the FASB issued Accounting Standards Update No. 2010-28 (“ASU No. 2010-28), Intangibles—Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts, which modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The amendments in ASU No. 2010-28 are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. Upon adoption of the amendments, any resulting goodwill impairment should be recorded as a cumulative-effect adjustment to beginning retained earnings in the period of adoption. Any goodwill impairments occurring after the initial adoption of the amendments should be included in earnings.  The adoption of this guidance did not have a significant impact on the consolidated earnings nor the consolidated financial position of the Company.
 
We periodically review new accounting standards that are issued.  Although some of these accounting standards may be applicable to us, we have not identified any other new standards that we believe merit further discussion, and we expect that none would have a significant impact on our consolidated financial statements.
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We subcontract the manufacture of products in China and, to a lesser extent, in Mexico, and we have a joint venture in India.  In addition, our principal executive office, with 19 employees, is located in Canada.  We do not believe that we have a material foreign currency exposure due to the fact that our purchase agreements with companies in China, India and Mexico are settled in U.S. dollars.  In addition, all sales transactions are in U.S. dollars.  In Canada, our foreign currency exposure is not material due to the fact that we do not conduct manufacturing operations in Canada.  Any such exposure is limited to payroll expenses in the Canadian branch office.
 
We do not expect any significant effect on our consolidated results of operations from inflation or interest or currency rate fluctuations. We do not hedge our interest rate or foreign exchange risks.
 
ITEM 4. CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures.
 
Under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act.”)) as of June 30, 2011 pursuant to the evaluation of these controls and procedures required by Rule 13a-15 of the Exchange Act. Disclosure controls and procedures are the controls and other procedures that we have designed to ensure that we record, process, summarize and report in a timely manner the information that we must disclose in reports that we file with or submit to the SEC under the Exchange Act.     
 
In designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and that we are required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures.
 
Based on the evaluation, our principal executive and financial officers concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
 
 
22

 
 
Alpha Pro Tech, Ltd.

 
Changes in Internal Control Over Financial Reporting
 
During the quarter to which this report relates, there was no change in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
PART II.  OTHER INFORMATION
 
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
ISSUER PURCHASES OF EQUITY SECURITIES
 
The following table sets forth purchases made by or on behalf of the Company or any “affiliated purchaser”, as defined in Rule 10b-18(a)(3) of the Exchange Act.
 
Issuer Purchases of Equity Securities
 
Period
 
Total Number of Shares Purchased
   
Weighted Average Price Paid per Share
   
Total Number of Shares Purchased as Part of Publicly Announced Plan (1)
   
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan (1)
 
April  1-30, 2011
    -       -       -     $ 2,862,000  
May 1-31, 2011
    -       -       -     $ 2,862,000  
June 1-30, 2011
    109,763     $ 1.16       109,763     $ 2,734,000  
Total
    109,763     $ 1.16       109,763     $ 2,734,000  
 
(1) On February 8, 2010, the Company announced that the Board of Directors had authorized a $2.0 million expansion of the Company’s existing share repurchase program. Under the share repurchase program, the Company is authorized to repurchase up to a total of $10,520,000 of common stock.
 
SECURITIES SOLD
 
We did not sell any unregistered equity securities during the period covered by this Form 10-Q.
 
 
23

 
 
Alpha Pro Tech, Ltd.

ITEM 6. EXHIBITS
 
 
3.1.1
Certificate of Incorporation of Alpha Pro Tech, Ltd., incorporated by reference to Exhibit 3(f) to Form 10-K for the year ended December 31, 1994, filed on March 31, 1995 (File No. 000-19893).
   
3.1.2
Certificate of Amendment of Certificate of Incorporation of Alpha Pro Tech, Ltd., incorporated by reference to Exhibit 3(j) to Form 10-K for the year ended December 31, 1994, filed on March 31, 1995 (File No. 000-19893).
   
3.1.3
Certificate of Ownership and Merger (BFD Industries, Inc. into Alpha Pro Tech, Ltd.), incorporated by reference to Exhibit 3(l) to Form 10-K for the year ended December 31, 1994, filed on March 31, 1995 (File No. 000-19893).
   
3.2
Bylaws of Alpha Pro Tech, Ltd., incorporated by reference to Exhibit 3(g) to Form 10-K for the year ended December 31, 1994, filed on March 31, 1995 (File No. 000-19893).
   
31.1
Certification Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act, signed by Chief Executive Officer and Director (filed herewith).
   
31.2
Certification Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act, signed by Chief Financial Officer (filed herewith).
   
32.1
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Chief Executive Officer and Director (filed herewith).
   
32.2
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Chief Financial Officer (filed herewith).

 
24

 
 
Alpha Pro Tech, Ltd.


 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
ALPHA PRO TECH, LTD.    
       
Date:  August 5, 2011
By:
/s/ Sheldon Hoffman  
    Sheldon Hoffman  
    Chief Executive Officer and Director   
       
 
 
Date:  August 5, 2011
By:
/s/ Lloyd Hoffman  
    Lloyd Hoffman  
    Chief Financial Officer  
       
 
  
 

25

 

 

 

 
 

 
 

 
 

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm
Alpha Pro Tech, Ltd.
EXHIBIT 31.1
 
Certification Under Exchange Act Rules 13a – 14(a) and 15d – 14(a)         
I, Sheldon Hoffman, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Alpha Pro Tech, Ltd.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter  that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
 DATE:     August 5, 2011
By:
/s/ Sheldon Hoffman  
       
   
Sheldon Hoffman
 
    Chief Executive Officer and Director   
       
 
 
26
EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm
Alpha Pro Tech, Ltd.
Exhibit 31.2
 
Certification Under Exchange Act Rules 13a – 14(a) and 15d – 14(a)        
I, Lloyd Hoffman, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Alpha Pro Tech, Ltd.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
       
DATE:  August 5, 2011
By:
/s/ Lloyd Hoffman  
       
   
Lloyd Hoffman
 
   
Chief Financial Officer
 
       
 
 
27
EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm
Alpha Pro Tech, Ltd.
 
 
EXHIBIT 32.1
 

 
 
Alpha Pro Tech, Ltd.
 
CERTIFICATION PURSUANT TO
 
18 U.S.C. SECTION 1350,
 
AS ADOPTED PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the quarterly report of Alpha Pro Tech, Ltd. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sheldon Hoffman, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

 
       
DATE:    August 5, 2011
By:
/s/ Sheldon Hoffman  
       
   
Sheldon Hoffman
 
    Chief Executive Officer and Director  
       
 
 
28
EX-32.2 5 ex32-2.htm EXHIBIT 32.2 ex32-2.htm
Alpha Pro Tech, Ltd.
 
 
EXHIBIT 32.2
 

 
Alpha Pro Tech, Ltd.
 
CERTIFICATION PURSUANT TO
 
18 U.S.C. SECTION 1350,
 
AS ADOPTED PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the quarterly report of Alpha Pro Tech, Ltd. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lloyd Hoffman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
       
DATE:   August 5, 2011
By:
/s/ Lloyd Hoffman  
       
    Lloyd Hoffman   
    Chief Financial Officer  
       
 
 
29
EX-101.INS 6 apt-20110630.xml 0000884269 2011-06-30 0000884269 2010-12-31 0000884269 2011-04-01 2011-06-30 0000884269 2010-04-01 2010-06-30 0000884269 2011-01-01 2011-06-30 0000884269 2010-01-01 2010-06-30 0000884269 us-gaap:CommonStockMember 2010-12-31 0000884269 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000884269 us-gaap:RetainedEarningsMember 2010-12-31 0000884269 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-06-30 0000884269 us-gaap:CommonStockMember 2011-01-01 2011-06-30 0000884269 us-gaap:RetainedEarningsMember 2011-01-01 2011-06-30 0000884269 us-gaap:CommonStockMember 2011-06-30 0000884269 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0000884269 us-gaap:RetainedEarningsMember 2011-06-30 0000884269 2009-12-31 0000884269 2010-06-30 0000884269 2011-07-29 iso4217:USD iso4217:USD xbrli:shares xbrli:shares The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date. 6431000 5316000 5706000 3816000 62000 77000 15120000 17318000 3559000 3719000 443000 443000 31259000 30612000 3832000 4162000 55000 55000 144000 164000 2175000 1941000 37465000 36934000 620000 487000 469000 296000 1089000 783000 639000 639000 1728000 1422000 223000 224000 0.01 0.01 50000000 50000000 22327855 22424285 22327855 22424285 23538000 23504000 11976000 11784000 35737000 35512000 37465000 36934000 10278000 11221000 19223000 22850000 6407000 7000000 12079000 13640000 3871000 4221000 7144000 9210000 3296000 3518000 6678000 7302000 206000 218000 449000 426000 369000 485000 17000 1482000 107000 99000 234000 172000 41000 9000 5000 15000 15000 485000 589000 307000 1669000 181000 217000 115000 611000 304000 372000 192000 1058000 0.01 0.02 0.01 0.05 0.01 0.02 0.01 0.05 22427403 22424285 22431009 22423788 22427403 22869037 22431009 23019380 22424285 224000 23504000 11784000 146000 146000 -109763 -1000 -128000 -129000 13333 16000 16000 192000 22327855 223000 23538000 11976000 146000 68000 77000 -1890000 2143000 2017000 -4768000 160000 -668000 306000 -4490000 1105000 -6326000 109000 462000 3000 4000 235000 123000 -466000 129000 16000 6000 -113000 6000 1115000 -6786000 9753000 2967000 ALPHA PRO TECH LTD 10-Q --12-31 22437616 false 0000884269 Yes No Smaller Reporting Company No 2011 Q2 2011-06-30 <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-4" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Company</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Alpha Pro Tech, Ltd. (&#8220;Alpha Pro Tech&#8221; or the &#8220;Company&#8221;) is in the business of protecting people, products and environments.&#160;&#160;The Company accomplishes this by developing, manufacturing and marketing a line of disposable protective apparel for the cleanroom, industrial and pharmaceutical markets, a line of building supply products for the new home and re-roofing markets and a line of infection control products for the medical and dental markets.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Disposable Protective Apparel segment consists of a complete line of shoecovers, bouffant caps, coveralls, gowns, frocks and lab coats.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Building Supply segment consists of construction weatherization products, such as housewrap and synthetic roof underlayment.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Infection Control segment consists of a line of face masks and eye shields.&#160;&#160;It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s products are sold both under the "Alpha Pro Tech" brand name, as well as under private label, and are predominantly sold in the United States of America (&#8220;U.S.&#8221;).</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-5" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Basis of Presentation</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The interim financial information included herein is unaudited; however, the information reflects all adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary for the fair presentation of the consolidated financial position, results of operations and cash flows for the interim periods. These condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosures necessary to present the statements in accordance with U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;).&#160;&#160;The condensed consolidated financial statements should be read in conjunction with any of the Company&#8217;s current year filings on Form 8-K filed with the SEC, current year filing on Form 10-Q, as well as the consolidated financial statements for the year ended December 31, 2010, which are included in the Company&#8217;s Annual Report on Form 10-K (the &#8220;2010 10-K&#8221;), which was filed with the SEC on March 16, 2011. The results of operations for the three and six months ended June 30, 2011 are not necessarily indicative of the results to be expected for the full year. The consolidated balance sheet at December 31, 2010 was extracted from the audited consolidated financial statements contained in the 2010 10-K and does not include all disclosures required by GAAP for annual consolidated financial statements.</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-6" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock Based Compensation</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company maintains a stock option plan under which the Company may grant incentive stock options and non-qualified stock options to key employees and non-employee directors.&#160;&#160;Stock options have been granted with exercise prices at or above the current market price of the underlying shares of common stock on the date of grant.&#160;&#160;Options vest and expire according to terms established at the grant date.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company adopted the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (the &#8220;FASB ASC&#8221;, the &#8220;ASC&#8221; or the &#8220;Codification&#8221;) 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Stock Compensation</font> (&#8220;ASC 718&#8221;), effective January 1, 2006, using the modified prospective application method.&#160;&#160;ASC 718 requires companies to record compensation expense for the value of all outstanding and unvested share-based payments, including employee stock options and similar awards.&#160;&#160;During the first six months of 2011, there were no stock options granted under the stock option plan.&#160;&#160;During the first six months of 2010, there were no stock options granted under the stock option plan.&#160;&#160;The Company recognized $146,000 and $68,000 in share-based compensation expense in its consolidated financial statements for the six months ended June 30, 2011 and 2010, respectively, related to previously issued options.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock options to purchase 2,511,000 and 1,567,000 shares of common stock were outstanding at June 30, 2011 and 2010, respectively.&#160;&#160;As of June 30, 2011, no incremental shares were included in the computation of diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company&#8217;s common stock for the six months ended at June 30, 2011 and, therefore, there was no dilutive effect. As of June 30, 2010, 444,752 incremental shares were included in the computation of diluted earnings per share because the exercise prices of those stock options were less than the average share price of the Company&#8217;s common stock for the quarter and, therefore, the effect was dilutive. The remaining 1,122,248 were not included in the computation of the diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company&#8217;s common stock for the six months ended June 30, 2010 and, therefore, there was no dilutive effect.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company used the Black-Scholes-Merton option pricing model to value the options.&#160;&#160;Prior to 2008, the Company used the simplified method as discussed in the SEC&#8217;s Staff Accounting Bulletin No. 107, <font style="FONT-STYLE: italic; DISPLAY: inline">Share-Based Payment,</font> for estimating the expected life of the options.&#160;&#160;For options granted during a quarter or fiscal period, the Company uses historical data to estimate the expected life of the options.&#160;&#160;The risk-free interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility is based on historical volatility of the expected life in years.&#160;&#160;The Company uses an estimated dividend payout ratio of zero, as the Company has not paid dividends in the past and, at this time, does not expect to do so in the future.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes stock option activity during the six months ended June 30, 2011:</font> </div><br/><table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted-</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Average</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted-</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Average</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Remaining Contractual</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Life (in years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options outstanding at</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2010</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,542,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.57</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.53</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options outstanding at</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30, 2011</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,511,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.58</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.64</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="55%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options exercisable at</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30, 2011</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,377,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.60</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2011, $487,000 of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of 2.07 years.</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-7" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">New Accounting Standards</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2009, the FASB issued Accounting Standards Update No. 2009-17 (&#8220;ASU No. 2009-17&#8221;), <font style="FONT-STYLE: italic; DISPLAY: inline">Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities</font>.&#160;&#160;The amendments in ASU No. 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity&#8217;s economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity.&#160;&#160;An approach that is expected to be primarily qualitative will be more effective for identifying which reporting entity has a controlling financial interest in a variable interest entity.&#160;&#160;The amendments in ASU No. 2009-17 also require additional disclosures about a reporting entity&#8217;s involvement in variable interest entities, which will enhance the information provided to users of financial statements.&#160;&#160;The application of ASU No. 2009-17 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In January 2010, the FASB issued Accounting Standards Update No. 2010-06 (&#8220;ASU No. 2010-06&#8221;), <font style="FONT-STYLE: italic; DISPLAY: inline">Improving Disclosures About Fair Value Measurements</font>. The amendments in ASU No. 2010-06 require separate disclosure of the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and reasons for the transfers and separate presentation of information about purchases, sales, issuances, and settlements in the reconciliation for Level 3 fair value measurements. Additionally, ASU No. 2010-06 clarifies existing disclosures regarding level of disaggregation and inputs and valuation techniques. The new disclosures and clarifications of existing disclosures under ASU No. 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years ending after December 15, 2010 and for interim periods within those fiscal years. The adoption of the disclosure requirements did not have a significant impact on the Company&#8217;s consolidated earnings nor the consolidated financial position for the periods presented.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In April 2010, the FASB issued Accounting Standards Update No. 2010-13 (&#8220;ASU No. 2010-13&#8221;), <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation (Topic 718</font>): <font style="FONT-STYLE: italic; DISPLAY: inline">Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades &#8211; a consensus of the FASB Emerging Issues Task Force</font>.&#160;&#160;The amendments in ASU No. 2010-13 address the classification of a share-based payment award with an exercise price denominated in the currency of a market in which the underlying equity security trades.&#160;&#160;Topic 718 is amended to clarify that a share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades shall not be considered to contain a market, performance, or service condition.&#160;&#160;Therefore, such an award is not to be classified as a liability if it otherwise qualifies as equity classification.&#160;&#160;The application of ASU No. 2010-13 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2010, the FASB issued Accounting Standards Update No. 2010-28 (&#8220;ASU No. 2010-28), <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles&#8212;Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts</font>, which modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The amendments in ASU No. 2010-28 are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. As a result of the adoption of the amendments, any resulting goodwill impairment should be recorded as a cumulative-effect adjustment to beginning retained earnings in the period of adoption. Any goodwill impairments occurring after the initial adoption of the amendments should be included in earnings.&#160;&#160;Adoption of this guidance did not have a significant impact on the consolidated earnings nor the consolidated financial position of the Company.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We periodically review new accounting standards that are issued.&#160;&#160;Although some of these accounting standards may be applicable to us, we have not identified any other new standards that we believe merit further discussion, and we expect that none would have a significant impact on our consolidated financial statements.</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-8" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inventories</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inventories consist of the following:</font> </div><br/><table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="50%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="50%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,488,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,536,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="50%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Work in process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">929,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,797,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="50%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished goods</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,703,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,985,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="50%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,120,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,318,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-9" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">6.</font> </div> </td> <td> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Equity Investments in and Advances to Unconsolidated Affiliates</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2005, Alpha ProTech Engineered Products, Inc. (a subsidiary of Alpha Pro Tech, Ltd.) entered into a joint venture with a manufacturer in India for the production of building products.&#160;&#160;Under the terms of the joint venture agreement, a private company, Harmony Plastics Private Limited (&#8220;Harmony&#8221;), was created with ownership interests of 41.66% by Alpha ProTech Engineered Products, Inc. and 58.34% by Maple Industries and Associates.&#160;&#160;Alpha ProTech Engineered Products, Inc. contributed $508,000 for share capital, and Maple Industries and Associates contributed $708,000.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This joint venture positions Alpha ProTech Engineered Products, Inc. to respond to current and expected increased product demand for housewrap and synthetic roof underlayment and provides future capacity for sales of specialty roofing component products and custom products for industrial applications requiring high quality extrusion coated fabrics.&#160;&#160;In addition, the joint venture now supplies products for the Disposable Protective Apparel segment.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The capital from the initial funding, along with a bank loan, which is guaranteed exclusively by the individual shareholders of Maple Industries and Associates and collateralized by the assets of Harmony, were utilized to purchase an existing 33,000 square foot manufacturing facility in India.&#160;&#160;This facility includes manufacturing equipment necessary to produce coated material and to sew proprietary disposable protective apparel.&#160;&#160;This facility was expanded by a 38,500 square foot addition in mid-2010, bringing it to a total of 71,500 square feet.&#160;&#160;Also in 2005, Harmony built a 60,000 square foot facility in India for the manufacturing of housewrap and synthetic roof underlayment.&#160;&#160;Two additions have been made to this building: one was a 20,000 square foot addition in late 2009 and the other was a 22,000 square foot addition in mid-2010, for a total of 102,000 square feet.&#160;&#160;During the latter part of 2010, Harmony also added a new 16,000 square foot facility in India that sews proprietary disposable protective apparel. All additions have been financed by Harmony with no guarantees from Alpha Pro Tech.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is subject to the provisions of FASB ASC 810, <font style="FONT-STYLE: italic; DISPLAY: inline">Consolidation</font> (&#8220;ASC 810&#8221;), which defines the criteria by which the Company determines the proper accounting for its investments in related entities.&#160;&#160;Specifically, ASC 810 requires the Company to assess whether or not related entities are variable interest entities (&#8220;VIEs&#8221;), as defined.&#160;&#160;For those related entities that qualify as VIEs, ASC 810 requires the Company to determine whether or not the Company is the primary beneficiary of the VIE, and, if so, to consolidate the VIE.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has determined that Harmony is not a VIE and is, therefore, considered to be an unconsolidated affiliate.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company records its investment in Harmony as &#8220;Equity investments in and advances to unconsolidated affiliates&#8221; on the accompanying Consolidated Balance Sheets.&#160;&#160;The Company records its equity interest in Harmony&#8217;s results of operations as &#8220;Equity in income of unconsolidated affiliates&#8221; on the accompanying Consolidated Income Statements.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company reviews annually its investment in Harmony for impairment in accordance with FASB ASC 323, <font style="FONT-STYLE: italic; DISPLAY: inline">Investments &#8211; Equity Method and Joint Ventures</font> (&#8220;ASC 323&#8221;). ASC 323 requires recognition of a loss when the decline in an investment is other-than-temporary.&#160;&#160;In determining whether the decline is other-than-temporary, the Company considers the nature of the industry in which Harmony operates, its historical performance, its performance in relation to its peers and the current economic environment.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Alpha ProTech Engineered Products, Inc. initially invested $1,450,000 in the joint venture: $508,000 for share capital and $942,000 as a long term advance for materials.&#160;&#160;Fifty percent of the $942,000 long term advance for materials is to be repaid over a six year term that commenced in July 2006, and the balance is to be paid in the seventh year.&#160;&#160;As of June 30, 2011, Harmony has repaid a total of $525,000, leaving a balance of $417,000.&#160;&#160;Interest of 3.5% is to be paid annually on this advance, and the Company had an interest receivable of $7,000 as of June 30, 2011 related to the agreement.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended June 30, 2011 and 2010, Alpha Pro Tech purchased $3,108,000 and $3,801,000 of inventory, respectively, from Harmony.&#160;&#160;For the six months ended June 30, 2011 and 2010, the Company purchased $5,902,000 and $6,507,000 of inventory, respectively, from Harmony.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $107,000 and $99,000, respectively.&#160;&#160;For the six months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $234,000 and $172,000, respectively.&#160;&#160;As of June 30, 2011, the Company&#8217;s investment in Harmony was $2,175,000, which consists of its original $1,450,000 investment and cumulative equity in income of unconsolidated affiliates of $1,327,000, less $525,000 in repayments of the advance and payment of $77,000 in dividends.</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-10" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.</font> </div> </td> <td> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Accrued Liabilities</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Accrued liabilities consisted of the following:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payroll</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commission and bonus accrual</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued professional fees</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">133,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued rebates and other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">469,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">296,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s Chief Executive Officer and President are each entitled to a bonus equal to 5% of the pre-tax profits of the Company, excluding bonus expense.&#160;&#160;Executive bonuses of $34,000 were accrued for the six months ended June 30, 2011.&#160;&#160;The Chief Executive Officer and President voluntarily decided to forgo their bonuses for 2010.&#160;&#160;Therefore, no executive bonuses were accrued for the year ended December 31, 2010.</font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-11" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">8.</font> </div> </td> <td> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Basic and Diluted Net Income Per Share</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides a reconciliation of both net income and the number of shares used in the computation of &#8220;basic&#8221; earnings per share (&#8220;EPS&#8221;), which utilizes the weighted average number of shares outstanding without regard to potential shares, and &#8220;diluted&#8221; EPS, which includes all such dilutive shares for the three and six months ended June 30, 2011 and 2010, respectively:</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months Ended June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Six Months Ended</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income (Numerator)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">192,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,058,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares (Denominator):</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="MARGIN-LEFT: 9pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic weighted average shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,427,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,424,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,431,009</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,423,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Add: Dilutive effect of outstanding stock options</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">444,752</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">595,592</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted weighted average shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,427,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,869,037</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,431,009</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,019,380</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-12" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.</font> </div> </td> <td> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Activity of Business Segments</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company operates in three business segments:</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Disposable Protective Apparel:</font> consisting of a complete line of disposable protective clothing, such as shoecovers (including the Aqua Trak&#174; and spunbond shoecovers), bouffant caps, coveralls, frocks, lab coats, gowns and hoods for the pharmaceutical, cleanroom, industrial and medical markets.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Building Supply:</font> consisting of a line of construction supply weatherization products.&#160;&#160;The construction supply weatherization products consist of housewrap and synthetic roof underlayment.&#160;&#160;The Company&#8217;s equity in income of unconsolidated affiliates (Harmony) is included in the total segment income for Building Supply in the table below.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Infection Control:</font> consisting of a line of face masks and eye shields principally for the medical, dental and industrial markets.&#160;&#160;It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Segment data excludes charges allocated to head office and corporate sales/marketing departments and income taxes.&#160;&#160;The Company evaluates the performance of its segments and allocates resources to them based primarily on net sales.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows consolidated net sales for each segment for the three and six months ended June 30, 2011 and 2010, respectively:</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months Ended</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Six Months Ended</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="52%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disposable Protective Apparel</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,871,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,845,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,778,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,929,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building Supply</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,356,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,863,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,103,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,585,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Infection Control</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,051,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,513,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,342,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,336,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consolidated net sales</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,278,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,221,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,223,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,850,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows the reconciliation of total segment income to total consolidated net income for the three and six months ended June 30, 2011 and 2010, respectively:</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months Ended</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Six Months Ended</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disposable Protective Apparel</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">302,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">933,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">598,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,134,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building Supply</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,095,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">746,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,382,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,408,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Infection Control</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">328,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">319,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">691,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">840,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total segment income</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,725,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,998,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,671,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,382,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unallocated corporate</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">overhead&#160;&#160;expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,240,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,409,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,364,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,713,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision for income taxes</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(181,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(217,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(115,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(611,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="52%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">192,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,058,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows the consolidated net property, equipment, goodwill and intangible assets by segment:</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disposable Protective Apparel</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">728,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">816,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building Supply</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,173,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,277,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Infection Control</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,038,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,173,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total segment assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,939,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,266,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unallocated corporate assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consolidated assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,031,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,381,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads.&#160;&#160;As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill.&#160;&#160;The net gain on the sale of these assets was $41,000. Both of the transactions were executed in the three months ended March 31, 2011.</font> </div><br/> EX-101.SCH 7 apt-20110630.xsd 001 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Income Statements (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Shareholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Note 1 - The Company link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 2 - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 3 - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 4 - New Accounting Standards link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 5 - Inventories link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note 6 - Equity Investments in and Advances to Unconsolidated Affiliates link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note 7 - Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note 8 - Basic and Diluted Net Income Per Share link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 9 - Activity of Business Segments link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 apt-20110630_cal.xml EX-101.DEF 9 apt-20110630_def.xml EX-101.LAB 10 apt-20110630_lab.xml EX-101.PRE 11 apt-20110630_pre.xml XML 12 R3.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)
Jun. 30, 2011
Dec. 31, 2010
Allowance for doubtful accounts (in Dollars) $ 62,000 $ 77,000 [1]
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01 [1]
Common stock, shares authorized 50,000,000 50,000,000 [1]
Common stock, shares issued 22,327,855 22,424,285 [1]
Common stock, shares outstanding 22,327,855 22,424,285 [1]
[1] The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date.
XML 13 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Income Statements (Unaudited) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Net sales $ 10,278,000 $ 11,221,000 $ 19,223,000 $ 22,850,000
Cost of goods sold 6,407,000 7,000,000 12,079,000 13,640,000
Gross profit 3,871,000 4,221,000 7,144,000 9,210,000
Expenses:        
Selling, general and administrative 3,296,000 3,518,000 6,678,000 7,302,000
Depreciation and amortization 206,000 218,000 449,000 426,000
Income from operations 369,000 485,000 17,000 1,482,000
Other income:        
Equity in income of unconsolidated affiliates 107,000 99,000 234,000 172,000
Net gain on sales of assets     41,000  
Interest, net 9,000 5,000 15,000 15,000
Income before provision for income taxes 485,000 589,000 307,000 1,669,000
Provision for income taxes 181,000 217,000 115,000 611,000
Net income $ 304,000 $ 372,000 $ 192,000 $ 1,058,000
Basic net income per share (in Dollars per share) $ 0.01 $ 0.02 $ 0.01 $ 0.05
Diluted net income per share (in Dollars per share) $ 0.01 $ 0.02 $ 0.01 $ 0.05
Basic weighted average shares outstanding (in Shares) 22,427,403 22,424,285 22,431,009 22,423,788
Diluted weighted average shares outstanding (in Shares) 22,427,403 22,869,037 22,431,009 23,019,380
XML 14 R1.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Document And Entity Information
6 Months Ended
Jun. 30, 2011
Jul. 29, 2011
Document and Entity Information [Abstract]    
Entity Registrant Name ALPHA PRO TECH LTD  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   22,437,616
Amendment Flag false  
Entity Central Index Key 0000884269  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Jun. 30, 2011
Document Fiscal Year Focus 2011  
Document Fiscal Period Focus Q2  
ZIP 15 0001437749-11-005505-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-11-005505-xbrl.zip M4$L#!!0````(`"->!3^VA:[7TE$``'4R!0`0`!P`87!T+3(P,3$P-C,P+GAM M;%54"0`#\1`\3O$0/$YU>`L``00E#@``!#D!``#L76ESX[:R_?ZJWG_@<^JE MDBK+(K7+,Z,JC9<9)1[;U_9D>5]2%`E)N*$(!2"]W%__&EQ$$B1%<)'EI&;N MS8S-!7WZ=*/1`)KD^_]IM91/R$94=Y"IS%\4?/:#L_Y1:2EG9+VY-[`RLQTX M:SCX$<$Q^Q%1^!W.KQQG<]IN/ST]G1AP*3,P18RXU$",'U!:K8G"__SW?[WG M0LXHXB).E8>5JTS=I:+V%*USVM=.^QWEZ\.9TE$US;\)[GB>4TMY7ELV^W`4 M$\0/GQ"Z;'=4M=O&-G-TVT!'_I6G_"PN<;V^<1)7Z]9FI6\H<9"QXBJT.21U MT%7C`LQ(0KSU0=L_&5[JLI;SLD$1_(7.YM[%X1FO]9:JM;I:>).%[3]WX.>G MYSJ+]+5V7/S;%5P=0[/4]4TF&'XB`PMFI-?1AKOH]*\(;S"1P`Q#QLF2/+;A M1$;[SREEG[I>V]IX/&Y[9[>7LJSK`(/6_NW+U;VQ0FN]M37NQ'+#$;A#*[3XR3,SC]JA`T-;!H%N\.PH MV/QP9*A_3-G-HJO^Y-K\AD@D7(AL!SLOD^T!.(1-?G"!H=MX:%!"G9"FL]G/ M1Q,5_HQ&OCY9 M/^GVW\^SM-?VK'Z(\><7M)XC>C1Y+MY8V,".CTHQ,5S(,+$_'`5IR>F]`SSPVR_^<@$G3TF) M#;^RZ3-F1Y/PLI2&[]N9(B(08)`0U\''F*%@KZEI8@=HT*U;'9LS^TS?8$>W M(MO]PZRW4]]<2RIOTI8CP99WR-&QC>/QM_[X M6OWQX&D&=-@\)\@<1/]9=G_%4?3PEM9R+9T?LO]9YG[MF'UXFW>2RS;?^O2^ MQN3&EIRZ@L4DAN)_EOW>0F[%")VN/WQWZ/-W>+Z/U*IWQ#*FC4Q(^@<4(+?L.UN^;; MKX1.HA,R$*(X(;:2;/\UFIL528A(-%X MN,==IO&PH?`>2Y\CZ\/1PK&=/_R]93AD+P&YW?IZ?S1Y6"$%')41"YO^MKQN M\:U-A:T0Z(;3$HW,F:ZMM4,B-R'41/3#D<9UJ4#_U#"( M"Z+OP&\`QMQ"U\@Y:^W)P>S0"`VYAJEDFIG]",((?0&7*&1^]\4'"R=2.C08-6[Y M4(+-B^<-S'T0!+(;&#SHE#'D,%DGKM3&X5RWCLK-.NPY6B"09S[HS[[X$A&[ MU+T'<^>("@;F5\W(+B:D#?83G-AN>/,K$UG(W M'Y#72EHV2?,G0LPG;%F%E.9?>$#Z"M$W2=7,AJG_$D-6L8TD%\^&!=,<>RE- M8[5&VNDYT2LF!#74WC%<54VPF.--(6?V=+'`%H8))+MWYPR;6*<8,0!)#.\H M=*>?"+:=7^!RF.DSJ8RLP=8/:[1]$-6P-7U_DAP5WQ:_!=";)BJ8U]SJ+Z7F M=I*W'2PY*ZE7LVL5U$7F%=;GT#4D.][7_3@Q!N]I5A5KZ-PPU5=51N=M"*(?'$LJGKK`C%_T%F M&=*+[SW<5E$%#1L,KBGQ,\;<*N3FW7?`_*"L;DTF"2G9-Z[#RQ3X#+T\N3MO M?DL,RVC9Z,9;=J5<#%?QY*%"$T)?>[TY1'5U\^-R!=K%VC:8V[AKU^*C!&2, MO*RMD/8J31R*]AKJ-DJ[9^$5L:`9YAI!)(7L)6N:AGAX:I:Q,:]KO:H)*&215W5<=4 MI[\_5)/@=HF)*@2E0'ETERSJJBI;9CBLHW;*Y>)5--5MH?4U;HT8KGB[JA16JUXIWK$&&I5E$OHMJ,&ICKKO5XW@6N'D(D\ M'(_BB$'I1?RE*#HE&W M(_A_OIBLP+,#5-"?2U7@5/-*-?C2J2ZL;I:,-^*KFH MC",G.ZNNUS:S:K+`IKJEQSUMKV3Y#E,C@@][@W[&,").%GPQL2&MT;%L,.[V M)$!D%J34G$QE3/>2[H5ROJ.&/P\XHS\H9YHW+%%VPT0&TU^F4 M@"66AM1(=HHI[P M-_N4$)G>,)"`*;);HCY%0L,=Q%?4,$]!L=8C0A<\*B]-_>SZ$J9PJO\G$YXH M:Q?Q*5PBX1)%*KM5V<%Q-54*=/&+/FKR"W&A,QSU^SM`^7)V1Z<$HFQFIIFC8<]GWA=7\3+!Y*7AF M.4>3BT)%LE*)1"$X<=(@6Y'2X"*3C%*"<^@68G?H$=DNX@NSK&#W)/_S$>)B M``Q_2?-G2*J/)_\+#6)W[G2T5\"3_Q$$<1E5G([M!T_^=P;$B=>HKU;`.A1RY(2,C!1?&H.LNPS3>7IC&*1=I*,.QT4@*J.0=0RM MZVWME$'QB1+&;BE9[,XL9/VA.QHF>VZL_8SA3E*ZK"?TQ+C1B'19'QB*&X>- M2)>U_=A375KZ/;(LOK_G?7S-@@%H:JZQC9E#=?ZMM:"$I!&7$->[Y41GA-/: MD&7]J-L7*I@.!UG6^08#<0@_&&19CQUVU4XCD,_1AB*^9PFS+?C90OP'?ON: M4`?_QW_W8`.>W!$J367D-H]6UHD[@@\?!JVL__9ZXB[$(=#*NFZOTX0GW&SX M.U/!XV>V0=;H"N)U(P%7V!S-$),Q()0$(STDC_K[!R.=I0VEL-2!(IVJ]4:= M8C!"94IX@HOP)XE?D+,B9JRLHYGY8)(G*<%-@Y5UL/&X"M:,LI^:>&5]L-,5 MJZ\.0*ZTEPX[M<&>8[8A3+<@'W4WU\2!WSD6#%-5,W!Z8G_2LU5\TKXYRAL? M]HM/UB.[N6/M?O%)>^%@4)+`+(0/^G/@L1]A. M+&I_M%M^$D"XE1L6-7W4&39DBJFDO"%55I4I+F/B4!F6E)?XL#JO"$O*>UZ? M+2FO\F'UZ\,ZQY;K(//UO"L06.SU)9`UXV#[0-:,C^T#63-NEHOL5X27*S@S M?82D?8FN7?X-G9M%JB9+Z!:956!2CK>M!QOVU&X$N!2._:HAY:4Y96UO2`TI MEP[5X"\,&;])-:3\?VN-[G`TVK<:05\J6_.YA]Z1AR25*C6K29D.,H+)6G?X M5C790Q\YD"8ENDE7U<;=D=J<)M4*RP?)ZK2,KP_7J=2N4T=9"EG&8R=9E7,U MX`P%.+L_^EM4!%RUZ','P)$`,.<[MD45LA)5E%/SWVZPIO]`)M3&VYR,$7FN4O!J?UV_*!3]'"$FNLY MQ3&OI:GCX:`K]!))8'D]N_#V0D-6U4GU-$KU>CE`65&TOBK-].N6)CPN6DJO M/5E)MKL!^''#X/V!..V2WLF;#:>573PC:F!6F"G4ZD!:%_X(FI4"E]>)THUX M?!0HN+=Q99`V8!F$TF:LIJ1TX&]<#>E58B`\SQ!R"4W!XG4#*;/623ZF(I4S MEWD\LT826`Y;Q@/EQ0_XE`34%0"5S)N[&?&\N:1>ZPGH))-F\8$YJ:=T@H7F M9&:TCSPM6Y)(5&DXTMMX(RDTZ>79S+*A<^\3[K;);N@Y+_GE.\L\V#12:9S< ME2T'(&MGE"+0$R9@WK\S._WVSV;R!*]V(;E16B@Y72I6"ZST,TF:\,9$.:Q9 M=7C";>';0PO>+R)=?Z>F]^CS)1:R*8E.EL96;S@07YZZ$UX1ON"5H.%+73)? M#=I8*K$3M@P2*8>HJY*T+0:%II#32;)#!F_1XF7CJ3="-5-J-)#LH;N02)FH MKDKRW:4G'2(+E!+36/YR\UM*^)A@?GSY"L/:S-[6:$\-!T:+I@RC:6I?3&8E MQ>\'N'P/Z0H/0I1"GH0.]@F7G`P8H"G*?0EJ(YRKPJN3I:5/]@%;^L$3\46Q MC<$6WP+:3,39B544V21$:4+K0:3$0,CTJN$A?X1,$O-79=XL/KH,IA=P2T// M#"3C@X18R<#@I[_-1S1AMBDO?;(/V/+#R4`JG&7BSG;>2T*CE;V;A>1;=.1Y MSHYB^5(SAN^X-[W64E.AS(PWB%<'*3VC+8M1QEY#NL`=-$^/3"AK'[Y0XMO=: M7R-9[YQ,KVX_3Y7;NQOEX>+LLW+U?$GJ:U_ M^0+BMR<;#E[)>XF9H5N_(YU>V.:Y[L@+:;6T3JNK^7+R6IN(!-9X.Z#F5WQT MQC^Y5FXQTG"@#>+<2KX@D-\P!:),3M:EI2^E:5B`?.1+3#0P2?G.&9RANC6S M3?3\,WJ1EL#GS:-1KS,8)Q1+MI;AJX%-(+_@S[;;2_Z^49=)B_T=L82\S-8$ M"OU+?R$6S.-U^G*)+43E)5Z3N$"AE4Q)WJDS\+,EH?*$WH//P'W*5A>%+X3K M]DM`B^Q83#D&T:THK8YK4W2D2#J8Y=P1)Y=_G7\\V4C$?^[I0Y:734I,]%:^CD9W9^*;1\H M%I3++TR=?&\Y[[RGZ13=PDO[P_=_N<1Y9R#^Y*?_LS+W/X#H_Z8&!PTP\D8W M>>S).,,VNI$^@\W@P(K/;_G_3?Y>\5YP^@F;SBJX0E/5_PT.,^?%0L'ARYOK MA];E],OLZO=3Q<%KR`YM]*2`L#$C65-KL]+39,'<5'E`QNI8N7+,$^6'[_7UYMUWHTY']>_87K`]H;U3 M"%63J21;1#96.B87V.Z MAL,42$`59#]B2FQO'>C$%Z`-U'?13^"@6S],LJL;!ARW,%L!8\X*`,U?(!M^ M1!;9`(!C!?AS^3=^O>H@3]I:IW^B&+IM4PHW!5?`]%^CP8>U4)='&.$V&TB; M+67A$Z48%M)M2LCZ.*TFC$TNWY#7+4\D4$[7NH%/D4M`++@&@9M>X>WGA$V%DK#]H(K16QOH*?$ M2K>_1J:'E;?#QUG=$AL+)&4&V^"B1#QX^UWV=?IL+-J&\LXCA[N-'&X:.!Q# M2V\S!FS%8'KL]3%=\?P>.4CPXM#$;$6001YAOG`,T=Y=+'3>@KZ!7[W#D/C# MCTO(L^&?!04Z6;+K<\-;^ARNUO.,_,W*I:S\,>CCRKW?I[/LRG]VJ.MUSG18 M>4(ZWZ4/7PL7=MICB!+&2M$91`27H2>J;SSSL1<;+H>8H_#H(,)Q(7^FEK_\ M_JT3US?O;!M4SX*@FMUQPQX*HQ*$69V%'2]N:&]4?$'0BS&RS.Q!<>:``Z!' M#"8'9\(V__XA,B,!Z5;#F#Z'RV#VY0\2&^3P`WSTU!WE"9R(\7?[FOZ`R8>" M!:;,$<+,7ZY.88[']>`SP2S_^>8]9;Q'2*^TX3L62Y(H\JTR)\[*[[B>9?P6 MMRE=VN)>CA?,PRFWMJVO(?L"(S_!/)O_ZS>VH?B1+S1`P$?6L9\\4)1*1L#? M3++F&QT.CU\<49#_?;4Q?U[=^Y*/Y^?3-<0I0Q?<)IZ)?CVY/XEGDU7&F-BN M3&H10]P!X`_QLIO%+46,YS/!^R[OP2?P`I#:3E!VPZO(B84-C-@#>G8^^+8F4(\P+%IDT*3RZQ8/(CM2I&6J_K8LT,TB"8!1.8EGLIVS9]@O0:P9B&^@`5W\Z]5>HL4T:T_^ED9C,7' MX4C+US6XM&V"%\W';7V)^&W'$(4-Q)A.7[;S^86.^3`?N2T7G5KOX4!A[#/Y M5X=B3,'DU'LRYAA0,M?R,UD2;1=`OI#V3$-G*V5AD:=H42&TP<;;CV`G"MB) M>=L;)J]"-D5V*3(<2GRSPCR5@CHB;ZY*;P*CO24^.+9X,.MMQZUQHQQ)G_P&C&:H&61!2_]2J@7O,4>,CO(A-"&(X= M?L3V!>E4X5\7MY?@![9R"6901JV?^;$4L*T;@:6/LYK8ML`+$.+Y=KJ;.#X; M!7X>]B!/!@+N4GWE'-R`/Q&F=+5C/B=3CY6G%>;+`OS;GV%X"X)(!A-)QJ:V M[0("?V,XKLW/*6_GLKPS<<.+_NY#X;-+C\\$@[SY+SJ%\]K@^/_;^Q;FMHUD MW;^"N\?GEE,+.7R*DCH4"`Q%Q"`&QD,2\^MO]\P` MQ&/`AT12`-FIK;4D@H.9?GS]F)EN&4XB,*184V%E#GA2LL33D,E4:.3>&S,P M*]-(DLD`UYP9_.'4R[H_(+(EA">#8&\\<% M@(\)[S1M&;(UBK.HN7(1HB,?-BF*%M<'LT/8;8P73QL:+U*TF'_1/H.?/D6+ MFQ%,G*JKB18%0!AY#*G-E6Z'MA0N;C$?"U&5*^PE!`OP:H1V'LC-%S#D*GLJ MG9NXLDF="\WFQ@T>:T4["IB+KD5^,!F)^-P_^0:&$^P5<^3G%'S.V&*`]"_E*3A@I>V8A_J]A*O"9!9!E9BTJ?H^\5(#)8QMG$.,1 M`FO,;YET:I5;+/>)Y5/:H%-N1.%A8T,>=Y4;87A<-:62]%30==!N;(AI:A>F M+D`8>/M%[JK1!J_S5S#7/1YA2>5K=")C%<<_BF/DX]!WUY`KJE8:TKBXRD?U,OV3/UA3^+APFJ9FU/P4"A,>=<],/2LD;:__^`6(B[5) M7#LG&Y(]>JM4)+G6$A6/"5U=XC0*(9W!)A-Y-*&ZK/<6N/SAW!!12P?".#P/ M)+ND.9U"[Z=6D?%@/C M9>VSTS/Q&83$>>9J90>S='$Y";9^!J>B90]`\)5\`@\/3D?BM[-&4 MY$:J@%"(`OS$=5)0Y'!>)/28*5Y=&,M$U7/QNMRL<*XO-RDY9S&KP[#A*GS`JN<3E!").YB9D5BS`P9*S ML61%8O62JHM9-GR5[&_>RZS3T)0;I1GE>6/F$_H*Y"S,HTD"H<63QO.%<1%5 MMV[R_('_'PP&YFC8RS.ICB=U^>2E3-+SI0**6C[Q,I_DE#P\^YNRI3)2/9O6 MXHI^D>D1)`WY%;$%#U(&B&1L&3V`O!#;H<9US6ZO9_8&9ZEUBE>(?E'217BR M%IDU9"W/2J,-Z\N_9H=Q73HOL4]:25U/\BMQHU2$^A03F:+-@JCD MGYEYP1*SJ.H$>+B!2FA(S]X0*AG9210M-"NW82H$$\*TB<:'S`5RKQ(/6Q;[ MQD?^`B@UVDJ\)#P_D:\K4TRC6N\]9]`!#K'$[.8?+H5KKJR!%9Y0TOL&H+VX8MD^DALUF5+O^5X M*,##*IVY]Y5.@BR(FGMZ@6AV* MD0-Q'*_U1"8)'LNDX\&/Q?H)]SQ^)U!&[!9&R6QFA1#81L5XW9+%1^:Y\]M% M!M?NCPM?]N5#&"5G])`=R?R6X]F3[SB6-QQ7;1H6]B/'/([Y3+.NX5"WKD\7 MKU^_^_C3R:M?KZ]__?#2Z`7W2S9`'RAQJ^B5>^,"AY;LP2\FLFI?;TW:=!]( MFIU39NENWPIB;4PKFZ-ZI,3J*9*L2<&^CH2O?OW\^LWGC()C]`N1CH;(4:W> M0=T-_"[;_*X]_K#57?%'L5UM)>UK:QS,+%[D4NN2OVPF&CK)$"R[^.7=3Q]? M0LP^@4_702*M@+19Y0B>")X.#)[2)FTG1:[O>1:J1=P6CK@0F[4$3DLYKG'K M9/^3^R02D,NVF=;G/]E(LI&MH179R%:`)]G(HV#S0KL_I_M[^HE=+K+.J_,> MQ)`',^07=\+T,WGN^C(5_MW.K]&2T[`[0[CTS'EV@2._IC'8LYN0)[YS`L:3 MAR^-_[CLO(7_UKRQ\9CD:Y57575,N5?5OTUN7CP"5=QLW>G,TFMWM71)K^/M^.[&`YWOY0)W%+L&92TZ2L+T5E$F1/_W M2:S0XJ4]>['F*Y'S(,6)T*61Z/)LC0S;T:%*]\5P1(#2#M4B M0&D6H)"[LH0X_1==`I9]2](V\@EW4S=FU6P"Y1(.(I>0M;3;YW8CF3DRV%"^<==,G]Y* M;'Y[5$GSPFM-,;X+UNVY^U:MN^.=?B%B]]HLU\@K+V10+-W/!? M2ZGV>@)@V*83`$W$I"9I8+.$JTF4:10V-$:'1R0BRX8VWX4]L<+(62RV*+5;"YD&*$Z%+(]&EF=F+)T:5 M[HOA&0%*.U2+`*59@$+NRC)WY<7I@("EAU9@<)]=[T1FE/;J7^3J%8'LA!S]\GT0G-Y85O'SM M1K;'HR1DOTXN<\O[+%=R":N*1.-YT7=>]9F/KME]_`HEX4?YHA^RX5ADAZY8 M]*\38,J%;?/$Q_;SGT+NPX\V$P-\Y/$?++YP@#Z"KGX,(WYFD__ZF]W[W[>@ M1-V+($2>7/-^!YB$/_[M1P$3,O%1TU/&&//08:'Z)-_A>=/>SZZC_C"U_!L7 M_^?`>TY&.MCI/'EOZ&H.L8"8,0\T$ZQJ_@IL5#"='^/W=Z^O?Y804/[RFEF] M`LX\($&WA>S<*@Q1?]"WJ!EH-7`7.:]5I%VK0_Q6TIF/(AA\K7XR"\`PKO"X ME!4ZVI;&6R4P&=.-C>D[O_2VM$4-6-+.N6G$4V:\O;AZ!98O2@#B=7PUO@0. M&)DJR3_R%V*8D^[(>"X]IK->K_./BZLO^<^R3[K_^,[4+U?.__J/7V`!+MAS MU\Z17Y)@L:9+L-1XA\JJR<`_O^:!:QMGWA&0.9W_BWW;H$V=VX\-7ZS0E>8MG?X"(OBZOOA MRV[LLJ(^O,AYE-E/UT!]"Z;FR.FYOE$F79%Y(0L\RV:":]\2"]\#1+AE)V.T M^A!E1%\C`[@&#]X)SMF69R=>WA%*AYKPT'`8+&$F&MOA;I4]Q1"[XX(G%XN_63;03'`(7;3% M_(J879HL?-.*C1EZCQ'HMCMQ;:"_-S?<&?@E8F#M3%+A[X[^`;XED(O/0#;! M0P0&@.H",Y%?S[O?B:GQ,0"'8!?,N32>-8YX.#;`"XSDS/$+:G+`S.<].80( M-7'%L%X&LE$:9 M$DY@K.?AIS,>PMLF$X;T+U$;Q7$)D_-LM?)"5U;8/Q5RA[QW?2&&0N`0)X$%@I>@=R'*6!DT,NI&P%L)JO4D"P+`<3DV2*NB M6<5A36GHN)A8B('%(#)67LE2%4.E@''M#/X7,5E&,RM$-`,/'.2I_'!N^@&/ M!%>$W"U4-QM'1G`1T(1%&+8X^O!M:?#65+_CB1R/]Y:?6.%,<&5W8J5S7(K4QZ'%6$&I:A0V8RRU^*SV2*4>F48D8F`00`1ZV;F[P`TD' M6)7K!XFB,TZOD-C*$9G94]_]EK!(B)?(0A1L#GQ=34["<@[A\QBJF;61^`[X M4>6E6GF#CJ0LK4[8)7SJ2G&#MF-ZXO?%!K`H\;Y2::Z6#=H:F" M%G9OLR!.14UC5RMB4I[7*J$QT+W`%Z`;+;Q$Z3."NU?)**Z2'N`%CTJS#$O* M7R`BV*D(''>9-P1S[51IHXC1[>#\*SX0^E**\BF1T;D62\.IY,>7HF(Y,@-: MG)7R,7-0HV!(DJK>8E>,?-&"8P(3@HJ":U,PU&4SKHT[UK'KZ?HK$UIAV,FT M;V+:+\#O]QYCV`MFO=NO-^O=_O:3"=6]@G(F8=0M'NW_[N467OQ&J'P.@1<9 M&HP1?4O0#,F9]B@R/H6NS63,*G+])R+9;ZAL?\5*">Q2>':9A"'S[7FJTQ^L M\"L30<3O(C+`OWU!C/?F%1?G#>@\(-\5LY,0?[@.+0=$)5/?[C]D3`8*%259 M9(I"H,F-S%B(:7KC'8I'9%Q;T5?C+0]MMFFVI!RM&R5!P<@+E%RF`<#L15%F M]P0)2S(<"8+*/$H@"6I8@H)I7H*E;`@$&YR4394R6(KD=H[DEC'+"'Z7$3S) M"&XP0>,JO:*4Z+$@NIXNJ9#B]I4@D`SBI*V?5Z1:1/+6QBLNK3*W_O567*%X M,L:;MK'$[3!ES"(E\7\M@'/,FDCY4Z1`QTH2H\I!L-EHD,8R[H-@-E24`+&R M1!Y`3LK,)V!,H^*W0/1[BSR&[TE/KTX>0P:CP`A18LO*%C<$71KP#O%]``5A_>(19E^:!A>P5Z*PP_; M6.NOZ(Z MI5:\/\3]@-^G#'.KQB<)`+!(%D!HJX"G/%PZ&`3_X-T+B+S&/!N*ZV+_X(N/ M"56!FO]F(<=L[$<1OMVR"OA>6F$H$/]"!N@%>3855,ZX(W5?S*ZK9E<$E!LU M5:&5:FYQ.K=%E)4LYO:7G%ME2KZ:JV&G>*5O8/4,F6OQO]C(I2&F`B\EEL6IOBO$N@3 M0%T>:G:Z7#!/=NHHXL3\_(1FUEQ.2L5X^013=:R2SE9C^V)8FD7M99HO"517 M1J:5=',^3KV(1+X\2KPXE:(T;,U^SY98COB1M/*[2"P=^R2STB,_H:-,=$5` M[60F=M1NV8DD#\P"(5Z*+,^E,T*&3D%2U=-FL=3RA&PO<:0[ETY9ORU4&!KTYB8!R^[;%?/]*%_B$=Y$ M'B\7R"NS#N1!;.A!_%XFI)188*/GH5+=NC`(YAJMA>L09:Z#Q*50XSQ(AT,O M8![`07(S-2(^8XJ;$N%_9 M^Q<^N%A0:14PQ)AY+KO%!!]$(L8D"<6SF"!+P!?G?F7?#5$/OB?W2>4P/O>9 M<2:(X;)F&=Y.>WXS86[]PIPX<<"RR?+7SGW\(S/)POMD:RQ^\`C5\^=(-&FH^'&(0\XI\_.>"7\7X59J]934*[KG7*@U;5MO&W M<+9QT:T)=6>7@NT*8FU,*YNC>J3$ZBF2K$G!_N8M$58;L-W`]3+?H];[W*I3 M\BBV+\I]E&?2[YA;L+I$=BW9:VJH:(FWA3(J1U8>>J]`1T9A?5J146@%.I7/ MT%5#P7Z7C,,NC8.^A@<9AY8`WM)\PIH%`'?234`;ME$1P!H%VW%\^MFZTP/. MS,)-3LO3WHG="0;DI2=7;>3A!6V.-,QO5#T;*I"E(=X.\[]]Y^%5K/\39NB#D-HMV M7Y2&C.(A&T6J*+G,$^^=MZIK^&$81@(<`IPC!9RN.3JGBOMM]<:?,A^NV;O8 MI9M.?GKNK6]=WXVFZ<6.\JOQGDOKO/2-#\VU4^NW85V7[^\K$5^.E\=`.JW] MW81V>ON\1\H-S%&GWS+CW)Q-[<;'"01Y!'D$>47*G9KG9T."O,9(8'OV#,H\ M&!S818L]V!P=R=HIMCNS.4`BP^')V&.KC3&1JK'J2/ MCZJ1<5I3@5I'A-+^AV:#I*"_NB>*#SQB'TB_FC>Y.K;EP7/:G'8?N'!N11UV MK-+TQ5]>!2S][V(R$=7[M35%-B5*%=C*H->BCF)%2-Y?2=%>IS,TC0LOF%K& MIY!?,WMJO$'H8Z(`+_S)26PLC?C.MU\8SRU1^M=U7"LL20K6ITU',7`8T_@E M=EY\9PBH%I7I0%`LXT\./QAH4K`HO2Q77)H3+"'!NHGP`-864 M5*VX<>)Z3KX'3SJ(>DQ?!4^4RQ:C83G)K.YU86ZE25DW(1,5M$Q81!"ZMU@% MW99UZ4SC9RN<<7]N?/(LX*\=8;WOVZSN:CK&+^[,Q>)?^7JKZIO%VNAW5F38 M(1.5P@2)^)W/PFCJ!I5UIOV#Q"(&W1>GI_]IC.=K<+0RDN`P:O;P[$5_($;Y M8`6B79H#4ANZL@]%<4D74<1MH=$UU>#6G$9A$J))E#M."G5G?,M='%1$ET.5@E5DY;):6+IWR)&(8/,BN M(7,?]!T4%5PK4!M9S#VMHU[MRJ'::T7&)!'K`P$$_S&>2YG$+B6B5P_,R[4\ M^#,.6JUTB&#!?7Q%BDVRK0MPD\\6?Y.%5J4$6[KBR(NBX&FU7BS;.(703U6> MQ=*Q<9A@44-X:<$BIX-,K'$(,*75V7=^UOG,K,(B!F25X:($)\6BXBKPN^#[ M@S0(!QY8'JN2M!=!`(KLE0@4L1OD`%7YW%@C*]5;%40N.@6FI64GB>A)`]CI M<:RA+.RO,;;\KX;'+;]J%615:U$HU@HM,#98%/?>]D"\;K&>\WBNQ@?ZNTZ2 M2FS&4T3L*?B9LBF=UJ+D$5JC?3;WL%%V"`3'#N'JA584,6GTE`7%.J$@GDGL MRN>R)HPY/5:]A62#!-4JJ2\./A@1Z$Z(M+?Q"V0L^;:F2#C3JXO#9>(S%-6Y&Q'%\Z.CZ\E MD7%.,$LLBPV2*>H*BK=4.9FR&KMXXLRP++!(F71/5[.X/#M1XA=X&:U6H$QG MP,.IE*[7<5#6^Y5:DTY:@*_/%\BJ*1,O`+P86%';JVU82%52'"T;A+1_BA+/ M/`TP;]U(]=B3#38NKBZQ)_76.V`OS8(4NW*("92B1&&:'0:RQ52OI-`5M@&E M3'Q:%:A<$[>LFX+Z-DH]J%RN%KCP1>.JN^\6TT&@"++WFVIAJ]7M*W2/)[+T M.'9>O"RB%:PN[3T1%2:)U@';)D=9UP68E`_ZK-Y:F5PZ"]$&H;[/;H&^O[U[ M$Q6(6[*0D2*SON9YOM5&D1("4RHSE`V"YC@LOMA,Y:N6`!FCJOPL$27_13=E M*W9VGJOVT3:F;O15]F$N(J86G<,C;JKV2VE>3PP&SQ#^;!-_ID*V%'L=:8-2 M`R&;48%%`ZK+9J+5[M#QHI-5L7'66+BYB2XSFXEUFHXEEFZ3I;()283(F4-* M!,K,75FTX`/P>5-L(%<#LJ(1:R[GOAYG\ZB6=NQ`@!&5Y^5X@ MV7!74_#8ZMN%ZQ:N.IWE6KD7(;64]Q2-1&67%V%VT1*I'(>.6(LV.`MJV:KA M1)$P2TFAR:[4TN:=?,'5BG8-I#,/U!GL11*I5L/>?(GR9+V*,]8O.@&AGM@H MA"C&TL'.'+A^K[^=9F:96E:(EVNKJ>14;H8+Y7TOTFB_R31:<0.L[.M5Y1(F MG_=/7J0K6K@,J'PW?M9$QS(\+GVFG*0O$J,V+DK"2H',55]/!(]*U.QD8@B M^H['FD`+(FLL;8]-JPH-)E$.W2%ZTUP?&$A?"9:X-S M>.N&W*=L(1P!KI6`X=,T#=16YO:I5Z4*C%Y')0 MSX8]<<'#-#QFW8K>B-D$%VF\'/L'W9'<$-2"F_)C8.#^B^%_EI:8FJWJJ,+1 MP.:^DA<+6BT"`$>"L'H!X#AS;\71A?(&^[-1*E%EPF2!I\QAE,0@W;HF-W]C MO'F[:+J9%]YX"B0U0!+C*;BZ(AU>Y`=R669&B\F[RM:BVI(`P.B;704O`C_Z MYEFG*WX%9KOI(3RS+/6XZQB+K1A3)@N5ABQ)5#"AZW+R)2]Z^5+R8IM-O+RB M9T/SO--;K./4''9&U75HIEZ;WB4KN7>IS;&ZRI:LRV86Y*T3?N5!=V%RE6Q( MDWDN\3HO&JODN+S.35>7+:::1]QP<<:S7G^0+J:B%=U1;\W%:>V>SHM.^9,/ MH?4A$V[M/.N9W9$RB#6Y8=7'2;P?_5[PA\&=`FM:\(RR%\C3"VE+U?**-R=? MU^SWA#24#P5YF/U-S;GTP%77^^SH5NKJX)S49UIY&XW2,<1^-8B)-HY?BBV+ ML]'K'W@NG916W1FC3]8<+3W\&B;,^46UE'=9=.$[H@-V[D^+42]E1-'*T]1= M7:>N!ARGUAZXW5J#1MUAW4V.5=>==M[1T6K=Z_9_O'I4KYGE:56JR^@(7CA, MK.?(.C1_U"%KI>FU\\1#HIG&K['\%>O27?[(/]&V<]+EN3^*%SNXOE-ZGX]9 M(Z^.^_G%>`NNIV:8.:L:*BX3CR5^\9:Z*PZ?'K++1_ZWU6%QU*E66&SEY:\' M7ME\HLN#6U_U5EI>/\FGFIYKT7J?_PD9*?^QT]&>NI_3$:!T&DIVZG_\9.2G_H? M/QGI#[S_L3YLHPYL2_>L=A:??K+F(?>\E9*V-4VGED<;:TSS6QXUHD1BTUH= M]4[KVHXVTSRNA*)VZ18!#0'-<0!-MUO7P8"`YK@Z%9!OW23?^I+/9FZ$)23J MSO_A,=4Q]Y,(KRN&6#5I-;R1)TX&LGF$:86A/%_2?8%L)3GES50MPIPV8\Y@ M21<$PIR&^^>4_SYT'[U\$:/R]B#D$R:<>"R;RFI*UI.+WABK0.:RS>92702F M7!;YYT].#`*<8P"CSY=1E$^/-/;,3T9SRU\G$M;&I@X]M,!AV3\%RS6&U1K-E3V6O M.D_V#K#4J72&+>KP#\/_3(M0!B$[B:U[<2XFZWJ2#J2>49,S98=@+"V9CG:%I(>WZ%E;U)"PQ M?$'06^XE?FR%KH>M%&W7D32$B=V(+@QNF"UB4BW(CA?MZZ:3=G3S.5`NG5(Z M5IX*19*E)!%M/"0QTFH*6#1!O5*CQ'*`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`(,A MD&&%)[OATC4NF6Y7OU6.F?%TOEE6I]N(TW[AV&,"&X!AEQ'?%MTN5(,^"!2F M`%JQ:H]10I*T2Y2?".L-SXM^8Y&11++[EN@L!^Y6$J3:RDX%F*7:W_) ME,'!CF*JDUF^!>&;3U>:;LC9R+*Q'G@EGON7:E9\QS#6PYX>MRRT;JH3KV@6 M3^(HAF6*7H%N/(7?@4HW5BB"$RJ_;NJ:JN1F[$B=R:\1%I'VR`82 M@SN*C/!@P`2[9N/SN:XEV9B*S*DK)5OF(#>T?F:AN4Q1'66GF7RWEY?+XJ<: MYVMAU]M?K[V\>;*=_9"A-D]!U6#7S@@>6>&_TXVR-KT';"FOEZ^ARG,EMN>: MEE7=$,3B:X'%'R0&ORE@\&JMVMI9OR/;6*=RI@VE%:':8:#:%?B5>4Q;*1WK M(!DQXTD*CI,!:7#)4PHW*-QH?)UQ;;:<##-U02#4)W0B=#HF=*(R_(>A<81. MA$Z'AT[D.QV&QA$Z$3H='CJ1[]1JC5LKG_<$=R_UR3\JX5A[;&ZG6+UZ=/[1ZVAY)TN\,6G6OZFFI MU=![H@0S!#,-AYE1CV"&8*81Q""8.5B8Z9X3S!#,-(,8!#.'"S-F9UC?%(:@ MIMFUW+9==9IRB4W*)5[I+RFF_SU_S7P^X]M).O'!%K"-2GIP)O") M"-,&4[AUTI`Q)'0A="%T(71I"LT(70A="%T(79J@9\>E1(0NA"Z$+D^4)FS7 MLN:@ M-S('G3Y9.-IS;P(Q"'2.`W0&9N]L2*!#H-,$8A#H'`7H]+MFIW-.H$.@TP1B M$.@CT^N;H[(Q`IXT)Q*.,Y+K2$Q M9-\/[/3$)A-FQ]@[(=\D(8JQ(1`/L-U#I)/3!FZ4:/WQDD>01U!70-)UWJH&PP&YFC8TQ"-P([`KE54([`CL"._KF62 M1U!'4-=`TK4>ZH;G0W-X3GY=$V1O&YGGISRZ6N;,@++/NQ`WU5JZ3M0/\F3L M4L,].!@$V)GA!A(9#D_&'EMMN0^?;NM;[3JZZ?>(Z0#N0VS$H>DN(1XA7M/H M=AB(=W9Z;G;Z(T*\ALD@(1XA7M/H=AB(U\*CQX1XA'B$>(1X#T*\OMGIGIO] MLS5Z/Q'BM24G3557#[GJZJH.3@$+90):6W)52TRJNKI_`TM7@]IQ-8AJ"S6` M9H0NA"Z$+H0N3="SXU(B0A="%T(70A="%T(70I?&T&P;:4(ZNGKP1U=E0=>J MI-')TZ=6X&/;HVM":\-V[\J8<01Q!'$'<3B!.=Q..((X@ MKF54(X@CB",O[O"5=0WJ'"EE",8.',;T30`(QMJ8^FU*O5Q*^^ZT8L$JA:74 M+UG;W=.-K"T%#>U75H(X@CB".$K]'K"R$L01Q!'$D1='RDJI7X(Q@C%*_39, M69>F?N6'%@B0^!Q^&X??XX\_?)]$)S>6%;Q\8X6^Z]]$GUAXA3?$K]E]_`I3 MFC^J<7Y(G[QB-S/FQY]9P,,8OO+:C6R/1TGN.X8-RX!?/K/)?_W-[OWO6Z!" M]R((>YUN]YKW.^\3'W_\VX^"^SBO@H-IP_`L5`P=\]!AH?JDH_YH,\\++`?+ MIVH^B0++KG[B.NH/4\N_:[Z^6PTQ=PJ)2 MQ#S0S+6:O5Z!%`5]S(_T^[O7US^_-/JG:Q4X6`RCK<-02)YOIZ3"(_3T6O#@ M(_#@\S(>_J[(..:>LYC0^8LU#$9)>TOY]#H.%+5\R8.EY^K?O"9A]"N]L&/W MUHWG*][#)\:K)(+!HLA0**%MK/>H=6N`3K>!HH6[W>SRH&+42FX!V/Y,HMB= MS)>I^@Z$>/&ZZRDKT^R2SP++GQL\8*$5PSBN;\33D#%CG+(R4JRL*1HB1RI( M=PLHOA=Z/UKQP+8&/!*27)&43R&/F2T:7%X$`9ALK\@@-,*1&Z&)1LVTX/=9 MX+&8&?A:^%/)"CC9NXQ@,328]G@*0YA&E-A3PP)QF')F\UL61L9SU[>]1!0Q M+Y$UGL*LOB66<1U:7Y6/,QH`;WRP+4'BCSG^D(WTG0D+3R83"VAE6T%D%IU_ M\9`%AMTT)B&(`_SK66/XLQ7#CS?\SH_$R%/.G*LYA9X5<61WK4)RW8G1:\2EQ/)V17 M21!X\Q52KX1=_#T.$QO;O8(LXS>+[+UC%DA-Z/YEB4=`!QQX&MB]\-"SGP!( MZP?,S;!FS'22.*\I3R*&\8[4C;D/7P#YK$HO".K$2,!I#3UKCH!<.S.%Z?*/ M9[WNZ!^1P;XE8,"!VF4BJM)08FR<%O9%L43'@LG$]5QA$Y[_#(K#_?EWAHL& M`G4>'LC&RBM]S&/0(64RTL%1(U,F*JY).P//%\`M'6G,/'ZG4S12L]VIV3L? MVR2#G%;8<0G#AGR5?4DU;0(0"V`9?96@S.:LJ&C1U&4>X'00@GBX`>#Z/,7L M%'A-`V,S!<8+;*XJ18;)&E5X%\,KV*T+"B;D38GM8J(%E"^*GV-`>"GG'[`8 M_Q#!_*S8N$,+"&0SG"3$E>.D)VX(N@S6+L2PM:@3\!H,=FS'*`ZA,7A!#99_,PX.C:EH:*+(]%WTOY M048Z#'RH6#BZ2NH$=,76/:NU`57)2=UI!A%Z(K`3!01\:Q!P6+`MY,Z-%TXU MOJLZ3+JBR`A9Q)/0QH$XCC4SQE:$XAFZ,'<7!!OLBL_*A!*K(P!];'0TX<"( M.Z'GPC$&C_5.6N_,3`+M);4%AC$+G.2H(+NYP23&R?!*6'OWW@"[&D_!/ON( M3>\30*9^QQ28(1Z!'SJFQAE@42`]]+(#M#:VR!4]))-6R&(/GSI15C[?NC1] M^LACJ^LT/&MA\G@7>V`:TNR<,DO=FQ7$VIA6-D?U2(EUNM%V14\K7R_ID;_)^XU,UR-PK,)(169]6QV)$EMV$62L$>&K46FE&KL"77VE$ MFF)"6L^.A1Z2.3E,<[+T0`O%>A3K/9V9[FVFV]JC1,TTTRT/+3!KMLZ!$T+] MQFL'3N0['8;&$3H1.AT>.I'OU&J->XI\ MW@I!.=1BO8O$?#M4-24/\;4AI2&E(:4AI2&E*:IM&,E(:4AI1F M/9JM%0>NJ%']E.T)-R])O6YAB]5IH.IL=IL86B)K.Y:VZL7W\NNKU]_W==AK M.[40Z111HYKY-J'X5\.:^/;,LU'7['3TB5>RD:TINTI00U#3;*@9F&>#(4$- M04U#B$%0<[!0,S1'HS."&H*:AA"#H.9@H>;FOWA*9E&\L(;0@R"G(.'G(%Y=MHGR"'( M:0@Q"'(.'G*Z7;/;J<<<`AT"G4;J%H%.BT'GW!R>T5YJ6[..3WFT47,=<9?I M2,I'YMY:;KY0?KEJP;#&)DO#^$B!`(\`CP"O"'C#;MLRKP1X!'@$>`1X#[PYTQ_T M"/":)W\$>`1X#21=ZP&O;_;[;3O.<\B`MXU,],[.O[8]S?]`7#RNG3+:0FSQ M%B+51VD`S0A="%T(70A=FJ!GQZ5$A"Z$+H0NA"Z$+H0NA"Z-H=DVDEI-.EXY MH..5>Y/!:QY;GAY*#V=[4L!B0R' M)V./K=Z8VB/=FE!992-ZZ>WT/@\<=DB)/#;726@MQ:#I+2$=(1TBWS1NF MO5[]87)".D*Z=E&-D(Z03H]TYX!TK;M+3TA'2$=(1TBWT>GQGGDV[!#2-4=G MEV:>Y8>B50U^#K^-P^_3'[??R+E_NFXGYS^3*'8G\UI1?@#IKP7I/P+I/Z]* MN$XKG7LFW//XG>O?&():1C3E=Y$13YD1,IO[MNNY%MZ`-_C$B#%?:T3L9L:` M9V5^N;[-9PP>4L]5$KCJ@0D/Q?CQ-&3,L'S'B-S[\K1F0()I9##?@2^_3WQF M]#NFT>MTN^(;V'G:A!E&@>PVY,U?+D6T0D:X*`QRV3;SO,!RL/BHHGE',0\_ MB0++KGY20+BA3ATWTI"Z/]1\O]YZR#V776ZCK'-&NX6(L@TO8`W2[)PRZ@\[ M[1R>T:K861W>O8*C&1$UJ<5&9%6 M8-9*(W+EWJ\V(61`R("0`7G]T:ZMP5Z.3BYE M/2;'5FL((7\+M(X0BA#J,!%JC=TS0J@6:!TAU+$AU,''T^0_'8S&$3H1.AT> M.I'OU&J-6RNOU^";LM0">7?RMWCK:S<*>"0.KM5$;9]"'LM33\9%$%@AT_4? MV0DH4-.NC96K^74EFG`4N&'U)/J=NCK1S;2C3TNMAMY<()@AF&DVS)SWZVY. M$,@9#>HZOQ'<$-PT4:L(;EH,-UVS?]:VWKH$.00Y!#DMAIQ!I[Z:.$%. ML_.-36KYT:.6'WN3P7?^!,\NO![O2\ MKKD1@1V!7:NH1F!'8+><;F>#NJX?!'9MS#SO[*1KV]/Z#\3$X]H9HRW#%F\9 M;ITTM&E(Z$+H0NA"Z-(4FA&Z$+H0NA"Z-$'/CDN)"%T(70A=GBBI174A#_W@ MY#7VU-43QDA;\JH.NSIQ;/#)R:6S;+SVDI4\'BO9-4<]NL=]`+O\CR"'(::9F$>2T&'(&5#ZBQ-R@9 MVA#31#:[Q3;[>=?LU1Z-?PAICL!J?[<&(!'8$-@0V%3!9M"INV%-8$-@TS"= M(K!I,]CTS/YI?2L+`AL"FT;I%(%-N\%FU*WK`TA@LQ.PV4;2DPI8'F@CF"N0/258*Y(X:YTRX% MK4\.<]O(-%/!2BK+0IN#6R=,&S8'J2Q+`VA&Z$+H0NA"Z-($/3LN)2)T(70A M="%T(70A="%T:0S-MI'4:M+QR0$=G]R;#"XM8VES7V32\:XYC+:DGF5;ST\. MGCRCW21CJ]U/`1(9#D_&'EN]%[5'NCW;UH;GMO>?ZNBE-])[I%B_4W>'JIG& M66L8#DU;">,(XPCCMH=QH[JR581QA'&MHAIA'&&)S^&T"]!^!])]795:GK"RO$^YY_,[U;PQ!+2.:\KO(B*>LFFD-0AZP M,)Z;%5:Q;XD;8'F&UO^C8OC6E'$XL@8S]-&1"^7J%$A M65ODG9RES3POL!P'YJU(U%&TQD^BP+*KGQ3@:*C3GHT$NNX/-=^OAWJY%[*= M[8U1YZ&7'5H(`-LPV6N09N>447_X70'0F'O.VL3:F%8V1_5(B=7;S.3T-[_Q ML)ZQV3XB+]O:*@"R#5C$PN5,WS_;WR<^T\^DWS&WL-E%9->2O=?I=E>#TM9V M$X_LSLQ>@8Z,POJT(J/0"G1ZS6PV&\.\:H@&QJ%+QF&7QF&-`GQD')H+>$T] ME:8/VZB;R=.X] MY^*[*\_`UAW>WB=11KVZ9'LS+>E*U&J7;A'0$-`[>F*[[M MJB?DAC?)#7^5N!YN\.F#_ZLD"+SY'L-Q,H@;ZU/S#>)3$:85AK%G=D?U72?( M.)(7WDC=(M!I-^CT1K4EI@ET&NZ1/V5RG#K>/)VO_LZ?8#Z\MN/-);PXY+HL MN9Z2C?'7-SY'UT[=W]GI=RH:O)85?G35X#T?A.^W_R#\`2HO01Y!7A-)=PB0 MU[Y4R"%#7J-W#]H>"#X0&8\LFT)IIC:GF:@V8`-H1OA"^$+X0OC20.>03GD? M>LIZ:951=4==W5K7B6.#<]:TW4MVLBUVLF^>]\];EE@Y#"M)H$.@PB-+O/9&^^VT\4H; MK[3Q6J1<;5W9!Y&-]EV;%300XA'B$>*5CIITAZVZCGK(<-?VG03J8M;0_85" M;=U6;C(L-=V'4V1Z9Z:;RL)O:*\WJPN_WW1BI]]M63KQD`O#$](1TA'2[0;I M^F>$=,W1V49OI[1]KXJ.J=).^*'OA-,QU0;0C/"%\(7PA?!EG\ZA_+"%_=$> M1/SU.Z3]ZFOH_):-P\0*Y\:9:6"'&%/T1[ODL\#RYX;H5VI%S+!N0L;$^7+X1L0\SW#CR,!Y&WQB!"PVQLR)1`>UK*)*;IP/%HR# M?8#49(H3@`%M[JNL&;\',C#0">@1>4EDELM5Q7)PSK/'9<"`&<7TQ.O.C;#4`4/Y)-K)F;:H/'O(V M;96G)=4U+!>;[MU8\!886S+(0UJ7)PSZ-Z_=R/9XE(3LFMW'KQ!'?H31?OC^?AQZ M/XJ9_G]02P,$%`````@`(UX%/[%L.@^]"```8%H``!0`'`!A<'0M,C`Q,3`V M,S!?8V%L+GAM;%54"0`#\1`\3O$0/$YU>`L``00E#@``!#D!``#M7&USVK@6 M_GYG]C_XLE_NS@XUA*0IF28S!)*4-`D,+VG2G9T=80M0:DN.)//27W\E8U)> M;##&BIUN^Z6)$7J.GT?G2.=(RL?_YO/:%<20`@Y-K3?54/5_W/Y#RVM58CMM M`VEUS,6G!D%0DF?-\S-6IY,Y(.E]N.2U[I8+I=U[].7I@P% M-13=%O6'VYNV,80VR"/,.,"&!&#HA'D/;X@!."(X@EU::`OY6W[>+"\?Y8L' M^5+QW829N;,90LASFNRVVZHOO0&PG"%P*.'0&$H)==E( M#^U#G^N;I)5U+(!AFXN?;8AC&[K:C;`U63NK@`TO+3*.:^#+]_4SGT(#6(9K M>>/J1ABR9"*<<(A-:,Z-E-WM(]V9KYN`M8BQ!&7)L4WH',D"/6B=YER6'P#@ M_%-A#')6=2GUQ%FDS+?&&^1]P'K>2/>_ITLN=6AQ-G_BL9LO%/T!_WLPP,(0 MV]E4R7`%>T1?/+MH!"S1(ZOP*J!TBO#@'E@N5/$*T8#U!0T6I*_0Y7<$U)C; M*'YC1"82KW=UZY,%P](C.G!& M"!SKJY-S[,'>I,01^=^T*=:27/B77!@X5"3HX$FTB*FQFCBO+ M%2'F&%F6"@E>^LXRW3\(")F+8U-;QR+['R"QM'J)6!<3PW)-L0)627LDW*Q& MH6BDA4[$L1>HC$L78W51A43:R]INCR$3`8H@$\80PWLJ//*:(,SO17.7 M0B4SQ7X&95?:O6@.F>1C:GZ#0$\8P`6HPB57`,H^$66>M#7!5&9LKY#>KB"E MO4P,5RTHMUVE*>%Z`W6A^3K#*!PL]<0JLB)A;(4O:/;U:\4.G7*<#7C11<8W M4)W8DGXA)UN`NR/8>)4D-A@S0R%J2QX;PEG"#M'FQ/@V));HE,E4@D]5R!*` MLE@5A;W0NL"^"Q21X[Q.=-Z*F:%)LK>_]G MKW(B8/6,1,PDZHH2QIJ4]-4$J<7NX^9Y;6!!UH(CB%THZT],4;DZ$"?U$1P@ MT-)@#20GS!=CK@09;_2]SMO"*]0L!)?&G+8%&?T**2=W3QKR^W]Z6__WHP''?RB(_*YO?CT>!Q MBKLU=WQU3,O'GP^>NITILXY'QO>"=N M/)G.H/3M_@*?E]R".>UVR$.Y\ES^/)P8E<\7O5:]V2F@VVX-@L[=HZT_-,#[ M;K4_*COCI[^U:KOUX]1FG#@++4N6^+WSI):8+BNFC3!B7`HR@OZ^O)+(&PTY M_3VLB*,S*I/A42-N-C.B!+"TN4J04B'QY2Y3_&$A#P*+7D0^/D+"F/-IE\D"YOQ5P[\Q].RHZ:(+K-"5Y+&?]E#$MG,@K)%W7(5_*4MK0Y#27F?O MITP8?4F?:@Y>S=>0M!F;K$%KLAXB9RP!K\2C=K0@W?77?J+N2G;X.>M?=:7DI:P"4N?>7>)W1E=Q7+OQ\Y/[X8>$_R=02-9,E/IG0T]OTA<*QH"*P< MJYH[0(15#N`B%H1?EE6@:'3VCP2BJLCO0'+:E MD(R^JU?!7T76-=#,%L/CZKE.:[(GBD+,O4088".M>24(/9EYQ3NPWW"\VN;% M!%(#,:CDF/)VT,P.U0W:ATTJ(;0FN9RM1LYTMEP$^8E>/W`N MWO)'%'^BUP\,#6';?*&G33Z^_.5CK]7_`5!+`P04````"``C7@4_) MTR9=+`I9HFVF,NF25&+WUQ]2EUBR)44W6M(N^]+$D6=&WPPY,^0,^>Z79K-Q M`1`@&@-&8[1LP.Y_V.R_C6:CBV?S6QTV^HCQO^H,/@'^&7H"A/_._SYE;'[2 M:CT_/[_1^:-4AP10;!$=4/%!H]G\7T/\^_>_W@DF70($BY/&<&HU.M:DT3YH M[.Z='.Z>'.XU[H;=QEY[=]?Y$O^&"='WD49!8S$S$7V_XV.V&!'S#2:3UEZ[ MO=_R'MQQGCQ9B`\"SS_OVT_O'A\?M^R_OCQ*8=B#G.QNZ_[RTZT^!3.M"1%E M&M(%`PI/J/WA)ZQK#&*40*Y&Y!/BMZ;W6%-\U-S=:^[OOEE0XT5$_HS!7MCX M"1RVG#_NV(`U&N\(-L$-&#?L=SQARSEXOT/A;&X*T>W/I@2,W^]H<]846+=_ MWV\+7K_R#[YQQ5)L0D.HZ%0SQ0O?3@%@.PU!]NZF'WA5S9Q/M3G!#.A3H>N6 M>*@52:/E&8(L*;]=:P0@-@4,ZII)BQ!ZG:24=^@C+@>X9?SG&6>65>YU,ES6 M_'+>3CD`4VP:@-"S'Q9DRR$GL(?)?AHQ8Z@XB!8+:%>CTW,3/V=%\N7[K4)& MU15GE484^_G"+$U0:Z=EWR[PU=OIN;<+,PN'7`8)VL6,'Y=8%@%<$(J3(9,0 M[8(M,;L@Q=ID#CD*M\X\LA1@ISVL6\)C=)!QAAB?G/MHC,G,CFW22!5+QP>9 M1O2DLD:$35[4(^*E0_L=#,@Y4\ZH:8"Q9IGZA*%A;/-(@RR^I\6S*T4TZ"Z-8(-%\XIQ,XC(!_4I$"L0U- MX&2*-`@3CY&IC8#Y?L>BS8FFS;^]Q*-<0M#G/])0J.P7'FMT9+^U^^66F*9: MP&34^\2>N)KM73=!^C6&B\_"L@L]U$81NBU*8(=#:P7O2J<=$I29VX`GBFL. MR>S%_1#J6`TUB')`_,]B*.1<1R6QS2X8L_ MH=_SSX05`S#F95T,]_SJ3V>H8OF*YV#B/['8]J29G`WML*Y&R!*BR6?-M*0$ M-?"'?X58*Z44N:7.'[!>+F:BHD' M+##[9%)('SUQ2I@LKX`4!03H5WAZ"L?#Q7<_.[[7!,PU:)PMYMSU`S[$!FP* MB*-WB7:?A*W,J+,H=22"S]720:X$N`?&@-,SAMK"(2]W8HIC5X-A$HN6JX_# M[*-&^O@(&PFE09[`]#9#T'6TVWGF*,QS=;:\-C5G*9M'`'-A`I)\0BR_DG61 M=%J*0\S5R.\Y%B8N,#:>X6HEJTCX7VC7`NH5$BZL1SE@[2.FH0GD4=3+0#M; MZ*9E\!!7)N2)^$I;=B@N-DJ"GJNFMYES!!&"42:DH7W4&8^A";ET]-8:46A` MC4!`.7^LVY_RP?KKZ/L^>$MC')\_+5UX"' M@)?.9?#E(JG\!+415QZ#MIHV*Y!2+"\E)E59;-,!XB&?(9/VI?-^?JF7\L*^ M7.%,X+77]A#=R^&NO<6/:VTI5CZVL$ZTQJGLA;L8@PI;)%K'J8CE.F(!PR>& M7!U$,"MGI2*3'J+@*F([9CMJB,2_M(GH52OTZR`&_'91"T0^'E<8Z5M9)0KG M66$'D1PW;VSLYW`5/M*2!T69(4]2&XP8$#E'0GAU?(I()SZ.K*HAO_;:GOD> MY##?+I[-,+IE6/\N;Z]RG4<)AIS,A`([DQO(%#*;=PS#?E_-O-:@T4==;0Z9 M9OJX20EQ7N=:9@E$E!4&8IP$P.5?DKX!C`L+C#.-((@FE(<`ULPR18TFGP.A M#J6XVP1),#EWS6V90@,82D56IM<2HY$DYMEL'YQ$ZVU22QOS".6-[:B MDU=YENK(L^GG=1R#V9M=B-X*5J+[BONW5Z*^WJNI*M95Q;JJ6%<5ZZIB?3L5 MZQW3Q,]B-C['I(>M$1M;YF;!GLPETU0"U*'@*R6D:\NJN9-O[E`'Q);4L$/L M:T#L=%5R/A[)M@XJ2P1?H,:[`$799&G'8E-,X,]51"5)01OL*KQ>E0BM_)6M M&^3[E%I;4H3+JA8%3)$X!HH)R, MLL'8)GJ+34E199!%'1#?@*60O.J"8$JO"1[+V5;SDZ]LO6@H%OXL*76IA-NT MEJ84=.,K%4XSPU\QD-1DFW6!:8J&`OML5K.#C(XQX^\M&(BC6%V64N;A9)Q+ M;!N.,JG`I)P0O_R;]#TP)T"T!?"7YS^;P$:!,YQAPN!/]S2UXO64B&])Q2U) M-)0,MT+3M=<6$&XSCHRN7[S""'NSKK031Q+P+3$-23P4D\"7_^BDU9#O,$;@R&)B MU6N(G=(BN=-E*,NH6RE.B.M"!5>7,Z,:D@OZ59+.&+N_>YRB[D"&4H32\R*CK"(`]%6.%J% M-/[Z"@`O`^Y)4IWDY=JE*F7XVECKBZB.],"1V6TM3P'Q#,O<)$FLBU"60"$#MX`\05VT M?$%LW``=3QP,I9UG(UWFRJ\+R]=:Y@+(P)QQ`^86T:="B`[B7!@DP.A9A+M3 MA[$T&TG#OA:30"H\"^@P2\;/F8_*4Z#+O_K%3^G@+*(6S>;H>(H-"['_-I@+ ME.C9`A`=4CE^-[T0-5%E.F"+J'*+8.N83-D*C9.B#KM&6<`MI-9#U1EL*B.\ MSN!M21L[_MY<<4W:N8F?=W*X5;6C\T_=T7GW2[/9^//+Y>?]O_Z\U^?6X@$= M'AL_CYXF#TMTU[.>+X[(\=''O<>[X9*:1T_ZS[;Y@;V]ZWZZ-AZ^FON'Z'XT MZ/;ZRXOAC]'1XX=#ZZ;_^+7[6=/VP71QT5KTSP9_/!V=&C]:[=^Z7\X/^K\] M/,PFLW,#M4__N&/?YWL/G\\O'_NMZ<5];SA#G:\_EKL]>C"^?'NP?_]'[\D8 M?2##CW=?EA_NSJU9Y]&83_:_?SY#I_M6VUC>#?']<>?'\-)M%&)WJ1E;=R&5O8)71C6P? M0^\Z'+LL_Z5MI:,S^)3ZMHFDI"J[^I$.D-QU["HT2QJ:95F`%,H,+&.)-2BD M0_N>4[>R%XO[\+C"KPE^@CQR.UW>47%`2KZ!((-K=;-6:3@'#I+*ZF?1N;B24H MJ3%X2YI.JX[\902J"[PT9:=J),_1(Z::-6M@"SD;/;-O\:F^ZU(5GZYG.\M> MH)UP334T`>*"4/NN2C[)9+SL,!&=$H]8D:RU%%@6L?O'A2:`QWT]X/S/>6X< MIBQI:+[.MR3GG,J4UT9:`C!SUXIOLA$#&?$O2+K<+)YA&3EMP6H*X%?$38R; M+*X)F&O0\"YHJ=`N>1-T+5T7(O7%'Y7:G MU5A)_@;:3H9X$8M1R?V[I,7@I-QKT+Z9!LOL)P=N;`@X@6\A.R1QI.JS0Q(+ MB#_.S#1B^)CT:E!UGGX0P/7--VFI8%KK](^A M-.@6TJRUP;"/&)_'H9AVI<4QKS,M,2HN06H0-@V.+UH"T>LP@8 MC$\MRN<'SD:.SA*P+6_=+9?2D@!:0-M%A'\,D7:+L488]_K&&J%8!@IQ\\4: MYQ!I2"\DUH@C59]8(Q80?[%L+N=TCLFJC'XPEGQO58*8TQS#?%@9G_ MF&C_9+JU`O77F58EGDBKL]?1+*+D*6PJ#9%TBVXIC'M]W5(HEH$2]VR]M)P5 M3PG$?R(M>-),,;Z=+H;U1149NDO%O[K54MG@#)Z$6*0".]R&"%ERBBV=*/;E>8LX[P41,D)8#>Y MU*.J/P2=S?-=MNXEVZK-4OE)Y2>5GU1^"(?X&%7Q6W?3;?5"=?*42M' MK1RUFK\XI4BU0Y-^Y5R*L] MCZU\Z&<36PW*F--@N7&(7SG^5A5J*8^K M/*[RN,KC;LWCKA^+LW$FCG<>DN^CE0OI6H0((Y+IE0N6L!;I<=%:J4I"K4J\ ME(M7+EZY>.7BMYE4N_>.7P-B5Q3)S:$CF=6ABCH&JHJ42/N]J'*CRHTJ-ZK< MJ'*CVW"CM\Y`N@%S<3<&FFQI43H)VSJXUD3PE>YD>UBWA)CB5$S$(%OVT1B3 MF7,1RC^AJLH`\)OSYC=@(F[ZT1"[TF8Q+I<"_%O\[TWUZ-2@>@N<)WS*40S'X!&SI#1XQ+D M!S22,Q63O!/NM\X#O4S[G.?&`QRC1D\,F\J-DAED?E59`$I[4#YK,J MX]H:F5`_-[$6YJ15@RT%R%2X5"'GW M/'<&!-;)5SBA@P M_.<#9T;8<:4OJ8H0QHH)VE,"'4Z]XM-$/#*!0Q.0P@!? M)UL/R]X`(W`X:$:$;5I=+L`$D\)FCB#1FD1I:T@$#O/,".X78)H?$7Y&MT"C M&`&C3ZFUDC,OS%'D:P)X)#H>].E/F_;GE%DJSYS1(#A(9SEH@D_ MV55N>!3_."Y-=3!X``$YR`0`4`!P`87!T+3(P M,3$P-C,P7VQA8BYX;6Q55`D``_$0/$[Q$#Q.=7@+``$$)0X```0Y`0``Y3UK M<]RVKM_OS/T//.F93C*UZ[6=U''ZF-GXD3I-8H\?:=),IR-+7%N)5MI(6MO; M7W_YD+34+DF1DDBJO?U2QR8!$(!```3!G_ZSN0E>P1BF7@X#<+T`X<'C?/H$ M;(*#9#J[\$-P$N?HKWX>WD'TN_@.INC?Z.^W>3Y[L;5U?W__O8^&9GZ8PBR9 MIS[,\"_`YN8O`/_WO__S$T9RD$*,X@6XO)V#\?P&C)Z"[9T7S[9?/-L!5Y<' M8&>TO4TGH1E1&'^Y]C(('J91G/W\B$'V<)U&WR?IS=;.:+2[50Y\1$>^>,"_ MJ(V_WR6CM_?W][?(7ZNA6<@;B,!N;WUX^^;"OX53;S.,L]R+?8P@"U]DY)=O M$M_+PR16H`L(1^!_;9;#-O&O-K=W-G>WOW_(@D>_4,X!\%.:1/`<3@`A_46^ MF,&?'V7A=!9ABLCO;E,XX5,2I>D6GK\5PQO,?(QE'V/9_@%C^:;X]1OO&D:/ M`!YY=7XB7-1^#1:=M+4D-,*_>(,(JI$*'W(8!S`HB<4@)&PC&(B0*L`8=.+7 M@$:8_TE:PB28?W[DS?*_D()F210&F,*77H0%=W$+89Y=Q=X\"-%OQ]=9CM6Y MSCTT=Q,KX.B'W1%AC2:PK5+7*;V8H!K%Y:>APP;TF66PD$V'A?X574=$Y='T M^`9))-Z\NGCT"PL`%!``!0$>5T">_+1%D/Y27]LXK0O$2_V21O1CP^**$5M^ M@E`BOD?L$B=I,FTKRCQIQ1LBNUXE%_4BM%%[J8%/):`_EP+\]XIPQ-@A97,Q MSS9O/&_VUSC+$%R^62@80!8_\;)KPH%BXA:V%ULPRK/R-\2";(ZV"R/^C0## MUB^V#`6?`(%!H(-8=;&J+W)Q8+V0K,:$^>5]Q&(2>!\K'<7]%O\IG"5?EOXN M/$]3&.>R+XN_X7+G]6^?Y3LKCPC1)DK'`H\,?N%PLY1QO#*JPI4Q0C:[`8HH MX.YU=>8.94_KQ.E1S?IK[5,'7G8[C@/\OZ.O\_#.BQ"&;)P?>&FZ"..;]UXT MY\<$';[-<]:\F6MMCHO=&UYM2_X?C)' M,,^A#Q'\ZPB^@WFAXT8<)AD^ZWN]A!B1*U5,`6DU9P/$,`?)!'A1E-P3MWV2 MI"!(YM?Y9!X!KYR"AOSWAYV-T6@$O!R\GL<0[(XV:'8$*^U_]_;*/QXBZ--K MF(+=;3)@Q-A%)PZ&@IK4W(TFSM9LBI;&GL1W"$B2+A!$$QI:@V_7]+&H!?I7 M#@EAYE@E>')@56!M,6U-U%D*9UX8'#W,8)Q!9`Y/\UN8T@W8H*520;NUYJ<8 MU0\%D@1J4\P$D$[-B+U)\&S@UWRQ2JE@\4 MJMD]4H;.KD&24")0M'(&"&,_F4*0>P_.+96"^%AU:EIT:U?+M,7BV::>H^LD M]Z+F=)1<12XQ$)'9<9D_D?DS7&/2=C]+9C#-%V>(*SFR5MBSGTT17$,.C12? M;9=;1HQP[Z)3R)X%R_'$ZW:>TE2197VK:EA^>[5ZE23!?1A%)E2H@FU;74K$ M`M4H_^S4:UEE/"OO&OU=8IX<+3M$852U(QT]^-$\".,;DW)7PFLCPZA#D#!R M*J<6>\ZJ!7$31*D+MAY<*?*AP^D9#N"R'!NG["0>3R9A%'HYS"[FUUD8A!X. M01'RQ">_1;;L=1+&^7LT?(ZD;BHR;T^0737M0*E`?_%6@3;!<`D:_4SV1"^X MPUFG#.0)F".WFSE']BK-5*C/"0*XKXJ02&'EP%ZT4,OU$0(R9$42+,.'52G1 MF?L=:B;*$\8S;X&/%RT<6:]@LIN)YQ/1=$@]HZ-=NVQ24?&.C3FK[%#@D,YA MP"B@6541(+-\4B@D1*PQ>#QK:UP'C(V"6U$(\Q]>S\8DFOUQZK49Z`R!$,TCNLT>N4M!- MBE(K[^?QNLNI5!"$^/*Z%YUY87`2'WBS$&V<#!HC06\SUM[O14ICWT9Z1$%P M-1'@>M+-,`8^G>N\SDA=LK6H6(T3;3+A)8ISF'MA#(,C+XW1EYJA0'P^G4?X M\!GYPZ$?&HE^%+!:5;EF>@0J5TX$L)CIM)))79BLEBDNOHN6$5VM;>9IT.:5B4"9TVYV9++#=6@03K;9^063D(M*(\C3@-1%T:@367)M5HF[A; M`U8S57D+8G0Q;UH?.I0W`8^3]+"X![A^)<[D0806`;8/)W2($_EJ#7!\GT&SG+W`S$E M2MJVEFT93AI$)$B!8G&7WW9#7H-[0A)-5G2I0&7[ZHR`#ATMHMDXY^Y=@_"D M^L,LNGT\L0;U=)F;M*)"+#[G>L00HZ-,3#YW>!K%$:A4K59YH*];JZWP3LCA M-]E(R9V&KETMF^%9K3S7(DVEKR4%`I90^*TMG39&5)8IKS>B&IVKD24JW*23 M-\`-G5YT)V`!.#:Z>O*NN63JC.ERDV"60MRQ($QB]',$\0\8US1)\_!O\GL3 MRJB$UV85H@I!PNL$RZE4`9DYSC-/.A*N7RY09$B'\L'3&7XK""DYC53?(`?$ MA++QT/3_<$*3K\BA0M@XB&0IL!Q!0F>AJ-[IL9U$4JS2B-;8)<5`>FM2>"8? MUN"AL?^Z!H<*@9*0D<4-)D?7XA4D5%,.P=IL>QP".GB^:HW)`[@*WP_']1_B M*`$N/^MC1`^M6WH+\]LD8)HCF?@ZU1#;;IZM0%-3;ZWR#F(R4>FDY::/EH;, MZ_VR5/G35AT/PVR69%[T*DWFLW=)COZ-%H3VGSD,3LN-\Y47QIB(T[@<;L2A M;4F*Y9QE2S(E:>X;-!C@LU><02:/$JPT[7+B]'93C)H?W(%CK;,$Y)U,](G0 M3Z@(]=XE<5+Z5\:>(E#`:[G]9B-!XO:;9.I:WUY';3>5!;K2=E-M_9W:;I9V M>ISG:7@]SW%QYV5RYIDJ%F[`:,`F-D9G!Z#Y>)F+]Y"_G1P;IAV)?>0Z'/+V$,#9T.B5#9CCD$=(@;D"MHDCM%$HIN M78/X2VZ?L$3VSFRRJ([`R76L&@D2UXLJAN,$-U<@K!ZLKZ:]],L;?V7-]TLO M"WT36L!'9-/SX5(@4`;R-_(H6&$KJF+_IBL`KNR(5)"L]HC9T,'C605Z&$;S MW$QQM@B5[0U(0(?H2(/^M:U*#4&C5F0JTRF6%^UMT^\PO+G%Q75WR#6_@>_F MN%7$Z62M?->8S=(CP'+B08LXJ9F[+R`!CX+BE'L3%:6@757F=M(*5EGU&=?: M+Q>@*CX/*Q<1=$FPF_'5I*[!N+96Y`'I<9-N*&BRE'NM7@QGLNC+XN?BDZE= MN>YZY4$7NHG$ANH="$U:56Y$,&7TR436YIU_4<)M97U+S>#5V;=AK95N,3T0 MVGBEHHT2<$]2__\JP\C`-H8<\S#!Q*2Y+-7`;T/!$_I++R+=#P;X5G27IB\C M$T99D?F2NZ.Z$A!XO`.Y[-CJ^NRJ9#0;TWV>%R?,EXF@*QE!>.UE,$!4X!0E M.P$DRW/H)S8@G&,4.1A"H/#>8KB`(K5V%>G M@]Y$T@X%0]>)O"A0@T3Y_7@""*1+2.!;;SK[$?V&0!O"-JZG"&O[NP:7VF?Z MU##1_2_5D72^?SKP,MNCZ/DOG.G M+T6@SMI]J=&G?\*%80$";/`G6LVR;CJ[:&"..R)HBN_2L]T MV&+3@FC0Q;4;*O(:3/M`"\)K;QIJIQ'X*"'VPPA64*;I3Z$04:;2P7E9/I/6#8EJ;ISX`8E`VU+TDY7 M:M>`]!G:9\RR3T4>PQO,5YEUZ=""@K?MOF(Z=O`:=CC*F@ZC9T>OM;CJ(E;N ME^_NYN,BOCJG!XLGAU^?5Z[_/K M9_/SD\]_'+SWO%UX^_!JZ^'DZ/37N[V7P=>MT7<'OQ\_/?GNX\?IS?0XB$SIY^_SI[H=?#^^"Z]?IY6]7 MOR]>7QW/I^//P>QF]\O[H_CE[GP4+*XNDP_[XZ_[O]T^^`>[B^^BL^.3+W_< M[R3;YWOW![_>CI^&'^,OX_W)AW?W?X*#B_/-S2&T83#52JE%9UH2^]\B?8+9 M23PFMF`.TV MG&HF2)0X*Y\"3:N1:[VG7&T[RL)=V774>-&KXN$=+4830C/%LW*$+NH,I10) M.T]5(YQWAVR6GURI5E?;I3IP'?I9"F=>B!^&AVD*@Z(9$3*CI#DJ-:IV]$R) MDF$HH`JIP@P#F5HFL^AFG)`^NCY]+W@0'2*[*8IQF&PNX=+*;%:-MF.QJ:-?D;GTJ;_=#;K=[JN0^NF(FJ>0"/[NNBX M^N&%";W6P&[@P2*%)G&*U$DZR&D>J[EO-:>I#BN5QCH,:]5YA"VAH)F97NJ> M9*#ZH@#+'N24%^W-*9)K:XJGMJH$NE[HDKKT'6/1D27K?'4M%> M65[#]K_.PQ0B6X2L3[XX0US/T1:*$[NSJ:&FRQK8G1R!J-,GBCR*"Y3X^&-6 MS"6N&2PG.MZ_].7/[E^:_&E[!K^&YB3.$9=#[.09"Y:;D?9Z9M!!*5<)4]#% ML)K".6H=A!Z*1"Q5/RXGVE^J+RL3L!4^#(D5SNFG071A%TFW+1D'!-\139T;KMI2`PX+@"%J-,'O;A1)D< MZMI%F6'E40X]RI2H@T*4*6)8YRCS.(R]V.\ERI2!^@NO40=%%QZ$J[;&YM([1QYBF"R27JI6G,*C@"74#7,.;,,8/`)&#@B'+=66MZ@+E M,JGW;U:MOY,J@;QN3Q(I0EQ6MBZ_?Z?PMMM=ZWCGT4QI=>\ MCL5V3+9.@DAIR$!L9Y9#P2?,>$`X_Z?3T$LLKYK[RE^L?G"%M1"_,I:=3LZ0 M1)"I(N"0`;L(;^)P$OKX')K6!>+FF4D4^L@I;F-R>D%C[8F=/JB56:T=9+4( M#JR(+!:7EYGZU(32QO7&R"YYJRY$F+"7G>BQ?'3=A5;)HX]KBD]\0@8L6,(% M)6"^G7;EX/>A5:Q5[\SI5@XEOD@?)1G93^HOA40X$W^09'FV[`M2E8RTV`'Z MPF3O#FM/%,LV@EVT$=!VW`0&8-$X/17K62_*_:!/EK9-RW6DP<2.T)4DV^YV M1WJ%SZB64$G_5K:14@$8$,@;@&VX5$(7[0Z..I_TH6(K'5`ZL[Q=A'`(,S\- MR7'.Z>0=O&?VH32)T8\^[3Z+#-I'F(^#9(;H:;5#](/(5N:B'W)EN\-3M#L@ MP*PO=('?TO72P%G):?\:4>T-_?&S0\JD%15&]H16A%C?"=I0*;+_2UAX`UC1 M_#H\@`""!41Q`@4YG!Q.)P6J6?S6K&UGY\M;^XOE5M/&BBN!L>?$JY`CL\'/ MD`UVWIM!5SRE255>?%M?6H;`A%&4XK-M^V3$-'3Y6`#&V1V,Z5*19OT2>0,# MVADB03>T;F:I!5!;CJ0^:3*#]0,R6$7_0`88Z:45!VB[O,.O[9#VS%?UCH)C M7D=!VU:NO>Q+F]>2FQU<1G6,)DRB!G8[NZX^80)U+K280J@I\Q"-I[X6-+>N M%3*KS2V3U08?:]T]RGXVS*^6^`]HJY\VIM<08GL^I)D%R(SX'C+B!1KPAM]_ MQG[S>Z/Z4_6_-\?KMDYNOR29V`-ZIM"V(]TO^4T]G@HL&[P/;(,X2007^VMF MP]D`!;[A[#QF])/=G0P(J&5HX*6XSA/7MY)D=ZM(H!&&M3J31E)D>\3SHHC$ M)SI[&$9S[,7C6G[:7!H@J/2DQ%E5G+*X*N==B2%=BD&$&(SXYD)DELLXA(2( M7.]B_%*'AF/N&B58\ZNE"V]5,G$!;[!O?@YG28JSL=WR$CK0K-DE#:)D%FJ? M>+'D+LT"9_3+_@Z@@.\PF]I"B*6-TF5.%VNE@,N$W5)!:]F"*9`D>IV)S@35 MU$&F#S0D77NS29$MK7NI,!>(W\+I-4Q-Z-LZ$KNIJC7\PJ>DR2UQ6K'UB0YU M76LB%)#@57)F@:V?A/-A[*5AOI225PU=1$NML,QRS@(0EP,X45G7AB+,R]R-RN)$=HM=NY ME!3AL[_E'(`G;88Q**;QMBXWF2L5D=8248U\Z.1MEVI+3V-PF642DPN-)/$G2*;T;I%%7 MK0+&XK4:!7)$%:+%5)+QII,!,WL@K\+IB*TJ?E9EBDV?E;8!+HYOA&^^DT'5 ML9AK@U^CF>M"K"^JA5,:P/`O*B@FM"89YNQTGF>X2A\9`+%ASZ#__4URMX7@ M4)N.?E@UY8HX;)W6JI$C.E"@'RN;0"FN\62`F>U*>_3$B=5)@QN6_3A$Q[(# M8(`,"MJ5PA0%[*3W$>T,).VT0]-;#`QB;@LH@((!%,X&()!\[*XOWD\=N[SB M5P-8XMM$0IC_8\3\``N`N>+2_7O@0K5B>T7818F9=F`P?7WJ;)!MTC M[401$X@@\*D7G<0!?/@-+GH+/E?`6C+Y0@(:(DPZ&)#1``UWYH%*A;(20G)6 M:/=P$JG?29;-.1&/L)NW.'2DD+B1XD91/%$`!!5$Q_98FP/".%*?C38ES11H M-^3U:E7Q`TGNK5//$X-HC1VC]N,P\[V(BO08_4YR(J@;PJ^#MA:W"$EHBN[I MA-)E)E-<9N\:I;0:_/,7W%)'"CVC,#]"+SV*@T,O[R'+(X1L,^TK(D)4)E?< MD"E4!$\`1_B.`IKBR,ZK"*G4$.EJK;K2>F^/\:PXO@Y"XMPS]FF'J_)I!][[ MOZZ-O,WGVBR'1O4;4\0EN$VB`*89K390V(NK*#9?."\A;%I.P^8L88%5J1S" M"41??'#I/3#4O4/KEWM(Y3R`)M8O$2[GNOZ8FM;&$Y$:/YSD%*1OU:HFAI9S MP4JR?1"9H-[>[EWU>%UM5T6?\AZVJPK2\++RZ6,\VG7:G+,`GA"$ZVR3BROCB[/R+95^X@`^6(NY."X!34%B$1VN M.?^NHD.N4%8CP_45VLS0O$J1^B%[,`F%C@<9`N@8U^:/(9?W::VMINV9,4V4 MOD^B.=KITL5Q&"&7L:\4]RI8ZRGN%0+D*>YJ,*"CG<4!C7*I9[EYB[3Y92VM M^SC/T_!ZGN-F%I?)F2?S\FO[&6!G8I^2SG5[+4>^+MY7J<()NS4Q3*"A$`0[ M=BL82AI"W#YLWMG\.@K]XRCQ\K[L'0O25N78&F:YD:,#`1GIKC9&*(&Z95M= ME7YSFR4L8AP/D.=QDZ2]G>'6@=JO&*[AEPN>#`7E6,>GMUQAU&6_OC3MZ[#K MQQ(XZVSDC&D)V(Y]EU"@>,!$3@_6CI<SO,(I^BY/[^`)Z61+#@!192.Y-ZNV.(O#V]TD!)?(=$T_:_()G@7(: M+<%)'1ZV*@FNOI/*%F\U[[E:$7L2GZ5PYH5!>3)R](!U&Y9=#^5'$)QJ8MR- MNP`)"EA,X\FU&P#.PLH67!"$FZWYV28%6U6K'T=>#W?PZN#L^4TUO(UW"?`@ MA]\[E^=KUP>JE70+B<_A38COQ,;Y.V_:0W*="]5:"18/N]SB+\<"/-BYF>?+ MHV[=.>NS[(JMFR'F81=-Z\U]$F8H=IHA3LT[/=Q:EQ! M&OZI,6?1&J?&0I9U<+V+8KBJP2#NC])'6D(*W=X>*R.CX:)!4>2X;"M)9PW@ M-$8NLY6K!^*E]])*Z1)G#L3JTD/O)(K!3;,D@KNI.Q+X1(8Y[B_*%0BW\]%R M4;UHP)LPAB?H1[,=M)98[*?95DEH5@@\%)"Q`V@$*1045SOJJZPL=;$,]-V%,EVLAFGDJF2Y-!O#ZEW:[=0D0((8#K-9DW8+] M?SJ+?[7:K3Y>+&],V!H@A_W5=.`*L,_0"A#V._O[W'&6KSJ=N[N[9R9[E)J0 M`(I=8@+*/VBUV[^U^+^__^TU%](G@(MXU1K/W5;/G;6ZSUN'1Z]>'+YZ<=2Z M'?=;1]W#0_]+[!LV1-\G!@6M^X6-Z)N#D+#[";&?83+K''6[QYW-@P?^DZ_N M^0>1Y^^.O:FX4",/-;F'[4/C]K'A\_NJ77PFX]LP:. M,#D643.CE8X&U^T;='YAXSM9)!^^W_E-A6I73)2(*M[SRCR-M]85%=]5^.I= M<>E=96[A-R>A05=-_PD:DU$@`$&=#E)*=!5[HKPB:GVR@![*O;.(+@K\]`R; M+A\Q>L@Z1PX+S@,TQ63A4181K3+;"4&V9,2//>9]_I[I%=$8W#L`6<#:Z,Q; M+L(Z'L0RP38V([)LSLLPV8BRC0FPWQRD-45OD>%:D'W:FU"'4]P"7"6AL<". MN?5T:7MF&,NO#R/^V)C$;1W@YC')J4$G'IT,OMCARG:`[=#-)Y[Z[>YAP"K_ MD2)ATPWE-656!P/V(]6J[:.44`B+^5^/1%_`(.9&)_;CEO-%*7GP1&?ID<2V M.8?V@]]."5[(^)*#TRV+"2-0;PX.GX4CD+P5;DR`#`)Q[Q[J-41$T*.;[]$. MV7TE$?,H.E'HY7`/&KQ%=`E,.(7`.L,+`R(MV*<*BWA.F29("C_CR<<5H;-M*0]IV\0LH9H]M&P72U<*9_@<+??)QW)\LQP/\H) MGWSWLD,6E@M_IHE=IM,U,`'3CT7?*^`$[Z=E#(6Z.V12 MURO16CG\=GM.$#>4S)0`.X;]OGA0Q4M`G/7(-OQ4*>-72^Y[FL:_3'FEVS)O M',W"++#HBS+8RR7&UAVT;1V6>VB[)E9ZQ"*PR'_*X9..@6:0,=R'X'!^;]JN MQ:8M.JV52VXUDI\[V&<>_`(+ORQD8>GY`G7X:]`!ZDVGT(;LM>B-.Z'0@@:! M@#+%L>E]RF+%6PR1\Y$][C+$=4TPY!6JA4<40CQPE5_W[RJ^`^MC1'4PW@:# MP`HGQ6F/D"G>0V/"_,6!GF=LUP$)I$=S-U7E1'5^/#8YF<*Y:_$%<)\JAU45 M3F(G?;G:<_:LM][8HG`^NU"J>)N#TG.F*1RL]49?IB4X8RC5&Z.FKA, MV.,+Z+5=BK"R^IVP_=+`4I&>EC+@?BR7:K(28^5.UPV;+L-FQ=,L15.;(>6N M,#+WDM],EEFW)&<**+$BH6AQ-Z28YOY8+L//Z\4I?;&L3EB(Y>_@]=7M M0'FXO,0:CP+^V,>+!48W#C:_ZRM[B,LHI>/L]KQ(D<,6+DJXHAQ5M"S(`3+L MD0&M`>H;2\AZ8$A%+9QQM]1R)]-IKALACCF@*W$2<`T<@\4+Z]P@"*(9998@9]K=2!:H"(TON_N[B#KQ;42;S6'[W%X4WQ_< M[#9J=ALUNXV:W499?:79;=3L-JK?;B/;QG<\H%Q@V: M*K3G.G-,X,]'FJS)K%OB:K%$DHE7B=LUMO0:4.KNR8:!J-(S$Y(6W""E8B^& M,O,-78>?)<8++_=BP["\NAHR@IF:/1DEIQOBQWJ)1OF,M@KG&':W5WSVWN09 M*IUGR.U2`JF&)M'0)!J:1$,57F;_B88;PP9L\KL"R`5\NPG5M"TN44YEG"B3 M]"1#5&)V@#K#J:?(#;8U33>B(NIAIRU@2IOA7Q),Z8C@J9YB@W#SU1@',^T2 M04-^OEYH7TQP)(#(SHJMKU2[%VR_H?SD6E'=Z`VP;;Z+T3N_W.XAJV:"QEM$FG^32&'V:.T:&G9SHJ:FUDJW[9A+Y1D0&&?O9!AYV3-4%)@[\ M&1QIJMZ^N>26$AKS6#8?:DHJK:2L.ESR^P:8[_F3S?"PBKOF!M?&YT'%":)J87!DN"1/\5"08GXH^=.K=#F M;QTFS">XY&6A#'>.[I//!6*IXR.D2TP-FU%@=WF%'?:[B1&+'2ZP@C""T:4! M$7^+(=H\KF7(E%2E;-:;TQFDD2YOF/5N[F%^ZK]<0!RN,,*;\47;"7TYY)8Z MK\P=`/(`6.(*\6.$ZCD.@1/7X?F],?:K6/7&]T2)97?FO`>@9,,F?]R1BKVN MOG9CXSYPN%,V0=.4Z$D359/5XE2DE)QF)&D^%A/T3FNB`FIBJA@J\F<()>\> M$+;29CO$IESKU*#0U&&M9$$UR*JF("1_[E!1.A-7Z`S:KJ.G'"I-5$TZ6RI2 M!82JG1[KG()^$Y%0M)Q.M/5" M:V%-?5TMZNLD/2Y_M5TQF_AJ\+N?,>)*:B^Z2Q18D:3_[FJI9+C4[+2,M:VO M""]94#6F*%G^&*&\R6!%*_"*EO%_`'Q\U5,0%1=2,O_(=+Z4BOT-/+&R1[4G MZ.BS0;;`#-]2K_=E"QF MRP\(UV#I$G/.M>\AIIX#F?@SE[#QT]=8FWN)B*])!!)"5+Z8>P7(!(?+N36: MWX^DY=D_D%^1_(0"ZV\`5;"U6M[L_LBXY93>WX9+CBP]OP?$A%0/TQ!7HC8. M(`:M?,WJ5A!0Z@Z^EY;M#UE:5&8F)^,2F?"JN/NM*:317$A32J73]A3U:W>/ MD_BJ6RH9'OG*)W_V=XXL+3-X/:;+FL-7W7X90,D7024;L;S3:/H&G5_8^.Y` MYEZQE&7-39N%CZ/)V6AS)LW_T9KY;N=J#J:IQ()!@'@((W]3W ML-6V9SIP)7PW9MZF*@)R(MW)CT>!NQWBYSTT$T+-$\*"]Z>PMW[]2[O=^O/3 MAX_'?_WYV5RZ]U_0BQ/KY\O5[,L:W9ZY=Y#_[]Y+#]\&G?GEY[/Q`O7^ M^+$^/*//IQ]^?7[\^?>SE35Y2\;O;C^MW]Y>N(O>-VLY._[^\1R='KM=:WT[ MQI]/>C].WLWOS<[1N\[Y]+_.NP_CP]EB>=F_&HV_=98_?Q^M5T?#PW=_M?HW MU^VV!`>.K,CPY11D0AL\V&2,V8^\AXT(7D%&U4_7MY0?LECY4\/@0D;J,$]^M$)CQY%ESD%!MG4;L`"*1VHT4%Q%-I2Q!K$O0#V%=]D"R\F<*C1O!#WYZ4<$+`W(+X/U MM`F.TF&O[!V2Y0.P'[OGTJ3V#I$/;_G9A#Y/V42JD;'F88K/@$R3,`(;PF*_ MPT"F)K7WE'QXJ[CB2G8Y)B?ST;16DU=ZI3/;,F@6.'@]?GJ6_-*I/P51LG2: MU51MEDXS\2AP>K.2I5,60C:[ADPVC22`^1GS+&<]L@WDL,C")Y=+[SXR#7U5 M0'I)?574L\,]5P1;"6*?.E57Y0H#!C&:03[":"-[NX665VBFTO3;6$I0?I7Y M.^:+)@"6]W)GT'LYQR5@.#UU*0MI3$D]]LXAMJR,;R&#YX%3P4J`2D*6\(I[ M)&1)TNM,R!+1+)"?4T?(+B`RD*F$D&4U51M"EHE'@2.>E1*R"TP>]V@.IZ$] M!SJ'X0RI)53R=]C&DWLZ;"\DO\JC MN!R@JHZ45VC['G->0M;,3[4=6Y)/<"WZ>DX,B^Z]C!Z?I+BWQ[35M*DVO\V? MB-5#>VYESJZOPJ;;*_;[@?C@_"TSN\K32[*)]@KMH M!=RGV39;B6V.S;;99MML%;?-/LS(MB**EGGLMI2:\)DD?!3>$+I_TM*5.1J$ M7SE#A]-1V$K(NH$SQ#J4R9=%_=H6?@05MJ'))O`RO$:)F"*GE37,IZK,1Z4' M"E"CPJ[4L*.&'37LJ*[LJ$C4T>%QA?2IC%-F$JYBD*N@9B7QLJ[HQ6=\SZ&- MJ4=/HV>#V]Y1<)@Z]'';_$-MDP0O4R6IP&I,P\VJR\T4.Z((/6O(64/.&G)6 MA9?9/SDK&'9T.%U1E6J2%"N,?+TS:!Y5$^1J@)H$>H5-P^D5N`N16((1^]'T M#T1E[7\!3L_"2X:C%%53(ZA9/7R*/$VI$S8+C)4851N6UK"T2K,TF:"CA9M) M*5(71B:'27FP,\UH\D5H9GY6JFR7<]21XEXD)-,JL:PUI#DQJ: M5&6:E!53='A4IKR:D)YLS&K/;;H2]>4IATH6XSH2C3;YHR?(>^2=J\D556+0 M:DA00X*J3(+R!Q@=_B4@O18;,$705'=";4E<2:JL/7XBX]9QC)MC/$,?/<+7 M=PDWE`RCTB2XR3<]2=ZEUTV;#%4U!M.&G#7DK,KD3&T4TN&#BC6L219,M5WJ MGS<3+Z4_-PB":,8/H_'JUJ2R9#O;:'8F/D5VEMMWFFV'51D:&ZK54*TJ4ZW4 MD*(E[94JK#+NE)WF2@>KSKL!'[-:0BYT`V8XOZ>V6D[`$;$!=_)T4`JR"-[P1IDQ>ZXXRI'62F$',N!&,8A% M=&%$@TSR!0M!AOT%&.0<666%C(^-"/C%#A)NL3<1)0"-T MUY)4V.DQ'2RNQX5M*/#R:',EU7G)0!O#(70ADC@_C[07VEJH$-YPJ_6A(\F@ MA&XJD:4C03!B+1/#'C"Z?/\.K)7%[%BS9,TR4A9AHHS7D@3%4-E@7F6+Z#7\"MOT.X3MT`PR*$;`& ME+J`J`(^K?D:FB`5J8TQCA3,]T>;NV/43$V3FZU3L$D!9H/YL6RPV;3[.-^] M8)\HB.]I#==H8$W%9H-Z@0EGM&W?JEJ0#S=='P:?`<\&_!>/I#(EY?VZP]N< M&!1XO_X/4$L#!!0````(`"->!3_'NDUD]`<``,(Z```0`!P`87!T+3(P,3$P M-C,P+GAS9%54"0`#\1`\3O$0/$YU>`L``00E#@``!#D!``#M6FUOXK@6_K[2 M_0]>5EK-:L2$0#LMW&DE7MH.G1:J%F;:6:U&)G&(V\1.;8?"_OIKYP4"A!#F M=D=9#7P*MH_]G/,<'Y_XY,.OY3*X0`0Q*)`)1C.`VV^$^P()D&YD@)O_+?EL(KZ%I+R\O[PPYE!N8(4Y]9B"N&D"Y?`K4[S^_?%"+ MM!E22S3`P/9!TQ^#R@'0JXU#O7%8!<-!&U0KNAX*28DI;W##1BX$4]HP(9MEI-4]*5][5**1*8CIB#ET14RSO*QG)HI:9AP@4D!HK' M$]]-'VT*IHF9AS0Y`C%LE("`;(Q$#[J(>]!`.^+B2^-?:C$D7;N_OKH+=)YC MHB0'+$K*P)8Y8I>KNES8`XF3VG8]'J]K@6]\="U MD4#09C-D MG92DHY5CSKXY0S]<)7DFERZ0<#8JF:OI):)K!^NEEP3$YRFU.O194#GA^LE MUS1\)XVM9:74X(%4`ZB'X6TW.Q`&4\OS@U,'F^HD:$%'!>`[&R%1`M@,-/^V M<<1ITJHQA`4%IS*"RD/I3GI9$'."`VPQ%8CF`L%D'+P9$NB;6/;\\4%;G6IM M&9\CLT].@^=59X[$HR'K$).RRQZS*IFB7U)XA985Z3DUVA(WIV#5%5^1M6\W MD$E3V$A@"8YO)W%58#NGU>_C%+Q97BF-Y&QK_^0T=XEL1G/+IU.[.BA=N24^ M:UE\AO,M^K=MTSV%JQ3>V=+M;>J8B/&S9Q^+F9J@2EEMP6#&F+1-L43?019] M"=ZH!9++_/[;<54_^B\(E]O&ZI[3C=NR#;E][M"7]/TX[UT_P998/,S/HIH2 MJ#GW1^9.I/7D_P5)P;_MA]U[R44'<\.AW&=(_E%R0*4U`QL%[^.0S/8G63[K M5Y;-7]FV*8Y2C:_RCQ;D.-@,-PE+[FG(2<,J#Y7MI\QQ*A5AZD"-)T6(#%1J M/R#"-[&QYR*%BS4R*GF2MGHJ'RH7Z*$7T#0,ZA.!R5B='<2$S.0_`1_!I>:? M7ZX_U_[Z\][P_.D#.:R;?Q]-Q@\S,NSX+Q='K'[TJ?HX',RX73T>'GHWW8?O[8_0UA#]O1"FW;/^A\G1RWS M6:N\;7\Y/^B^?7APQ^ZY22JMCT/QY%4?/I]?/W8U^^*^,W!)\^OS3._P`^OZ M^*!V_[$S,4>7;/!I^&5V.3SWW>:CZ8UK3Y_/2*OF5\S9<$#OZ\WG^B=[:K38 ML%F=/C2_3/WCB[?#YOC2TM'EX[@U'MU^%)\&?X'VW>WB/O=U7''=%P-GS/)$ MO9+JB2J?Z9*)]"#*,$ISOGUHWL!!"@F5[9F*NJA/X4'E+U&*K^C@(DPC,0$R M+("F.5%OZQP("H;R32^1WYCEY+)>0X2CV-8/=TL..KK=)#(KXGN4$L?,O> M;YH=>4HG*D\NI!^D8(,[!'1H'07"_C;;1TZ&&KTS5 M).:9S";%K$LLRMP`2DA7YHBM+Q5KJ4,\'9#S@7!"D)CQY[EO_*`MU4[#,JNV M5F>=EU^QZU$F`$DM@&^JLH?5_"MJ!/-EB*A_Y5BNK)K*>K55L%V@Q'+?1>,[*+[!B`!B*3D&$(O$-20(_A\KO)BKCFB'2VS_F%#'N.L M2BG3U)5I]/?_/Y#DIPR[@:&DEX$G!Z+4SP[RNDLLH!8_7#=#]!E$L.I):5-Q MC,_O5YLC+M07-R405HF#;UD:LDV^8W<%1BF,;KF!9GEI:)_D5$51+P-:)G\%9FP;1WEB MR4HUMN#A9#O:#.<\FZJ;WP*YY!J@W*PM+-"WUKV@V!SNBCWZ@BB_0>*"9L%] M.2?DK&@;2YTSZO8]]36N5"AZHRQ4[,T+-$/9IOGH1W>#`WJ+#$H,[*`>$F%, M&%#YJ-:Y872"39EYS(9"S@;Z5_&A`9>-X3+"%#2C?/>:%TQMYDAC2$L9GE,A' M(TQ#>E0\(-$TJ2>7+J"M7D>-C+T75X-G"UJ*9X9<(#/](4RTKY&PJ9FHN!99 MZ>^`G)5*AI[#Y7Y26*+ZY?+]1U_8B"6:%DM%%PG%,](_I%:V+T%&I)[\!K$@ M3A7/*ML19ATT427N%JD+8#E-D3?)+E@S#]>,BEEAE,T%`Q0````(`"->!3^VA:[7TE$``'4R!0`0`!@```````$```"D@0`` M``!A<'0M,C`Q,3`V,S`N>&UL550%``/Q$#Q.=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`(UX%/[%L.@^]"```8%H``!0`&````````0```*2!'%(``&%P M="TR,#$Q,#8S,%]C86PN>&UL550%``/Q$#Q.=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`(UX%/W+`J$MC$0``O1$!`!0`&````````0```*2!)UL``&%P M="TR,#$Q,#8S,%]D968N>&UL550%``/Q$#Q.=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`(UX%/\X+DUU,'@``3G(!`!0`&````````0```*2!V&P``&%P M="TR,#$Q,#8S,%]L86(N>&UL550%``/Q$#Q.=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`(UX%/Z(!V\8!$P``=CL!`!0`&````````0```*2!`L``00E#@``!#D!``!02P4&```` /``8`!@`4`@``_Z8````` ` end XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 17 R12.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 6 - Equity Investments in and Advances to Unconsolidated Affiliates
3 Months Ended
Jun. 30, 2011
Equity Method Investments Disclosure [Text Block]
6.
Equity Investments in and Advances to Unconsolidated Affiliates

In 2005, Alpha ProTech Engineered Products, Inc. (a subsidiary of Alpha Pro Tech, Ltd.) entered into a joint venture with a manufacturer in India for the production of building products.  Under the terms of the joint venture agreement, a private company, Harmony Plastics Private Limited (“Harmony”), was created with ownership interests of 41.66% by Alpha ProTech Engineered Products, Inc. and 58.34% by Maple Industries and Associates.  Alpha ProTech Engineered Products, Inc. contributed $508,000 for share capital, and Maple Industries and Associates contributed $708,000.

This joint venture positions Alpha ProTech Engineered Products, Inc. to respond to current and expected increased product demand for housewrap and synthetic roof underlayment and provides future capacity for sales of specialty roofing component products and custom products for industrial applications requiring high quality extrusion coated fabrics.  In addition, the joint venture now supplies products for the Disposable Protective Apparel segment.

The capital from the initial funding, along with a bank loan, which is guaranteed exclusively by the individual shareholders of Maple Industries and Associates and collateralized by the assets of Harmony, were utilized to purchase an existing 33,000 square foot manufacturing facility in India.  This facility includes manufacturing equipment necessary to produce coated material and to sew proprietary disposable protective apparel.  This facility was expanded by a 38,500 square foot addition in mid-2010, bringing it to a total of 71,500 square feet.  Also in 2005, Harmony built a 60,000 square foot facility in India for the manufacturing of housewrap and synthetic roof underlayment.  Two additions have been made to this building: one was a 20,000 square foot addition in late 2009 and the other was a 22,000 square foot addition in mid-2010, for a total of 102,000 square feet.  During the latter part of 2010, Harmony also added a new 16,000 square foot facility in India that sews proprietary disposable protective apparel. All additions have been financed by Harmony with no guarantees from Alpha Pro Tech.

The Company is subject to the provisions of FASB ASC 810, Consolidation (“ASC 810”), which defines the criteria by which the Company determines the proper accounting for its investments in related entities.  Specifically, ASC 810 requires the Company to assess whether or not related entities are variable interest entities (“VIEs”), as defined.  For those related entities that qualify as VIEs, ASC 810 requires the Company to determine whether or not the Company is the primary beneficiary of the VIE, and, if so, to consolidate the VIE.

The Company has determined that Harmony is not a VIE and is, therefore, considered to be an unconsolidated affiliate.

The Company records its investment in Harmony as “Equity investments in and advances to unconsolidated affiliates” on the accompanying Consolidated Balance Sheets.  The Company records its equity interest in Harmony’s results of operations as “Equity in income of unconsolidated affiliates” on the accompanying Consolidated Income Statements.

The Company reviews annually its investment in Harmony for impairment in accordance with FASB ASC 323, Investments – Equity Method and Joint Ventures (“ASC 323”). ASC 323 requires recognition of a loss when the decline in an investment is other-than-temporary.  In determining whether the decline is other-than-temporary, the Company considers the nature of the industry in which Harmony operates, its historical performance, its performance in relation to its peers and the current economic environment.

Alpha ProTech Engineered Products, Inc. initially invested $1,450,000 in the joint venture: $508,000 for share capital and $942,000 as a long term advance for materials.  Fifty percent of the $942,000 long term advance for materials is to be repaid over a six year term that commenced in July 2006, and the balance is to be paid in the seventh year.  As of June 30, 2011, Harmony has repaid a total of $525,000, leaving a balance of $417,000.  Interest of 3.5% is to be paid annually on this advance, and the Company had an interest receivable of $7,000 as of June 30, 2011 related to the agreement.

For the three months ended June 30, 2011 and 2010, Alpha Pro Tech purchased $3,108,000 and $3,801,000 of inventory, respectively, from Harmony.  For the six months ended June 30, 2011 and 2010, the Company purchased $5,902,000 and $6,507,000 of inventory, respectively, from Harmony.

For the three months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $107,000 and $99,000, respectively.  For the six months ended June 30, 2011 and 2010, the Company recorded equity in income of unconsolidated affiliates of $234,000 and $172,000, respectively.  As of June 30, 2011, the Company’s investment in Harmony was $2,175,000, which consists of its original $1,450,000 investment and cumulative equity in income of unconsolidated affiliates of $1,327,000, less $525,000 in repayments of the advance and payment of $77,000 in dividends.

XML 18 R8.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 2 - Basis of Presentation
3 Months Ended
Jun. 30, 2011
Basis of Presentation and Significant Accounting Policies [Text Block]
2.
Basis of Presentation

The interim financial information included herein is unaudited; however, the information reflects all adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary for the fair presentation of the consolidated financial position, results of operations and cash flows for the interim periods. These condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, therefore, omit certain information and footnote disclosures necessary to present the statements in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).  The condensed consolidated financial statements should be read in conjunction with any of the Company’s current year filings on Form 8-K filed with the SEC, current year filing on Form 10-Q, as well as the consolidated financial statements for the year ended December 31, 2010, which are included in the Company’s Annual Report on Form 10-K (the “2010 10-K”), which was filed with the SEC on March 16, 2011. The results of operations for the three and six months ended June 30, 2011 are not necessarily indicative of the results to be expected for the full year. The consolidated balance sheet at December 31, 2010 was extracted from the audited consolidated financial statements contained in the 2010 10-K and does not include all disclosures required by GAAP for annual consolidated financial statements.

XML 19 R14.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 8 - Basic and Diluted Net Income Per Share
3 Months Ended
Jun. 30, 2011
Earnings Per Share [Text Block]
8.
Basic and Diluted Net Income Per Share

The following table provides a reconciliation of both net income and the number of shares used in the computation of “basic” earnings per share (“EPS”), which utilizes the weighted average number of shares outstanding without regard to potential shares, and “diluted” EPS, which includes all such dilutive shares for the three and six months ended June 30, 2011 and 2010, respectively:

   
For the Three Months Ended June 30,
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net income (Numerator)
  $ 304,000     $ 372,000     $ 192,000     $ 1,058,000  
Shares (Denominator):
                               
Basic weighted average shares outstanding
    22,427,403       22,424,285       22,431,009       22,423,788  
Add: Dilutive effect of outstanding stock options
    -       444,752       -       595,592  
Diluted weighted average shares outstanding
    22,427,403       22,869,037       22,431,009       23,019,380  
Net income per share:
                               
Basic
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  
Diluted
  $ 0.01     $ 0.02     $ 0.01     $ 0.05  

XML 20 R15.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 9 - Activity of Business Segments
3 Months Ended
Jun. 30, 2011
Segment Reporting Disclosure [Text Block]
9.
Activity of Business Segments

The Company operates in three business segments:

Disposable Protective Apparel: consisting of a complete line of disposable protective clothing, such as shoecovers (including the Aqua Trak® and spunbond shoecovers), bouffant caps, coveralls, frocks, lab coats, gowns and hoods for the pharmaceutical, cleanroom, industrial and medical markets.

Building Supply: consisting of a line of construction supply weatherization products.  The construction supply weatherization products consist of housewrap and synthetic roof underlayment.  The Company’s equity in income of unconsolidated affiliates (Harmony) is included in the total segment income for Building Supply in the table below.

Infection Control: consisting of a line of face masks and eye shields principally for the medical, dental and industrial markets.  It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.

Segment data excludes charges allocated to head office and corporate sales/marketing departments and income taxes.  The Company evaluates the performance of its segments and allocates resources to them based primarily on net sales.

The following table shows consolidated net sales for each segment for the three and six months ended June 30, 2011 and 2010, respectively:

   
For the Three Months Ended
June 30,
   
For the Six Months Ended
 June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Disposable Protective Apparel
  $ 2,871,000     $ 4,845,000     $ 5,778,000     $ 9,929,000  
Building Supply
    6,356,000       4,863,000       11,103,000       9,585,000  
Infection Control
    1,051,000       1,513,000       2,342,000       3,336,000  
                                 
Total consolidated net sales
  $ 10,278,000     $ 11,221,000     $ 19,223,000     $ 22,850,000  

The following table shows the reconciliation of total segment income to total consolidated net income for the three and six months ended June 30, 2011 and 2010, respectively:

   
For the Three Months Ended
June 30,
   
For the Six Months Ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Disposable Protective Apparel
  $ 302,000     $ 933,000     $ 598,000     $ 2,134,000  
Building Supply
    1,095,000       746,000       1,382,000       1,408,000  
Infection Control
    328,000       319,000       691,000       840,000  
                                 
Total segment income
    1,725,000       1,998,000       2,671,000       4,382,000  
Unallocated corporate overhead  expenses
    (1,240,000 )     (1,409,000 )     (2,364,000 )     (2,713,000 )
Provision for income taxes
    (181,000 )     (217,000 )     (115,000 )     (611,000 )
                                 
Total consolidated net income
  $ 304,000     $ 372,000     $ 192,000     $ 1,058,000  

The following table shows the consolidated net property, equipment, goodwill and intangible assets by segment:

   
June 30,
2011
   
December 31,
2010
 
Disposable Protective Apparel
  $ 728,000     $ 816,000  
Building Supply
    2,173,000       2,277,000  
Infection Control
    1,038,000       1,173,000  
                 
Total segment assets
    3,939,000       4,266,000  
Unallocated corporate assets
    92,000       115,000  
Total consolidated assets
  $ 4,031,000     $ 4,381,000  
                 

On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads.  As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill.  The net gain on the sale of these assets was $41,000. Both of the transactions were executed in the three months ended March 31, 2011.

XML 21 R13.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 7 - Accrued Liabilities
3 Months Ended
Jun. 30, 2011
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
7.
Accrued Liabilities

Accrued liabilities consisted of the following:

             
   
June 30,
2011
   
December 31,
2010
 
Payroll
  $ 266,000     $ 115,000  
Commission and bonus accrual
    90,000       48,000  
Accrued professional fees
    107,000       133,000  
Accrued rebates and other
    6,000       -  
    $ 469,000     $ 296,000  

The Company’s Chief Executive Officer and President are each entitled to a bonus equal to 5% of the pre-tax profits of the Company, excluding bonus expense.  Executive bonuses of $34,000 were accrued for the six months ended June 30, 2011.  The Chief Executive Officer and President voluntarily decided to forgo their bonuses for 2010.  Therefore, no executive bonuses were accrued for the year ended December 31, 2010.

XML 22 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Net income $ 192,000 $ 1,058,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Share-based compensation expense 146,000 68,000
Proceeds from dividends from equity investments in unconsolidated affiliates   77,000
Depreciation and amortization 449,000 426,000
Gain on sale of assets (41,000)  
Equity in income of unconsolidated affiliates (234,000) (172,000)
Changes in assets and liabilities:    
Accounts receivable, net (1,890,000) 2,143,000
Inventories 2,017,000 (4,768,000)
Prepaid expenses and other current assets 160,000 (668,000)
Accounts payable and accrued liabilities 306,000 (4,490,000)
Net cash provided by (used in) operating activities 1,105,000 (6,326,000)
Cash Flows From Investing Activities:    
Purchase of property and equipment (109,000) (462,000)
Purchase of intangible assets (3,000) (4,000)
Proceeds from sale of Janesville 235,000  
Net cash provided by (used in) investing activities 123,000 (466,000)
Cash Flows From Financing Activities:    
Payment for the repurchase of common stock (129,000)  
Proceeds from the exercise of stock options 16,000 6,000
Net cash provided by (used in) financing activities (113,000) 6,000
Increase (decrease) in cash and cash equivalents during the period 1,115,000 (6,786,000)
Cash and cash equivalents, beginning of period 5,316,000 [1] 9,753,000
Cash and cash equivalents, end of period $ 6,431,000 $ 2,967,000
[1] The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date.
XML 23 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 3 - Stock Based Compensation
3 Months Ended
Jun. 30, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
3.
Stock Based Compensation

The Company maintains a stock option plan under which the Company may grant incentive stock options and non-qualified stock options to key employees and non-employee directors.  Stock options have been granted with exercise prices at or above the current market price of the underlying shares of common stock on the date of grant.  Options vest and expire according to terms established at the grant date.

The Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “FASB ASC”, the “ASC” or the “Codification”) 718, Stock Compensation (“ASC 718”), effective January 1, 2006, using the modified prospective application method.  ASC 718 requires companies to record compensation expense for the value of all outstanding and unvested share-based payments, including employee stock options and similar awards.  During the first six months of 2011, there were no stock options granted under the stock option plan.  During the first six months of 2010, there were no stock options granted under the stock option plan.  The Company recognized $146,000 and $68,000 in share-based compensation expense in its consolidated financial statements for the six months ended June 30, 2011 and 2010, respectively, related to previously issued options.

Stock options to purchase 2,511,000 and 1,567,000 shares of common stock were outstanding at June 30, 2011 and 2010, respectively.  As of June 30, 2011, no incremental shares were included in the computation of diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company’s common stock for the six months ended at June 30, 2011 and, therefore, there was no dilutive effect. As of June 30, 2010, 444,752 incremental shares were included in the computation of diluted earnings per share because the exercise prices of those stock options were less than the average share price of the Company’s common stock for the quarter and, therefore, the effect was dilutive. The remaining 1,122,248 were not included in the computation of the diluted earnings per share because the exercise prices of these stock options were greater than the average share price of the Company’s common stock for the six months ended June 30, 2010 and, therefore, there was no dilutive effect.

The Company used the Black-Scholes-Merton option pricing model to value the options.  Prior to 2008, the Company used the simplified method as discussed in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment, for estimating the expected life of the options.  For options granted during a quarter or fiscal period, the Company uses historical data to estimate the expected life of the options.  The risk-free interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility is based on historical volatility of the expected life in years.  The Company uses an estimated dividend payout ratio of zero, as the Company has not paid dividends in the past and, at this time, does not expect to do so in the future.

The following table summarizes stock option activity during the six months ended June 30, 2011:

   
Options
   
Weighted-Average
Exercise Price
   
Weighted-Average
 Remaining Contractual
Life (in years)
 
Options outstanding at December 31, 2010
    2,542,000     $ 1.57       3.17  
Exercised
    (13,000 )   $ 1.23       -  
Granted
    -       -       -  
Forfeited or expired
    (18,000 )   $ 1.53       -  
Options outstanding at June 30, 2011
    2,511,000     $ 1.58       2.64  
Options exercisable at June 30, 2011
    1,377,000     $ 1.60       1.63  

As of June 30, 2011, $487,000 of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of 2.07 years.

XML 24 R10.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 4 - New Accounting Standards
3 Months Ended
Jun. 30, 2011
Description of New Accounting Pronouncements Not yet Adopted [Text Block]
4.
New Accounting Standards

In December 2009, the FASB issued Accounting Standards Update No. 2009-17 (“ASU No. 2009-17”), Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities.  The amendments in ASU No. 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity.  An approach that is expected to be primarily qualitative will be more effective for identifying which reporting entity has a controlling financial interest in a variable interest entity.  The amendments in ASU No. 2009-17 also require additional disclosures about a reporting entity’s involvement in variable interest entities, which will enhance the information provided to users of financial statements.  The application of ASU No. 2009-17 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.

In January 2010, the FASB issued Accounting Standards Update No. 2010-06 (“ASU No. 2010-06”), Improving Disclosures About Fair Value Measurements. The amendments in ASU No. 2010-06 require separate disclosure of the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and reasons for the transfers and separate presentation of information about purchases, sales, issuances, and settlements in the reconciliation for Level 3 fair value measurements. Additionally, ASU No. 2010-06 clarifies existing disclosures regarding level of disaggregation and inputs and valuation techniques. The new disclosures and clarifications of existing disclosures under ASU No. 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years ending after December 15, 2010 and for interim periods within those fiscal years. The adoption of the disclosure requirements did not have a significant impact on the Company’s consolidated earnings nor the consolidated financial position for the periods presented.

In April 2010, the FASB issued Accounting Standards Update No. 2010-13 (“ASU No. 2010-13”), Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades – a consensus of the FASB Emerging Issues Task Force.  The amendments in ASU No. 2010-13 address the classification of a share-based payment award with an exercise price denominated in the currency of a market in which the underlying equity security trades.  Topic 718 is amended to clarify that a share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades shall not be considered to contain a market, performance, or service condition.  Therefore, such an award is not to be classified as a liability if it otherwise qualifies as equity classification.  The application of ASU No. 2010-13 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.

In December 2010, the FASB issued Accounting Standards Update No. 2010-28 (“ASU No. 2010-28), Intangibles—Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts, which modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The amendments in ASU No. 2010-28 are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. As a result of the adoption of the amendments, any resulting goodwill impairment should be recorded as a cumulative-effect adjustment to beginning retained earnings in the period of adoption. Any goodwill impairments occurring after the initial adoption of the amendments should be included in earnings.  Adoption of this guidance did not have a significant impact on the consolidated earnings nor the consolidated financial position of the Company.

We periodically review new accounting standards that are issued.  Although some of these accounting standards may be applicable to us, we have not identified any other new standards that we believe merit further discussion, and we expect that none would have a significant impact on our consolidated financial statements.

XML 25 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 26 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 5 - Inventories
3 Months Ended
Jun. 30, 2011
Inventory Disclosure [Text Block]
5.
Inventories

            Inventories consist of the following:

   
June 30,
2011
   
December 31,
2010
 
Raw materials
  $ 9,488,000     $ 8,536,000  
Work in process
    929,000       1,797,000  
Finished goods
    4,703,000       6,985,000  
    $ 15,120,000     $ 17,318,000  

XML 27 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Shareholders’ Equity (Unaudited) (USD $)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Balance at December 31, 2010 at Dec. 31, 2010 $ 35,512,000 [1] $ 224,000 $ 23,504,000 $ 11,784,000
Balance at December 31, 2010 (in Shares) at Dec. 31, 2010 22,424,285 [1] 22,424,285    
Share-based compensation expense 146,000   146,000  
Common Stock repurchased & retired (129,000) (1,000) (128,000)  
Common Stock repurchased & retired (in Shares)   (109,763)    
Stock options exercised 16,000   16,000  
Stock options exercised (in Shares)   13,333    
Net income 192,000     192,000
Balance at June 30, 2011 at Jun. 30, 2011 $ 35,737,000 $ 223,000 $ 23,538,000 $ 11,976,000
Balance at June 30, 2011 (in Shares) at Jun. 30, 2011 22,327,855 22,327,855    
[1] The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date.
XML 28 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Note 1 - The Company
3 Months Ended
Jun. 30, 2011
Nature of Operations [Text Block]
1.
The Company

Alpha Pro Tech, Ltd. (“Alpha Pro Tech” or the “Company”) is in the business of protecting people, products and environments.  The Company accomplishes this by developing, manufacturing and marketing a line of disposable protective apparel for the cleanroom, industrial and pharmaceutical markets, a line of building supply products for the new home and re-roofing markets and a line of infection control products for the medical and dental markets.

The Disposable Protective Apparel segment consists of a complete line of shoecovers, bouffant caps, coveralls, gowns, frocks and lab coats.

The Building Supply segment consists of construction weatherization products, such as housewrap and synthetic roof underlayment.

The Infection Control segment consists of a line of face masks and eye shields.  It previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.

The Company’s products are sold both under the "Alpha Pro Tech" brand name, as well as under private label, and are predominantly sold in the United States of America (“U.S.”).

XML 29 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Balance Sheets (Unaudited) (USD $)
Jun. 30, 2011
Dec. 31, 2010
Current assets:    
Cash and cash equivalents $ 6,431,000 $ 5,316,000 [1]
Accounts receivable, net of allowance for doubtful accounts of $62,000 at June 30, 2011 and $77,000 at December 31, 2010 5,706,000 3,816,000 [1]
Inventories 15,120,000 17,318,000 [1]
Prepaid expenses and other current assets 3,559,000 3,719,000 [1]
Deferred income taxes 443,000 443,000 [1]
Total current assets 31,259,000 30,612,000 [1]
Property and equipment, net 3,832,000 4,162,000 [1]
Goodwill 55,000 55,000 [1]
Intangible assets, net 144,000 164,000 [1]
Equity investments in and advances to unconsolidated affiliates 2,175,000 1,941,000 [1]
Total assets 37,465,000 36,934,000 [1]
Current liabilities:    
Accounts payable 620,000 487,000 [1]
Accrued liabilities 469,000 296,000 [1]
Total current liabilities 1,089,000 783,000 [1]
Deferred income taxes 639,000 639,000 [1]
Total liabilities 1,728,000 1,422,000 [1]
Shareholders’ equity:    
Common stock, $0.01 par value, 50,000,000 shares authorized, 22,327,855 and 22,424,285 issued and outstanding at June 30, 2011 and December 31, 2010, respectively 223,000 224,000 [1]
Additional paid-in capital 23,538,000 23,504,000 [1]
Retained earnings 11,976,000 11,784,000 [1]
Total shareholders’ equity 35,737,000 35,512,000 [1]
Total liabilities and shareholders’ equity $ 37,465,000 $ 36,934,000 [1]
[1] The consolidated balance sheet as of December 31, 2010 has been prepared using information from the audited financial statements at that date.
XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.11 Html 18 84 1 true 3 0 false 3 true false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.alphaprotech.com/role/DocumentAndEntityInformation Document And Entity Information false false R2.htm 001 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://www.alphaprotech.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets (Unaudited) false false R3.htm 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.alphaprotech.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Unaudited) (Parentheticals) false false R4.htm 003 - Statement - Consolidated Income Statements (Unaudited) Sheet http://www.alphaprotech.com/role/ConsolidatedIncomeStatement Consolidated Income Statements (Unaudited) false false R5.htm 004 - Statement - Consolidated Statements of Shareholders’ Equity (Unaudited) Sheet http://www.alphaprotech.com/role/ShareholdersEquityType2or3 Consolidated Statements of Shareholders’ Equity (Unaudited) false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.alphaprotech.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 006 - Disclosure - Note 1 - The Company Sheet http://www.alphaprotech.com/role/Note Note 1 - The Company false false R8.htm 007 - Disclosure - Note 2 - Basis of Presentation Sheet http://www.alphaprotech.com/role/Note0 Note 2 - Basis of Presentation false false R9.htm 008 - Disclosure - Note 3 - Stock Based Compensation Sheet http://www.alphaprotech.com/role/Note00 Note 3 - Stock Based Compensation false false R10.htm 009 - Disclosure - Note 4 - New Accounting Standards Sheet http://www.alphaprotech.com/role/Note000 Note 4 - New Accounting Standards false false R11.htm 010 - Disclosure - Note 5 - Inventories Sheet http://www.alphaprotech.com/role/Note0000 Note 5 - Inventories false false R12.htm 011 - Disclosure - Note 6 - Equity Investments in and Advances to Unconsolidated Affiliates Sheet http://www.alphaprotech.com/role/Note00000 Note 6 - Equity Investments in and Advances to Unconsolidated Affiliates false false R13.htm 012 - Disclosure - Note 7 - Accrued Liabilities Sheet http://www.alphaprotech.com/role/Note000000 Note 7 - Accrued Liabilities false false R14.htm 013 - Disclosure - Note 8 - Basic and Diluted Net Income Per Share Sheet http://www.alphaprotech.com/role/Note0000000 Note 8 - Basic and Diluted Net Income Per Share false false R15.htm 014 - Disclosure - Note 9 - Activity of Business Segments Sheet http://www.alphaprotech.com/role/Note00000000 Note 9 - Activity of Business Segments false false All Reports Book All Reports Process Flow-Through: 001 - Statement - Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Process Flow-Through: 003 - Statement - Consolidated Income Statements (Unaudited) Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) apt-20110630.xml apt-20110630.xsd apt-20110630_cal.xml apt-20110630_def.xml apt-20110630_lab.xml apt-20110630_pre.xml true true EXCEL 31 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P,39B9C=C8U]E-3)B7S0W8F9?.6(U9E]D9&0X M-F8P.3EA8S$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7U-H M83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,5]4:&5?0V]M<&%N>3PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,E]"87-I#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?.%]"87-I8U]A;F1?1&EL=71E M9%].971?23PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?.5]!8W1I=FET>5]O9E]"=7-I;F5S#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O6QE#I!8W1I M=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0 M&UL/CPA M6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G M92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7S`Q-F)F-V-C7V4U,F)?-#=B9E\Y8C5F7V1D9#@V9C`Y.6%C,0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P,39B9C=C8U]E-3)B7S0W M8F9?.6(U9E]D9&0X-F8P.3EA8S$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^04Q02$$@4%)/(%1%0T@@ M3%1$/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!6 M;VQU;G1A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P,39B9C=C8U]E M-3)B7S0W8F9?.6(U9E]D9&0X-F8P.3EA8S$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,#$V8F8W8V-?934R8E\T-V)F7SEB-69?9&1D.#9F,#DY M86,Q+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA M2!I;G9E&5S/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XV,SDL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF5D+"`R M,BPS,C3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E2!I;B!I;F-O;64@;V8@=6YC M;VYS;VQI9&%T960@869F:6QI871E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#8L,#`P/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S&5R8VES960\+W1D/@T*("`@("`@ M("`\=&0@8VQA&5R8VES960@*&EN M(%-H87)E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!S=&]C M:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPP M,#`\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@86QI M9VX],T1C96YT97(@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P M86-I;F<],T0P(&ED/3-$:&%N9VEN9VEN9&5N="TT('=I9'1H/3-$,3`P)2!S M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^#0H@(`T*("`@("`@("`\='(@=F%L:6=N/3-$=&]P('-T M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R<^#0H@("`@#0H@("`@("`@("`@ M/'1D('-T>6QE/3-$)U=)1%1(.B`S-G!T)SX-"B`-"B`@("`@("`@("`@(#QD M:78@3X-"B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^5&AE#0H@("`@(`T*("`@("`@("`@("`@("!#;VUP M86YY/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`- M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY!;'!H80T*("`@("`-"B`@("`@(%!R;R!496-H+"!,=&0N("@F(S@R M,C`[06QP:&$@4')O(%1E8V@F(S@R,C$[(&]R('1H90T*(`T*("`@("`@)B,X M,C(P.T-O;7!A;GDF(S@R,C$[*2!I0T*("`-"B`@("`@ M(&%C8V]M<&QI2!P M3X-"B`@(`T* M("`@("`@/&9O;G0@3X-"B`@ M(`T*("`@("`@/&9O;G0@3X-"B`@(`T* M("`@("`@/&9O;G0@2!S;VQD(&EN('1H M92!5;FET960@4W1A=&5S(&]F($%M97)I8V$-"B`@#0H@("`@("`H)B,X,C(P M.U4N4RXF(S@R,C$[*2X\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^/&)R+SX\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@ M(`T*("`@("`@:6YT97)I;2!F:6YA;F-I86P@:6YF;W)M871I;VX@:6YC;'5D M960@:&5R96EN(&ES('5N875D:71E9#L-"B`-"B`@("`@(&AO=V5V97(L('1H M92!I;F9O2!T;R!P0T*(`T*("`@("`@;V8@=&AE($-O;7!A;GDF(S@R,3<[65A"!M;VYT:',@96YD960@2G5N M92`S,"P-"B`@("`-"B`@("`@(#(P,3$@87)E(&YO="!N96-E2!I M;F1I8V%T:79E(&]F('1H92!R97-U;'1S('1O(&)E#0H@("`-"B`@("`@(&5X M<&5C=&5D(&9O2!'04%0(&9O7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R<^#0H@("`@#0H@("`@("`@("`@/'1D('-T>6QE/3-$)U=)1%1(.B`S-G!T M)SX-"B`-"B`@("`@("`@("`@(#QD:78@3X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4W1O8VL-"B`@ M#0H@("`@("`@("`@("`@($)A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@ M("`@0V]M<&%N>2!M86EN=&%I;G,@82!S=&]C:R!O<'1I;VX@<&QA;B!U;F1E M0T*("`@#0H@("`@("!M87D@9W)A;G0@:6YC M96YT:79E('-T;V-K(&]P=&EO;G,@86YD(&YO;BUQ=6%L:69I960@65E65E#0H@("`-"B`@("`@(&1I6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U! M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T* M("`@("`@0V]M<&%N>2!A9&]P=&5D('1H92!&:6YA;F-I86P@06-C;W5N=&EN M9R!3=&%N9&%R9',@0F]A65E('-T;V-K#0H@(`T*("`@("`@;W!T:6]N2!R96-O9VYI>F5D("9N8G-P.R0Q-#8L,#`P(&%N9`T*("`@(`T*("`@ M("`@)FYB6QE M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@ M,'!T)R!A;&EG;CTS1&IU6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&]C:PT*("`@("`-"B`@("`@(&]P M=&EO;G,@=&\@<'5R8VAA2XF(S$V,#LF(S$V,#M!6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@("`@ M0V]M<&%N>2!U2!U6UE;G0L/"]F;VYT/B!F;W(@97-T:6UA=&EN9R!T:&4@ M97AP96-T960@;&EF92!O9B!T:&4-"B`@(`T*("`@("`@;W!T:6]N2!I'!E8W1E9"!L M:69E(&EN#0H@(`T*("`@("`@>65A6]U M="!R871I;R!O9B!Z97)O+"!A2!H87,@;F]T('!A:60@ M9&EV:61E;F1S#0H@#0H@("`@("!I;B!T:&4@<&%S="!A;F0L(&%T('1H:7,@ M=&EM92P@9&]E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@("`@ M9F]L;&]W:6YG('1A8FQE('-U;6UA"!M;VYT:',@96YD960@2G5N M92`S,"P@,C`Q,3H\+V9O;G0^#0H@#0H@("`@/"]D:78^/&)R+SX\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#@P)2!S M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^#0H@#0H@("`@("`@(#QT6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U) M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@ M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E M&5R8VES93PO9F]N M=#X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)R!A;&EG;CTS1&-E;G1E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E<@T*("`@ M(`T*("`@("`@("`@("`@("`S,2P@,C`Q,#PO9F]N=#X-"B`-"B`@("`@("`@ M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR+#4T,BPP,#`\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS+C$W/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,3,L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ+C(S/"]F;VYT/@T*("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@ M(`T*("`@("`@("`\='(@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE'!I6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ+C4S/"]F;VYT/@T*("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY*=6YE#0H@("`@(`T* M("`@("`@("`@("`@("`S,"P@,C`Q,3PO9F]N=#X-"B`-"B`@("`@("`@("`@ M(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR+#4Q,2PP,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M+C8T/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY* M=6YE#0H@("`@(`T*("`@("`@("`@("`@("`S,"P@,C`Q,3PO9F]N=#X-"B`- M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T* M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#,W-RPP,#`\+V9O;G0^#0H@("`- M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+C8S/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@/"]T86)L93X\8G(O M/CQD:78@3X-"B`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\P,39B9C=C8U]E-3)B7S0W8F9?.6(U9E]D9&0X-F8P.3EA8S$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#$V8F8W8V-?934R8E\T-V)F7SEB M-69?9&1D.#9F,#DY86,Q+U=O'0O:'1M;#L@8VAA65T($%D;W!T960@6U1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@86QI9VX],T1C M96YT97(@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<] M,T0P(&ED/3-$:&%N9VEN9VEN9&5N="TW('=I9'1H/3-$,3`P)2!S='EL93TS M1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^#0H@(`T*("`@("`@("`\='(@=F%L:6=N/3-$=&]P('-T>6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R<^#0H@("`@#0H@("`@("`@("`@/'1D('-T M>6QE/3-$)U=)1%1(.B`S-G!T)SX-"B`-"B`@("`@("`@("`@(#QD:78@3X-"B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^3F5W#0H@("`@(`T*("`@("`@("`@("`@("!!8V-O=6YT:6YG M(%-T86YD87)D6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE)SY#;VYS;VQI9&%T:6]N2!H87,@=&AE('!O=V5R('1O M(&1I28C.#(Q-SMS(&5C;VYO;6EC('!E M2!Q=6%L:71A=&EV92!W:6QL(&)E M(&UO2!H87,@82!C;VYT&ES=&EN9R!D:7-C;&]S=7)E M&-E<'0@9F]R('1H92!D:7-C;&]S=7)E6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M)SY%9F9E8W0@;V8-"B`@(`T*("`@("`@1&5N;VUI;F%T:6YG('1H92!%>&5R M8VES92!06UE;G0-"B`@(`T*("`@ M("`@07=A2!396-U2!4 M2=S(&5Q=6ET>2!S96-U2!C;&%S6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);@T*("`- M"B`@("`@($1E8V5M8F5R(#(P,3`L('1H92!&05-"(&ES6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY);G1A;F=I8FQE M6EN9R!!;6]U;G1S/"]F;VYT/BP@=VAI8V@@;6]D:69I97,@4W1E<"`Q(&]F M('1H90T*(`T*("`@("`@9V]O9'=I;&P@:6UP86ER;65N="!T97-T(&9O6EN9R!A;6]U;G1S+B!&;W(@=&AO&ES M=',L(&%N(&5N=&ET>2!S:&]U;&0-"B`@#0H@("`@("!C;VYS:61E65A2!R97-U;'1I;F<@ M9V]O9'=I;&P@:6UP86ER;65N="!S:&]U;&0@8F4@2!G;V]D=VEL;"!I;7!A:7)M96YT6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY790T*("`-"B`@("`@('!E2!R979I97<@;F5W(&%C8V]U M;G1I;F<@7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^-2X\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D M:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT M9#X-"B`-"B`@("`@("`@("`@(#QD:78@86QI9VX],T1J=7-T:69Y/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^2G5N90T*(`T*("`@("`@("`@ M("`@("`S,"P\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T* M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$S)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1&5C96UB97(- M"B`@("`@#0H@("`@("`@("`@("`@(#,Q+#PO9F]N=#X-"B`-"B`@("`@("`@ M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q M,#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\ M='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO M='(^#0H@("`@(`T*("`@("`@("`\='(@#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$ M1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:6YI6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L M:6=N/3-$"<^#0H@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-2PQ,C`L,#`P/"]F;VYT/@T*("`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@ M("`@("`@/&9O;G0@'1087)T7S`Q-F)F-V-C7V4U,F)?-#=B9E\Y8C5F7V1D9#@V9C`Y.6%C M,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P,39B9C=C8U]E-3)B M7S0W8F9?.6(U9E]D9&0X-F8P.3EA8S$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!-971H;V0@26YV97-T;65N=',@1&ES M8VQO6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R<^ M#0H@#0H@("`@("`@("`@("`\=&0@3X-"B`@(`T*("`@ M("`@/&9O;G0@6YT:&5T:6,@6UE;G0@86YD#0H@("`-"B`@("`@('!R M;W9I9&5S(&9U='5R92!C87!A8VET>2!F;W(@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4 M:&4-"B`@(`T*("`@("`@8V%P:71A;"!FF5D('1O#0H@ M("`@#0H@("`@("!P=7)C:&%S92!A;B!E>&ES=&EN9R`S,RPP,#`@'!A;F1E M9"!B>2!A(#,X+#4P,`T*("`@#0H@("`@("!S<75A2!B=6EL="!A#0H@("`@(`T*("`@("`@-C`L,#`P('-Q M=6%R92!F;V]T(&9A8VEL:71Y(&EN($EN9&EA(&9O2!(87)M;VYY('=I=&@@;F\@9W5A3X-"B`@(`T* M("`@("`@/&9O;G0@2!T;R!D971E3X-"B`@(`T*("`@("`@/&9O;G0@2!I3X-"B`@(`T*("`@("`@/&9O;G0@2!A6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@ M(`T*("`@("`@0V]M<&%N>2!R979I97=S(&%N;G5A;&QY(&ET6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY);G9E2!-971H;V0@86YD($IO:6YT M(%9E;G1U2XF(S$V M,#LF(S$V,#M);B!D971E2P@=&AE($-O;7!A M;GD@8V]N2!O<&5R871E3X-"B`@(`T*("`@("`@/&9O;G0@2!I;G9E65A3X-"B`@(`T*("`@("`@/&9O;G0@ M2P- M"B`-"B`@("`@(')E2P@9G)O;2!(87)M;VYY+B8C,38P.R8C M,38P.T9O2P@2X\+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@ M3X-"B`@(`T*("`@("`@/&9O;G0@ M2!R96-O28C.#(Q-SMS(&EN=F5S=&UE;G0@:6X@2&%R;6]N>2!W M87,@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P,39B9C=C8U]E-3)B7S0W8F9?.6(U9E]D9&0X-F8P.3EA M8S$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#$V8F8W8V-?934R M8E\T-V)F7SEB-69?9&1D.#9F,#DY86,Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)TQ)3D4M2$5)1TA4.B`Q M+C(U.R<^#0H@("`-"B`@("`@("`@("`@("`@/'1D('-T>6QE/3-$)U=)1%1( M.B`S-G!T)SX-"B`@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^#0H@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)TQ)3D4M2$5)1TA4 M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^,C`Q,3PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T* M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58 M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#;VUM:7-S:6]N#0H@("`-"B`@("`@("`@("`@("`@ M86YD(&)O;G5S(&%C8W)U86P\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@ M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY,"PP,#`\+V9O;G0^#0H@("`@(`T* M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXT."PP,#`\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^ M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)V)A8VMG6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY!8V-R=65D#0H@("`@(`T*("`@("`@("`@ M("`@("!P6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^ M#0H@("`@(`T*("`@("`@("`\='(@"<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@ M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@ M("`@(`T*("`@("`@/"]T86)L93X\8G(O/CQD:78@3X-"B`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&5C=71I=F4@3V9F:6-E'!E;G-E+B8C,38P.R8C,38P.T5X96-U M=&EV90T*(`T*("`@("`@8F]N=7-E"!M;VYT:',@96YD960@2G5N90T*("`@#0H@ M("`@("`S,"P@,C`Q,2XF(S$V,#LF(S$V,#M4:&4@0VAI968@17AE8W5T:79E M($]F9FEC97(@86YD#0H@(`T*("`@("`@4')E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^."X\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@("`@("`@ M("`\+V1I=CX-"B`@(`T*("`@("`@("`@("`@("`@("`@/"]T9#X-"B`@("`@ M#0H@("`@("`@("`@("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U7 M14E'2%0Z(&)O;&0G/D)A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@("`@ M9F]L;&]W:6YG('1A8FQE('!R;W9I9&5S(&$@6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@"<^ M#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=( M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E M;G1E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58 M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4 M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M<'@@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q M,3PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@ M(`T*("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"87-I8PT*("`@#0H@("`@ M("`@("`@("`@('=E:6=H=&5D(&%V97)A9V4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR,BPT,C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,BPT,C,L-S@X/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^ M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)V)A8VMG#L@5$585"U)3D1% M3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0[ M($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!9&0Z#0H@(`T*("`@("`@("`@("`@("!$:6QU M=&EV92!E9F9E8W0@;V8@;W5T"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXT-#0L-S4R/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@"<^#0H@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0G M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR,BPT,S$L,#`Y/"]F;VYT/@T*("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P M<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@ M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`R/"]F;VYT/@T* M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P M<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@ M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP M+C`Q/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@/"]T86)L93X\8G(O M/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O M9B!"=7-I;F5S'0^/'1A M8FQE(&%L:6=N/3-$8V5N=&5R(&)O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^.2X\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@("`@("`@("`\ M+V1I=CX-"B`@(`T*("`@("`@("`@("`@("`@("`@/"]T9#X-"B`@("`@#0H@ M("`@("`@("`@("`@("`@("`\=&0^#0H@("`@#0H@("`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E' M2%0Z(&)O;&0G/D%C=&EV:71Y#0H@("`@#0H@("`@("`@("`@("`@("`@("`@ M(&]F($)U6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@("`@0V]M<&%N M>2!O<&5R871E6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&IU6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!B;VQD)SY$:7-P;W-A8FQE#0H@("`@(`T*("`@("`@4')O M=&5C=&EV92!!<'!A0T*(`T*("`@("`@=V5A=&AEF%T:6]N('!R;V1U8W1S(&-O;G-I6YT:&5T:6,-"B`@("`@#0H@("`@("!R;V]F('5N9&5R;&%Y;65N="XF(S$V M,#LF(S$V,#M4:&4@0V]M<&%N>28C.#(Q-SMS(&5Q=6ET>2!I;@T*("`@#0H@ M("`@("!I;F-O;64@;V8@=6YC;VYS;VQI9&%T960@869F:6QI871E2D@:7,@:6YC;'5D960@:6X-"B`@#0H@("`@("!T:&4@=&]T86P@3X-"B`@(`T*("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/DEN9F5C M=&EO;@T*("`@(`T*("`@("`@0V]N=')O;#H\+V9O;G0^(&-O;G-I2!F;W(@=&AE(&UE9&EC86PL(&1E;G1A;"!A;F0@ M:6YD=7-T2!I;F-L=61E9"!A(&QI;F4@;V8@;65D:6-A;`T*("`@ M("`-"B`@("`@(&)E9"!P861S(&%N9"!P970@8F5D6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&IU6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY396=M96YT#0H@(`T*("`@("`@9&%T82!E>&-L M=61E2!E=F%L=6%T97,@=&AE('!E3X-"B`@(`T*("`@("`@/&9O;G0@"!M;VYT M:',@96YD960@2G5N92`S,"P@,C`Q,2!A;F0@,C`Q,"P-"B`@("`@#0H@("`@ M("!R97-P96-T:79E;'DZ/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\ M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS M1#DU)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^#0H@#0H@("`@("`@(#QT6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@ M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=( M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U! M4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU M"!-;VYT:',@16YD960\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@ M("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,3PO9F]N=#X-"B`@ M("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=, M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&-E;G1E"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@"<^#0H@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T* M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^,C`Q,#PO9F]N=#X-"B`@("`-"B`@("`@("`@ M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO M='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X-"B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"B`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY$:7-P;W-A8FQE#0H@("`-"B`@("`@("`@("`@("`@4')O M=&5C=&EV92!!<'!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR+#@W,2PP,#`\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXY+#DR.2PP,#`\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"=6EL9&EN9PT*(`T*("`@ M("`@("`@("`@("!3=7!P;'D\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\ M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV+#,U-BPP,#`\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T* M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@"<^#0H@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@"<^#0H@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PR-S@L,#`P/"]F;VYT/@T* M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`- M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,2PR M,C$L,#`P/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ.2PR,C,L,#`P/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,BPX-3`L,#`P/"]F;VYT/@T* M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@ M("`@9F]L;&]W:6YG('1A8FQE('-H;W=S('1H92!R96-O;F-I;&EA=&EO;B!O M9B!T;W1A;"!S96=M96YT#0H@("`@#0H@("`@("!I;F-O;64@=&\@=&]T86P@ M8V]N6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<^#0H@(`T*("`@("`@("`@ M("`@/&9O;G0@"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M"<^#0H@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)TQ)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"!-;VYT:',@16YD960\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@ M(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^2G5N90T*(`T*("`@("`@("`@("`@("`S,"P\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@(`T*("`@("`@("`@("`@ M/&9O;G0@"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@+3(W<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O M;G0@"<^#0H@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@+3(W<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@(`T* M("`@("`@("`@("`@/&9O;G0@"<^#0H@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,#PO9F]N=#X-"B`@("`-"B`@("`@ M("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@ M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24@6QE/3-$ M)V)A8VMG3PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@ M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@#L@5$585"U)3D1%3E0Z(#!P M=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F9E8W1I;VX-"B`@ M#0H@("`@("`@("`@("`@($-O;G1R;VP\+V9O;G0^#0H@("`@(`T*("`@("`@ M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,3DL M,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@ M("`@(`T*("`@("`@("`\='(@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#,X,BPP,#`\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5 M;F%L;&]C871E9`T*("`@(`T*("`@("`@("`@("`@("!C;W)P;W)A=&4\+V9O M;G0^(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SYO=F5R:&5A M9"8C,38P.R8C,38P.V5X<&5N6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`- M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T* M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@ M("`\+W1D/@T*("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T* M("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`- M"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T* M("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS,#0L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXS-S(L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^ M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ.3(L,#`P/"]F;VYT/@T*(`T*("`@("`@ M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#`U."PP,#`\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@/"]T86)L93X\8G(O M/CQD:78@3X-"B`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=, M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,3PO M9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@ M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)R!A;&EG;CTS1&-E;G1E"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXW,C@L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@ M("`@(`T*("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#$W,RPP,#`\+V9O M;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@ M("`\='(@#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY);F9E8W1I;VX-"B`@#0H@("`@("`@("`@("`@($-O;G1R;VP\ M+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+#`S."PP,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&%L:6=N/3-$"<^#0H@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;`T*("`@ M#0H@("`@("`@("`@("`@('-E9VUE;G0@87-S971S/"]F;VYT/@T*("`-"B`@ M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY5;F%L;&]C871E9`T*("`@(`T*("`@("`@("`@("`@("!C;W)P;W)A M=&4@87-S971S/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@ M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXY,BPP,#`\+V9O;G0^#0H@("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@#L@5$585"U) M3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A M;`T*("`@#0H@("`@("`@("`@("`@(&-O;G-O;&ED871E9"!A6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@ M/"]T86)L93X\8G(O/CQD:78@3X- M"B`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY/;@T*("`@(`T*("`@("`@("!&96)R=6%R>2`X+"`R,#$Q+"!T:&4@0V]M M<&%N>2!E;G1E2!R96-E:79E M9"`F;F)S<#LD,C,U+#`P,"P@=VAI8V@-"B`-"B`@("`@("`@=V%S(&-O;7!R M:7-E9"!O9B`F;F)S<#LD,3@Q+#`P,"!O9B!I;G9E;G1O&5C=71E9"!I;B!T:&4@=&AR964@ M;6]N=&AS(&5N9&5D($UA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM+2TM M/5].97AT4&%R=%\P,39B9C=C8U]E-3)B7S0W8F9?.6(U9E]D9&0X-F8P.3EA &8S$M+0T* ` end